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ABSTRACT
DEVELOPMENT AND MAINTENANCE OF THE THYMIC EPITHELIAL
MICROENVIRONMENT
By
Shami Chakrabarti
Advisor: Dr. Karen Hubbard
Co-advisor: Dr. Mark Pezzano
The thymus plays a critical role in adaptive immunity by providing a suitable microenvironment
for developing and selecting the functional self-tolerant T-cell population. Thymic epithelial cells
play an essential role in the development of a naïve, self-tolerant T-cell population. Paradoxically
thymus undergoes acute age-related involution, which in turn causes loss of functional T-cell
populations. Involution reduces the functionality of the thymus markedly, but the thymus can still
develop self-tolerant naïve T-cells. It is crucial to understand how the thymic microenvironment
is maintained to provide a suitable T-cell population for life. It has been previously demonstrated
that the thymic epithelial homeostasis is maintained by the thymic epithelial progenitor cells
(TEPCs). Apart from TEPCs, thymic microenvironment maintenance is also regulated via different
signal transduction pathways. In this current study, we focused on understanding the key players
in maintaining the thymic epithelial microenvironment. Our study challenged the established
dogma of thymus organogenesis. It demonstrated a unique hematopoietic stem cell derived bone
marrow population expressing pan-hematopoietic marker, CD45, and thymic epithelial cell
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marker, EpCAM, that can migrate to the thymus and differentiate into keratin-expressing thymic
epithelial cells.
Canonical Wnt signaling has been previously shown to be critical for thymocyte maturation
and proliferation in addition to maintenance of thymic epithelial architecture. Overexpression of
DKK1, a Wnt inhibitor, leads to loss of thymic progenitor and rapid thymic degeneration in the
thymus. Thus, Wnt signaling has involved the maintenance of adult thymic epithelial progenitor
cells. Therefore, we hypothesized Wnt signaling could also be involved in the fetal thymic
epithelial progenitor cell maintenance and development. But no characterization of the fetal thymic
epithelial cell undergoing Wnt signaling is documented. In this study, using a new H2BGFP Wnt
reporter model, we identified which specific thymic epithelial cell populations were undergoing
active canonical Wnt signaling during the critical crosstalk dependent stages of fetal thymic
development.
In summary, this study addresses the dual aspect of thymic epithelial microenvironment
maintenance. Identification of bone marrow derived TEPC and deciphering which TEC
populations undergo active Wnt signaling during fetal development equip future studies with a
better understanding of TEC development and maintenance. These data should provide additional
targets for overcoming thymic atrophy and hence the development of more strategic therapies for
immunological-based diseases and cancer.

v

DEDICATION

To my mother and father, and Dr. Seema Rawat, because you made me believe.
“তারার পােন চাইিব যখন
চাইিব ের েতার �াণখুেল!
ত� ই েক?- েসটা ত� � তখন
যাসেন েযন গান ভ�েল!
তারার কােছ হাত েপেতেছ েয, েস
েপৗ�েছ েগেছ সব েপেয়িছর েদেশ।“

vi

ACKNOWLEDGEMENTS

First, I gratefully acknowledge my advisor Dr. Mark Pezzano, who kindly opened his lab
door and took a chance on me when I was thinking about leaving this program. He has since
continuously helped me understand the intricacies of complex topics within immunology and
developmental biology. Furthermore, he has also guided me to implement this knowledge in my
research, allowing my project to be my own yet steering me in the right direction whenever he
thought I needed it.
I would also like to thank Dr. Karen Hubbard for showing me nothing but compassion and
support from the day I first met her. I am especially thankful to her for helping me cut the red tape
within our department, which is what ultimately allowed me to do my work with Dr. Pezzano. I
am also grateful to Dr. Hubbard for being a member of my thesis committee and sharing invaluable
scientific knowledge that helped me enrich my research. And of course, I am also immensely
grateful for my other thesis committee members and would like to thank Dr. Spatz, Dr. Ortiz, and
Dr. Sant’Angelo. Not only did they give up their precious time to evaluate my work, but they also
gave me invaluable feedback and insight that helped further advance my work.
I would like to acknowledge all the members of Dr. Pezzano's lab: Mohammed Hoque,
Neelab Meer, Daniel Pollacksmith, Edwin Ortiz, Carla Schwartz and Varan Singh. I am thankful
for both their support and contribution to my work. Without them, this project would not have
been successful. I would also like to extend my heartfelt gratitude to our Flow cytometry core
facility manager Jeffrey Walker, a colleague that turned into a friend. Without the endless support
that he gave at any time of the day without question, most of my experiments would have failed.

vii

I would additionally like to extend my heartfelt thanks to my girl tribe: Ritwika Biswas,
Nawshin Zara Jamil, Christine Chrissian, Sohani Dassharma, Divya Singh. I am proud to call this
bunch of strong, successful, compassionate women my friends. They held my head up when I was
drowning, pushed me forward when I was indecisive, called me out when I was wrong, and always
believed in me even when I had stopped believing in myself. I would not be writing this
Acknowledgments page without having these women in my life.
I would also like to extend a big hug to my nephew Rayan Dassharma and my four-legged
nieces Vivian Chrissian, Titli Adhikari, Chandni Adhikari for giving me the reason to smile even
in the most stressful of moments, and to thank Dr. Debashish Adhikari and Sarmistha Adhikari for
being there for me from the very first moment I entered this country: thank you for sharing your
immense knowledge of cooking, singing and molecular diagnostics; your amazing ideas for my
career, and your Bengali cuisine for when I was feeling homesick.
Lastly, I would like to thank my parents for being an endless source of support and for
giving me the privilege of chasing down my dreams. Without their constant support and
encouragement, none of this would be possible.
The research in this thesis was made possible by the following financial awards given
below:
NIH/NIAID award number 9SC1AI04994,
NIH-NCI award number 1U54CA137788,
NIH-NCRR/NIMHD award Numbers 5G12RR03060/ 8G12MD7603.

viii

PREFACE
This study explores the newfound plasticity of bone marrow (BM)- derived cell population. It
identifies a subpopulation in the bone marrow cell that can migrate to the thymus and contribute
to the thymic stroma's non-hematopoietic component. The thymus plays a critical role in T-cell
development, which is a significant component of adaptive immunity. Thymic epithelial cells
(TECs) and their interaction with the T-cell progenitor populations are essential for developing a
naïve, self-tolerant T-cell population (1). Interestingly, the thymus undergoes acute age-associated
involution, which in turn causes a loss of functional naïve T-cells; and even after such an
involution, the thymus remains capable of developing a limited number of self-tolerant naïve Tcells. Few studies have identified the fetal and adult thymic epithelial progenitor cell (TEPC)
population and the role of different signal transduction pathways in developing and maintaining
the thymic epithelial microenvironment. For example, It has been demonstrated before that the
postnatal thymus contains a medullary thymic epithelial stem cell population that maintains the
medullary homeostasis to provide a lifelong T-cell self-tolerance (1). Other studies also identified
the adult bi-potent TEC progenitor's presence, but their role in maintaining the thymic
microenvironment is still unclear (2, 3). Apart from the TEPCs, different signal transduction
pathways, specifically Wnt signaling, plays a vital role in maintaining the TEC cellularity.
Heinonen et al. 2011 demonstrated that the Wnt4 ligand is critical for maintaining TEC numbers
and forming proper medulla during fetal thymopoiesis and post-natal thymic expansion (4).
This research primarily focuses on identifying and characterizing a novel TEPC population
found within the hematopoietic stem cell (HSC)-derived bone marrow population. It also
demonstrates this population's migration to the thymus and its contribution to thymic stromal
components, including true EpCAM and Keratin-expressing TECs. The results presented
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challenge our current understanding of the thymic epithelial progenitors' origin, which are thought
to be exclusively derived from the third pharyngeal pouch's endodermal layer.
The work presented here also extends previously published work showing a critical role
for canonical Wnt signaling in maintaining the thymus and the thymic involution (5, 6). The work
presented here utilizes a new H2BGFP Wnt Reporter mouse to provide the first characterization
of active Wnt signaling during fetal thymic stroma development.
This dissertation discusses the following: Chapter 1 discusses the background information
about thymus organogenesis and function during T-cell development. Additionally, it describes
the plasticity of BM-derived cell populations and their capacity to contribute to various organs and
tissues. It also discusses what is known about the Wnt signaling pathway's role in the maintenance
of the thymic epithelial cells. Wnt signaling is the most affected pathway during thymic
involution(7). The chapter concludes with an overview and significance of this research. Chapter
2 focuses on explaining the different experimental procedures in my research. Chapter 3 describes
the identification of BM-derived thymic epithelial cell population and its ability to differentiate
into keratin-expressing TEC populations. Chapter 4 shows that the CD45+EpCAM+ cell from
bone-marrow is a thymic epithelial progenitor cell population and is derived from the
hematopoietic stem cell population. Chapter 5 focuses on characterizing what specific cells are
undergoing active canonical Wnt signaling during fetal thymus development. The study illustrates
changes in cells undergoing Wnt signaling during the period that crosstalk between the developing
thymocytes and the TECs shapes the development of distinct functional regions of the thymus
responsible for controlling T-cell development and selection.
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CHAPTER 1
INTRODUCTION
OVERVIEW
This study aims to identify and characterize a bone marrow population exhibiting both
hematopoietic and epithelial characteristics. This population can migrate to the thymus and
contribute to the thymic stroma. The next goal is to determine whether the CD45+EpCAM+
population in both thymus and BM is affected by aging as well as thymic reconstitution. The next
aim is to identify the lineage of CD45+EpCAM+ cells. Apart from TEPCs, the thymic epithelial
microenvironment is also maintained by several signal transduction pathways. Previously our lab
identified that the suppression of canonical Wnt signal transduction pathway causes loss of adult
thymic epithelial progenitor cell (6). This study's secondary goal is to determine which specific
fetal thymic epithelial cell population undergoes active Wnt signaling.
This chapter will provide the background information to explain the logic and motivation
behind this research. It is organized as follows. First, I will provide brief background information
about thymus organogenesis, thymic epithelial cell development, fetal and adult thymic progenitor
cell population, thymic involution, thymic function (T-cell development). Second, I will highlight
the discussion on the newfound plasticity of bone marrow cells (8) and ways my research will
support the presence of bone marrow derived epithelial stem cell population and dispute the current
understanding of the origin of thymic epithelial progenitors, which are thought to be exclusively
derived from the endodermal layer of the third pharyngeal pouch. Lastly, I will explain the Wnt
signaling pathway and its role in TEC maintenance in the postnatal thymus to provide an
understanding of why we chose to characterize this signal transduction pathway during fetal
thymus development.
1

1. BACKGROUND INFORMATION
1.1.THYMUS ORGANOGENESIS
The thymus plays a major role in building the adaptive immune system by controlling the
development of functional T-cells with a diverse repertoire of TCRs that can respond to a vast
array of foreign antigens (7). It is a bi-lobed primary lymphoid organ located in the thoracic cavity,
directly above the heart and behind the sternum (9). An accessory thymus in the cervical region
has been documented in both mice and humans (10, 11). The thymus is a sponge-like structure
filled with different types of hematopoietic cells in a network of stromal (non-hematopoietic) cells.
The thymus' non-hematopoietic cells mainly consist of epithelial cells, endothelial cells and
fibroblasts, and non-fibroblast mesenchymal cells (12). The hematopoietic cells mainly consist of
T-cells at different developmental stages and B-cells, macrophages, and dendritic cells.
Understanding the organogenesis of the thymus can lead to a better comprehension of how T-cell
development is regulated.
Thymus organogenesis in vertebrates is a complex, multi-step process that depends on the
interaction between different embryonic germ layers, including endoderm derived epithelium,
neuroectoderm derived neural crest cell mesenchyme, mesoderm derived hematopoietic cells, and
endothelial cells of the blood vessels. The first sign of thymus organogenesis is observed as early
as embryonic day 10 (E10) in mice, even though the initiation signaling starts at E9(13). In
humans, thymus organogenesis is initiated during the 6th gestational week(10, 14). Both mouse
and human thymi are derived from the anterior region of the foregut, the pharynx (15). The thymus
and parathyroid glands are derived from the bilateral organ primordia that arise from the 3rd
pharyngeal pouch in mice, and for humans, both the 3rd and 4th pharyngeal pouches are involved
(16). The common primordium is formed by the invagination of the pharyngeal pouches and
2

extending into the underlying tissue layer of the pharyngeal cleft. The ventral aspect of the
pharyngeal pouch gives rise to the thymic primordia. At E9.5-E10.5, the ectoderm and endoderm
layers come into contact with each other. At E11, the 3rd pharyngeal pouch area, which is destined
to be the thymus and the parathyroid gland begins to extend away from the pharyngeal arch.
Specific transcription factors are responsible for separating the common thymus and
parathyroid gland primordia. From E11.5 to E12.5, the thymic and parathyroid rudiments begin to
separate into different domains. The transcription factor, Forkhead box N1, FoxN1, drives the
thymus development, while another transcription factor, Glial cells missing homolog 2, Gcm2,
drives the parathyroid gland development. It is still not clear how this differential expression is
established in the common primordia (17). But it has been shown that in terms of thymic rudiment
development, BMP (18-20), Shh (21), and Wnt signaling (22) play an important role (23). By E
13 in mouse embryos, the thymus primordia separate from the pharynx and travel to the anterior
chest cavity, also separating from the parathyroid primordia at the same time. The thymic
primordium gives rise to the thymic epithelial rudiment, the primary source of thymic epithelial
cells.
The thymic epithelial cells and the thymic mesenchymal cell are derived from different
parts of the pharynx. The endodermal layer of the 3rd pharyngeal pouch gives rise to the entire
thymic epithelial rudiment (12). The pharyngeal arch also plays a role in the formation of the
thymus primordia. The mesenchymal cells in the pharyngeal arch are derived from neural crest
cells (NCCs) (13, 23). The thymic primordia's epithelial rudiment is encapsulated with the
mesenchymal cells derived from the NCCs (24). Apart from forming perivascular regions of the
thymus, mesenchymal cells also contribute to the interlobular septae. Mesenchymal cells derived
from the NCCs are essential for the proper development of the thymus through inductive effects
3

of the growth factors (23, 25). Studies have shown that surgical removal of the chicken neural
crest, which helps develop the 3rd,4th, and 6th pharyngeal arch, results in impaired thymus
development (26). The thymic epithelial primordia of these NCCs impaired animals either do not
develop or are comparatively smaller than normal animals (26). These defective epithelial
primordia are not capable of inducing lymphoid precursor cell proliferation and differentiation
(26). A lineage study in transgenic mice confirmed NCCs contributes to the capsule and
perivascular space. Also, mesenchymal cells present in the thymic anlage help develop the thymic
stroma (27).
Apart from the interaction of different germ layers, thymus development is also dependent
on a variety of different signaling molecules expressed in the endoderm layer that are involved in
thymus organ formation, including Homeobox A3 (Hoxa3); eyes absent homolog 1(Eya1); Paired
Box protein 1/9(Pax1/9); sine oculis homolog1/4(Six 1/4); T-box 1(Tbx1)(28-30). Transcription
factors Hoxa-3, Pax1/9, Eya1, and Six 1 are expressed simultaneously in the endoderm. Studies
working on mutant phenotypes of Hoxa3, Pax1/9, Eya1, and Six1 have shown that endodermal
primordia's development requires the cascade of transcription factors Hoxa3-Pax1/9-Eya1-Six1 to
initiate patterning of the pharyngeal pouch and also to initiate thymus organogenesis (23). Wnt
signaling plays an essential role in FoxN1 expression during the development of the thymus (31).
The thymus' size depends on Fibroblast Growth factor Receptor IIIb (FGFR-IIIb) signaling (32).
1.2. STRUCTURE OF THYMUS & THYMIC CELLULARITY
Thymic epithelial cells play an integral role in presenting self-MHC and self-peptides to
develop T cells and ensure MHC restriction and self-tolerance of the mature T cell repertoire. They
also assure the emergence of an appropriate number of naïve T-cells to the periphery. Thus, proper
organization and maintenance of the TECs are critical for a properly functioning adaptive immune
4

system. Understanding the signals and cell-to-cell interactions that control both the development
and postnatal maintenance of thymic epithelial cells is essential in the field of immunology.
The thymic anlage patterning creates regional division in the thymus and divides the thymic
stroma into three main compartments: 1) Cortex, 2) Medulla, and 3) Cortico-medullary junction.
The main component of each compartment is thymic epithelial cells. It should be noted here that
the thymic epithelial cells are very diverse in nature and function. Each compartment has a unique
TEC population along with other types of cells. The cortex is mainly composed of cortical thymic
epithelial cells (cTEC) and immature thymocyte subsets, and it is involved in the positive selection
during T-cell development. The thymic medulla is primarily composed of medullary thymic
epithelial cells (mTEC) and is involved in the negative selection of thymocytes expressing
autoreactive T-cell antigen receptors. The cortico-medullary junction is the perivascular space
between the cortex and the medulla. It is the entry point of the DN thymocytes into the thymus.
Fully mature SP naïve T-cells also exit to the peripheral blood vessels through this region (33). A
detailed discussion of the TECs, thymic mesenchymal cells, and their importance to the T-cell
development is provided in the following sections.
1.2.1. CORTEX & CORTICAL THYMIC EPITHELIAL CELL (cTEC)
The thymic cortex is made up of cortical thymic epithelial cells, cTECs, surrounded
by immature thymocytes. The cTECs provide a suitable microenvironment for the T cell
commitment, the αβ versus γδ lineage commitment, and the positive selection of double-positive
(CD4+CD8+) thymocytes (34). A unique set of proteins and receptors expressed by the cTECs
plays a crucial role in the function of the cortex. The cTECs are characterized by the expression of
epithelial cell adhesion molecule (EpCAM), cytokeratin 8 (K8), cytokeratin 18 (K18). Mature
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cTECs are characterized by a unique profile of surface markers, including Ly51/BP1, CD205, and
MHCII (34).
Mature cTECs express CC-chemokine ligand 25 (CCL25) and CX-chemokine ligand-12
(CXCL-12), which promote the homing of the DP thymocytes to the cortex (34-36). The cTECs
also express cytokines, including IL-7 (37, 38) and stem cell factor (SCF), which are essential for
the proliferation and survival of the T-cells (35). The cTECs also express the Notch ligand Deltalike ligand 4, which plays a critical role in thymocyte lineage commitment (35, 39, 40). Curiously,
DLL4 is not expressed homogenously in the cTECs. The DLL4 expression decreases with age and
may contribute to the decline of the T cells’ production, observed in the aging thymus (36, 39, 40).
The cTECs also express some unique proteins, including the thymoproteosome subunit β5t,
Ly51/BP1, Cathepsin L, thymus-specific serine proteases (TSSP) (34). This set of proteins are
essential for antigen processing and presentation for the positive selection of the developing Tcells.
For the positive selection of T-cells, the cTECs present self-antigen via MHC I and MHC
II molecules. During the Positive selection, a DP thymocyte must interact successfully with an
MHC II molecule and self-peptide complex to become a CD4+ T-cell, whereas CD8+ T-cells
interact with MHC I molecule and self-peptide complexes. Different proteins are involved in
producing the self-peptides presented on the MHCI or MHC II molecules (34). The Psmb11 gene
encodes the cTEC specific proteasome β5t, which is essential for the MHC I loading (34, 41). β5t
breaks down endogenous proteins and degrades them to be packaged into the MHC I molecule. In
Psmb11-/- mice, there was a marked reduction in the presence of the CD8+ thymocytes.
Additionally, while there was a small population of CD8+ cells, they showed impaired immune
function giving credence to the essential role of β5t in the CD8+ T-cell production and function
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(42-44). On the other hand, the MHC II loading is driven by the proteases cathepsin-L (uniquely
expressed in cTEC) (45) and the thymic specific serine protease (TSSP), which break down the
cytosolic proteins (44, 46, 47). These degraded products are then loaded into the MHC II molecule
in the endoplasmic reticulum and then transported to the cell's surface to be presented to the
developing thymocytes (44, 48).
A subset of cTECs forms multicellular complexes with developing DP thymocytes and is
termed thymic nurse cells (TNCs). The TNCs are several viable lymphoid cells completely
enveloped by the large cortical epithelial cells. This cell population was first reported by Wekerle
et al. in 1980 (49). The Thymic nurse cells provide a suitable microenvironment for the DP
thymocytes to undergo TCR (T-cell receptors) secondary rearrangements (50). Specific TNC
characteristics are not entirely defined. However, it has been observed that these complexes
express high levels of CXCL12 and vascular cell adhesion molecule 1 (VCAM1) (51).
1.2.2. MEDULLA & MEDULLARY THYMIC EPITHELIAL CELLS (mTEC)
The thymic medulla is composed of the medullary thymic epithelial cells and the medullary
dendritic cells, and the SP thymocytes. The mTEC population is highly heterogeneous in nature.
In the fetal thymus, the immature mTEC population expresses a high level of Claudin 3 and 4
(CLDN3/4). A subset of the CLDN3hiCLDN4hi population also expresses SSEA-1(stage specific
embryonic antigen-1) (34). This fetal mTEC population shows some clonogenic capacity (1). The
mature mTEC population is characterized as the Ulex Europaeus Agglutinin Type 1 (UEA-1)
binding subpopulation within the EpCAM+ TEC population. Apart from UEA-1 binding, mTECs
are also defined by cytokeratin 5 (K5), cytokeratin 14 (K14), CD80, AIRE (autoimmune
regulator), and Cathepsin-S (52). Mature mTECs also express K8. Postnatal mTECs, having two
major subpopulations defined by the expression level of MHC II and CD80: mTEC lo (MHC
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IIloCD80lo) and mTEChi (MHCIIhiCD80hi) (52). It was first assumed that the mTEC lo population
consists of immature cells only (53, 54). But later, it was shown that the mTEClo population is
heterogeneous in nature (52, 55). One mTEClo subpopulation expresses a high level of podoplanin
(PDPN) and the chemokine ligands Ccl21a, Ccl21b, Ccl21c (56). This subpopulation primarily
localizes in the cortico-medullary junction. Another mTEClo subpopulation expresses cytokeratin
10 (K10) and involucrin. It has been demonstrated that this population is a terminally differentiated
mTEC subset, which arises from the mTEChiAIRE+ population (34, 57). The mTEChi population
is also heterogeneous in nature. There two main subpopulations in the mTEChi population: 1)
AIRE+mTEChi, and 2) AIRE-mTEChi. mTEChi can be again subdivided according to tissue
restricted antigen (TRA) presentation. TRA antigen presentation can be AIRE-dependent or AIREindependent (58). Additionally, the Aire+mTEChi population can be further subdivided into two
populations depending on osteoprotegerin (OPG) expression. OPG maintains the size of the
thymus's medullary region by regulating the cellularity of the mTECs (52). The thymic medulla is
important for the T-cell development, as it provides the microenvironment for the development of
a self-tolerant T-cell antigen receptor repertoire (33). Thymocytes that have undergone proper
positive selection enter the medulla by following the chemokine signals produced by the mTECs,
mainly CCL21. In the medulla the mTECs and the mDCs drive the negative selection of SP
thymocytes.
The medullary thymic epithelial cells are critical for ensuring that the T-cell repertoire is
self-tolerant through the process of promiscuous gene expression (PGE). PGE is mediated by the
transcription factors Fez family Zinc finger protein 2, Fezf2 and the Autoimmune regulator, AIRE
(59-61). PGE promotes the expression of other tissue-specific genes that would not otherwise be
expressed in the thymus. These exogenous genes are termed as the Tissue specific antigens (TSA)
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or Tissue restricted antigens (TRAs). Presentation of TRAs informs the SP thymocytes on self vs.
non-self. Fezf2 and AIRE seem to produce some gene products that overlap but have many
mutually exclusive genes to either AIRE or Fezf2 (59).
As discussed previously, AIRE+ and Fezf2+ mTECs are responsible for the development
and survival of T-cells. Counterintuitively, for the mTECs to become an AIRE or Fezf2 expressing
cell, they also require T-cells signaling. It has been shown that the AIRE and Fezf2 are maintained
by the NF-κB (nuclear factor kappa-light-chain-enhancer of activated B cells) signaling pathway
(59, 62, 63). Rossi et al. 2007 have shown that the RANKL signals from CD4+ T-cells regulate
the development of AIRE+ mTECs (62). Takaba et al. 2015 have demonstrated that the LTβR
signaling leads to the Fezf2+ mTECs (59). In a contradictory study, Cosway et al. 2017
demonstrated that RANKL signaling promotes the development of Fezf2+ mTECs (63).
1.2.3. CORTICO-MEDULLARY JUNCTION
The cortico-medullary junction is the perivascular space between the cortex and medulla
of the thymus. This space is characterized by the presence of high numbers of blood vessels and
mature and immature thymocytes (64). It serves as the entry point of lymphoid progenitor cells to
the thymus through the blood vessels. From this region, the DN1 T-cell migrate towards the cortex
as they differentiate into DN2, DN3 cells rearrange and express the TCR as they progress. The
CMJ is also the mature single positive T-cells' exit point to the peripheral blood vessel (65). It has
been thought that the cortico-medullary junction contains the medullary TEC progenitor cells.
Klug et al.1998, showed a small population of the K5+K8+ TECs mostly present in the corticomedullary junction, which can give rise to the cortical thymic epithelial cells(K5-K8+) (66). Onder
et al. 2015 observed the cortico-medullary junction has a distinct population of mTEClo podoplanin

9

expressing cells. They characterized this cell population as lineage-committed mTEC progenitor
cells (67).
1.2.4. THYMIC MESENCHYMAL DERIVED CELLS
Apart from the thymic epithelial cells, the thymic stroma also contains mesenchymal cells.
It has been demonstrated that the thymic mesenchymal cells originate from the neural crest (NC)
by utilizing the bird embryos (68). During the thymic organogenesis at embryonic day 12 (E12),
the thymic epithelial rudiment gets surrounded by the NC derived mesenchymal cells. At E13, this
peri-thymic mesenchyme then migrates into the epithelial rudiment, forms a fibroblast network,
and contributes to the thymic capsule and septae (12, 69-71). The thymic mesenchymal cells are
essential for T-cell development (72, 73). Suniara et al. 2000 showed that E12 fetal thymus without
mesenchymal cells could not support T cell development beyond the double-negative stage (72).
Studies have shown that the NC cells are essential for thymus organogenesis (12, 74). It appears
that the mesenchymal cells not only induce T-cell development by providing soluble growth
factors on the extracellular matrix but also play a critical role in the development of the thymic
epithelial cells. There are two distinct mechanisms by which the mesenchymal cells can induce the
TEC development: 1) by helping T-cell maturation beyond the double-negative stage, which then
provides crosstalk for the TEC development; and 2) by directly supporting the development of the
immature thymic epithelial cells. Fibroblast growth factor (FGF) secreted by mesenchymal cells
can induce proliferation of FGF-receptor bearing epithelial cells. This epithelial-mesenchymal
interaction is critical during the development of epithelial cells in the limb bud and the
organogenesis of several organs like the lung and ear (70, 75). During embryogenesis,
mesenchymal cells in the thymus anlage produce FGF7 and FGF10, which helps in the
proliferation of epithelial cells expressing FGFR2IIIb (fibroblast growth factor receptor 2IIIb) (27,
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73, 76). Mesenchymal cells also induce the expression of the MHC class II molecules on the TECs
(77).
From the above discussion, it is evident that mesenchymal cells play an important role in
fetal thymus development. It is crucial for the embryonic immature thymic epithelial cell
development and differentiation. Mesenchyme derived fibroblasts also play an essential role in
thymocyte development in the adult thymus (73). Keratinocyte growth factor, KGF, also known
as Fibroblast growth factor 7, FGF7, administration in mice helps in regeneration of the thymus
following irradiation (78, 79). Rossi et al. 2007, showed that KGF helps in the proliferation of
mature and immature TECs in the adult thymus. KGF activates both the NF-κB and the p53
signaling pathways, which induce the production of several target genes, including BMP4, Wnt5b,
and Wnt10b. Both BMP4 and Wnt signaling are essential for TEC function (78). In a recent study,
Sun et al., 2015, have shown that in the adult thymus, a subpopulation of fibroblasts expressing
FSP1(Fibroblast specific protein 1) is involved the maintenance and proliferation of mTECs (80).
FSP1 is a cytoplasmic calcium-binding protein and belongs to the S100 superfamily. It is mainly
expressed in fibroblasts, but macrophages also express this protein (81). Previous studies have
shown the involvement of FSP-1 in the regeneration of the myocardium following injury (82).
Deletion of the FSP-1 gene disrupts the thymic structure and lowers the MHC class II expression
in TECs. FSP1-expressing fibroblasts induce TEC proliferation via IL-6, FGF7, and FSP1
signaling (80). FSP1 knock-out mice exhibit dramatical reduction in the mTEC number. It can
cause TEC regeneration following thymic injury (80). FSP1 is also recognized as an epithelialmesenchymal transition marker (83). The thymus undergoes age-related involution and
consequently weakening of adaptive immunity. Understanding the source of FSP1 cells and the
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mechanisms by which FSP1 promotes the TEC regeneration will help introduce new approaches
to regeneration of the aged thymus.
1.3. THYMIC EPITHELIAL PROGENITOR CELLS
1.3.1. FETAL THYMIC EPITHELIAL PROGENITOR CELLS
The origin of the thymic epithelial cell has always been a controversial issue. Previously it
was proposed that the TECs have a dual origin. The dual origin theory stated that the cTECs have
an ectodermal origin, whereas the mTECs are derived from the endoderm (23, 84-86). Different
morphological and histological studies, including analysis of nude mouse embryos (85) and the
study of chick-quail chimeras (68), supported the dual origin of the thymic epithelial cells. Later
it was demonstrated that the thymic epithelial cells are all derived from endoderm during fetal
development. Several lineage studies were done to prove the single origin of both cTECs and
mTECs (19, 87, 88). Rodewald et al. 2001 showed a common origin of cTEC and mTECs by
injecting embryonic stem cells in the blastocyst with different MHC II types (88). Later, Gordon
et al. 2002 experimentally proved that the thymic epithelial rudiment originates from the
endodermal layer of the third pharyngeal pouch by injecting tracking dye in the ectoderm and
observing its fate during embryogenesis (19, 84, 88). Gordon et al. 2004 transplanted the 3rd
pharyngeal pouch endodermal tissue under a nude mouse's kidney capsule in another study. 23-36
days post-transplantation, the endodermal layer gave rise to a functional thymic tissue. This study
definitively proved that the thymic epithelial rudiment is only derived from the endodermal layer.
It was previously demonstrated that even though the ectodermal layer does not contribute to the
thymic epithelial primordia, contact between endoderm and ectoderm is vital for the induction of
thymus organogenesis (13).
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Although the thymic epithelial rudiment's single origin was established, the developmental
processes leading to mature cTECs and mTECs are still not transparent. The single-origin theory
led to the hypothesis that both cTEC and mTEC populations originate from a common bi-potent
progenitor population in the thymus. A few studies have shown that in the fetal murine thymus, at
E12.5, all thymic epithelial cells express the same proteins, EpCAM1. In the 7-week-old fetal
human thymus, all epithelial cells express the A2B5 protein (a medullary thymic epithelial cell
marker in humans) (87). In the mouse fetal thymus, at E14.5, all the TECs express 4F1(a murine
cortical thymic epithelial cell marker) (89, 90). Several experimental approaches gave direct
evidence of subpopulations of cells expressing both cTEC and mTEC markers. First, Ropke et al.
1995, showed that the fetal murine thymic epithelial cells from E14.5 to E16.5 contain a small
subpopulation of cells that express both TR4( a cTEC marker) and TR5 (an mTEC marker) (87).
Later, Klug et al.1998, showed a small population of K5+K8+ TECs mostly present in the corticomedullary junction, which can give rise to cortical thymic epithelial cells(K5-K8+) (66).
In pursuit of further characterizing the thymic epithelial progenitor cell (TEPC), Gill et al.
2002 (91) and Bennet et al. 2002 (90) showed that MTS24 could be used as a marker for the thymic
epithelial progenitor cells. But their finding was disputed by Rossi et al. 2006, who later showed
that both MTS24+ and MTS24- cell populations isolated from murine fetal thymus could give rise
to the functional thymus (92). They also demonstrated the uniform expression of Plet-1 in the bipotent TEPCs (92). Depeter et al. 2008, showed that Plet-1 could be used as a marker for TEPCs
(93). The presence of a bi-potent progenitor cell population for the TECs was proven by Rossi et
al. 2006 when they performed a clonal analysis assay on individual EpCAM+eYFP+ E12 fetal
thymic cells and showed that EpCAM+eYFP+ thymic epithelial progenitor cell could give rise to
both cTECs and mTECs (92). From the studies mentioned above, it is apparent that during
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embryonic development, the fetal thymus contains a bi-potent thymic epithelial progenitor cell,
which gives rise to both cTECs and mTECs during thymus organogenesis. However, this
progenitor cell population's characteristics or whether it persists in the postnatal thymus are not
completely clear. Apart from identifying the fetal thymic epithelial progenitor cell population,
previous studies also recognized FoxN1 as an essential transcription factor for the fetal TEC
development.
FoxN1 seems to be the critical transcription factor for developing the thymic epithelial
cells, as shown by the lack of a functional thymus in FoxN1-/- (nude) mice. Although FoxN1 is not
required for the thymus organogenesis, it is essential for the epithelial rudiment committing to the
TEC lineage (94-96). Furthermore, in the FoxN1 rescue experiments, where the FoxN1 is turned
on later in the development, the adult mice have fully functioning thymuses (95, 97). Interestingly,
even though the thymic primordium is formed in the FoxN1-/- mice, committed TECs were not
observed. These data imply that the FoxN1 expression is not needed for early thymus
organogenesis (97), but it is crucial for developing and maintaining the thymic epithelial cells (9496). Blackburn et al. 1996, demonstrated with nude/wild-type chimeras that the Foxn1 gene acts
cell-autonomously in the thymic epithelial cell development (95, 96). Additionally, Rode et al.
2015 have shown that at least 94% of the thymic epithelial cells (defined by EpCAM) express
FoxN1 throughout gestation(96, 98). In the nude mouse, where the Foxn1 gene is mutated,
functional thymus development is inhibited. It has been shown that the FoxN1 gene is expressed
autonomously in the epithelial progenitor cells derived from the endoderm (95). O'Neil et al. 2016
showed FoxN1 is heterogeneously expressed in the fetal thymus. For example, Dec205+MHCIIhi
cells expressed more FoxN1 than UEA1+MHCIIhi cells. They also demonstrated downregulation
of FoxN1 expression is essential for mTEC divergence (99). Thymic epithelial progenitor cells
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lacking Foxn1 expression do not develop fully, but if the Foxn1 expression is rescued, it can give
rise to the fully developed thymus in adults (94, 100). Though the function of Foxn1 in the thymus
has been shown in different studies, how the Foxn1 expression is regulated in the thymic anlage
during embryogenesis is not fully understood. Bone Morphogenic Protein (BMP) expressed in the
endoderm plays a regulatory role in the Foxn1 expression. It has been shown that inhibition of
BMP signaling caused inhibition of Foxn1 expression in the thymic primordium (18, 101). Studies
have shown that the Wnt signal transduction pathway also plays a critical role in the FoxN1
expression (22). Studies have shown that Foxn1 is important in maintaining the adult thymic
epithelial cells in a dosage-dependent manner. Deleting Foxn1 in the adult thymic epithelial cells
causes rapid degeneration of the thymic architecture (94).
1.3.2. ADULT THYMIC EPITHELIAL PROGENITOR CELLS
While the presence of bi-potent TEC progenitors is apparent in the fetus, its existence in
the postnatal thymus is still the subject of debate. Earlier, it was believed that the adult thymus
does not have an epithelial progenitor cell population, unlike other epithelial tissues. Some studies
have shown an epithelial progenitor cell population in the adult thymus (102-104). Bleul. et al.
2006, showed that in the postnatal mouse, reversion of a Foxn1 mutant allele to wild type (WT) in
individual TECs could give rise to a fully functional thymus with both cortical and medullary areas
(100). Later, Ucar et al. 2014, argued that adult thymus stromal cells that exhibit a low cycling rate
and self-renewal capacity could form thymospheres containing both cTECs and mTECs (103).
Further, lineage-tracing experiments showed that they originate from FoxN1- cells (103).
Ulyanchenko et al. 2016, presented that the Ly-51+Plet-1+MHCIIhi cells are the TEPC population
in the adult thymus and exhibit stem cell-like properties (104). Several studies have shown that
some cTEC markers like Dec205 and β5t define the progenitor cell population of thymic epithelia
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(105, 106). These studies supported the serial progression model for the TEC development. The
first evidence of a lineage-committed TEC progenitor was shown by Rodewald et al. 2001 when
they showed the thymus medulla's formation from clonal islets (88). Hamazaki et al. 2007, later
revealed that the mTEC lineage-committed progenitor cells express a high level of Claudin 3 and
4 (107). In the case of a cTEC lineage-committed progenitor population, it was first thought that
DEC205+ cells are committed to the cTEC lineage. However, it was later shown that DEC205+
cells could give rise to both cTECs and mTECs (106). Two different studies reported that a β5texpressing progenitor population could give rise to most mTEC subpopulations (105, 108). Osada
et al. 2013, have previously utilized label retention to identify a stem cell-like population within
the postnatal thymus, which can differentiate into both TEC subsets in vivo as well as multiple
mesenchymal lineages including adipocyte, chondrocyte, and osteoblasts in vitro (109). The
following markers characterize this thymic mesenchymal stem cell-like(TMSC) population: Sca1,
CD49f, CD29, PDGFRα and CD90 (109). Wong et al. 2014, showed that an EpCAM+
subpopulation, which expresses an MHCIIlo Sca1+CD49f+ phenotype, of the adult thymus was
capable of self-renewal and can differentiate into cTECs and mTECs. Though there have been
extensive studies on the presence of adult TEPCs, no consensus has been formed on the definitive
characteristics of this population. Characterizing the TEPC population is important as they could
be used in therapeutics to improve thymic function.
1.4. FUNCTION OF THYMUS
The thymus's primary function is developing a functional self-tolerant T-cell repertoire
critical for the adaptive immune system (110). It has been shown that thymectomy in adult mice
results in severe immune deficiency (111, 112). At E12.5, the thymus receives its first influx of
the lymphoid progenitors fated to become T-cells. This first influx of cells originates from the fetal
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liver, where the bone marrow is yet to form (113). Another wave of the lymphoid progenitors
colonizes the thymus around E18 when the bone marrow has been appropriately formed (98). A
detailed discussion of T-cell development is provided in the following section.
1.4.1.T-CELL DEVELOPMENT
T-cell development exclusively happens in the thymus. The T-cell development process is
very dynamic and depends on the interaction of the thymocytes with a properly organized thymic
stroma (48). The thymus gives rise to two distinct T-cell lineages: αβ and γδ T-cells, which are
defined by the expression of αβ– or γδ–T cell receptor (TCR) complexes.
The lymphoid progenitor cells go through different developmental stages in the thymus to
form mature αβ–T-cells and γδ–T cells. The αβ–T-cell lineage gives rise to two distinct cell
lineages CD4+T -helper cells and CD8+ cytotoxic T-cells. The peripheral T-cell pool mainly
consists of αβ T-cells. In addition to αβ T –cells, the thymus is also involved in γδ–T cell
development. γδ–T cells are primarily found in epithelial and mucosal sites and lack expression of
the CD4 and CD8 co-receptors.
During the developmental process, T-cell undergoes a series of selection steps that direct
the differentiation process and determine the TCR repertoire. The distinct stages of T-cell
development include, 1) entry of the lymphoid progenitor cells at the cortico-medullary junction
of the thymus; 2) rearrangement and expression of the TCR genes during the progression through
the four double negative stages of T cell development defined by expression of CD44 and CD25;
3) α/β TCR+ CD4+CD8+ T-cell population (DP); 4) Positive selection of the double-positive Tcells in the thymus cortex;5) Negative selection of the positively selected SP T-cells in the thymic
medulla to produce self-tolerant T-cells; 5) emergence of mature naive T-cells from the thymus to
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the peripheral blood circulation (114-116). A detailed account for all the T-cell developmental
steps is given below.
In the first step of T-cell development, lymphocyte progenitor cells arrive in the thymus
through the blood system. Prenatally, lymphoid progenitor cells are derived from the fetal liver
and postnatally from the bone marrow. In mice, lymphoid progenitor cells arrive in the thymus as
early as embryonic day 12 (E12). The seeding of lymphoid progenitor cells in the thymus happens
in two different pathways of a vasculature-independent pathway and/or vasculature-dependent
pathway (114). In the vasculature independent pathway, before vascularization of the embryonic
thymus, lymphocyte progenitors are guided to the thymus in a chemotactic manner. Chemokines
including CCL21, CCL25, and Cxcl12 expressed in the early thymic primordia guide the T-cell
progenitors to the thymus and are critical to T-cell development (117, 118). Receptors for the three
chemokines- Ccr7, Ccr9, and Cxcr4 are expressed on the lymphocyte progenitors. Analysis of Tcell development in Ccl21 deficient mutant embryos decreased colonization of the thymus
rudiment at embryonic day 14. It has also been shown that the lack of expression of Ccr7, the
receptor for Ccl21, in T-lymphocyte progenitor cells has the same impact on recruitment (58). The
absence of both Ccr7 and Ccr9 results in a more substantial effect on the colonization of T-cells in
the thymus; however, postnatally, this deficiency does not impact the T-cell migration (119). These
studies show that both Ccl21 and Ccl25 are important for T-cell migration in the prenatal thymus
but are not required in the postnatal thymus. The deficiency of another chemokine, Cxcl12, and its
receptor Cxcr2 do not cause any substantial impairment in the T-cell colonization, still their
absence affects the expansion of thymocytes at the DN3, DN4, and DP stages during
embryogenesis (120, 121). In the postnatal thymus, T-lymphocyte progenitors enter the thymus
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through blood vessels at the cortico-medullary junction. Additionally, P-selectin contributes to the
homing of T-cell progenitors to the adult thymus (122).
After the T-cell progenitors enter the thymus' cortico-medullary junction, they move
through the cortex to the subcapsular zone (SCZ) of the outer cortex. During this movement, they
transition through distinct developmental stages defined by differential expression of CD44 and
CD25 including: DN1(CD4-CD8-CD44+CD25-); DN2(CD4-CD8-CD44+CD25+); DN3(CD4-CD8CD44-CD25+) DN4(CD4-CD8-CD44-CD25-). Once the lymphocyte progenitor cells enter the
thymus, they are known as early thymic progenitors (ETPs). These DN1 cells will receive Notch
signals from the cTECs to commit to the T-cell fate, at which point they will become DN2 cells.
DN1 and DN2 stage is mainly characterized by the active proliferation of the T-cell progenitor
population. Here the ETPs lose the potential to become myeloid and B fated cells. At DN2 stage,
β, γ, and δ loci start undergoing gene rearrangement by V-D-J recombination for TCR. The β locus
undergoes D β and J

β

rearrangement by Recombination Activating Gene, RAG-1 and RAG-2

(123). At the DN3 stage, the thymocytes continue their V-D-J rearrangement with Vβ to DJβ. ATt
this stage, these cells are fully and irreversibly committed to the T-cell fate. At this stage, invariant
Pre-TCRα chains are expressed on the cell surface. The DN3 thymocytes that can rearrange the
TCRβ properly can pass the first checkpoint of T-cell development. However, if this is
unsuccessful, the cell will undergo apoptosis (β-selection).
Furthermore, if the β-chain is rearranged first, the rearrangement of the β chain will cease,
and the γ-chain will be silenced if the γ-chain is rearranged first. Only 20% of the DN population
express γδ-TCR. Notch signaling plays a vital role in the development of αβ lineage. γδ–T cells
are less sensitive to the Notch signaling. Inhibitor of DNA binding 3, Id3 plays a prominent role
in γδ T-cell differentiation by integrating Notch and TCR signaling. Strong TCR signal promotes
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the γδ lineage, whereas pre-TCR signals, in collaboration with Notch, cause the repression of E
protein, E47, and promote the αβ lineage (33, 124). Notch 1, Notch-3 ligands are expressed
prominently during the DN3 stage. The pre-TCR-αβ pair is then associated with the CD3 molecule.
The pre-TCR: CD3 complex provides constitutive signaling without any interaction with ligand.
DN3 cells expressing the pre-TCR complex will induce inhibition of β-locus rearrangement. After
the DN3 to DN4 transition, cells undergo rapid proliferation and repression of RAG-1 and RAG2. After the rapid proliferation stage ends, RAG-1 and RAG -2 are transcribed again. Chemokine
receptors such as Ccr7, Ccr9, and Cxcr12 help in the migration of DN4 lymphocytes to the
thymus's cortex (114, 125, 126). Then the DN4 thymocytes transition to the DP cells by expressing
the co-receptors CD4 and CD8.
The DP stage of T-cell development is marked by the expression of co-receptor CD4 and
CD8 (33, 127). Usually, CD8 is expressed first, followed by CD4 expression. During the DP stage,
the α-chain, locus starts to rearrange and replaces the pre-T-α. The α-chain locus is structured in a
way that multiple V/J recombination events can happen simultaneously on the same allele, each
time resulting in the excision of previously recombined DNA (127). From this subset of DP
thymocytes, the final stages of the T- cell development start: Positive selection, MHC restriction,
CD4/CD8 lineage commitment, and Negative selection occur to form single positive thymocytes
with functional and self-tolerant T-cell receptors. Notch signal also plays a significant role in the
SP T-cell lineage commitment (127). The positive selection of the DP thymocytes is dependent on
both T-cell receptors and co-receptors. In the cortex, interleukin-7 signaling is vital for further Tcell development (128).
Positive selection of the DP thymocyte is vital for understanding if the rearranged TCR is
functional or not. The Cortical thymic epithelial cells and the dendritic cells mediate the positive
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selection process. These two antigen presenting cell (APC) populations express self-antigen and
MHC molecule complex on their surface. If the TCR on the DP thymocytes can recognize peptideMHC molecule complexes with low-avidity, DP thymocytes receive signals for further
development (114, 116). The threshold for TCR and peptide-MHC complex interaction is very
small. If the interaction is too strong or if there is no interaction, those DP cells will undergo death
by neglect. This interaction between the TCR of DP thymocytes and self-peptide: MHC molecule
complex represented on the surface of cTECs was observed utilizing two-photon laser
fluorescence microscopy (129). Positive selection induced signaling causes the DP thymocytes to
downregulate CD8 and develop CD4+CD8lo cells regardless of their interaction with MHC I or
MHC II molecules. Suppose the TCR on the thymocyte is specific to MHC II molecules. In that
case, the CD4 expression will provide a stronger signal, mediated by a lymphocyte-specific
protein-tyrosine kinase (Lck), which will cause further differentiation along the CD4 lineage.
However, if the cell is interacting with MHCI, it will not lead to CD4 signaling mediated by Lck,
which in turn will determine CD8 lineage commitment. Two transcription factors ThPOK (THelper-Inducing POZ/Krueppel-Like Factor) and Runx3 (Runt Related Transcription Factor 3),
play a regulatory role in CD4 vs. CD8 lineage commitment (127). After positive selection and
CD4/CD8 lineage determination, SP thymocytes undergo negative selection.
Negative selection of the SP thymocyte is essential for the development of a self-tolerant
T-cell population. Thymocytes that have undergone successful positive selection will then express
the chemokine receptors CCR7 and CCR4 and move toward the cell population expressing CCR7
ligands, CCL19, and CCL21 in the medulla (58). In the medulla, the T-cells will undergo negative
selection. During negative selection, T-cells will bind onto the mTECs that uniquely express
exogenous peptides in their MHC molecules that are not native to the thymus. The mTECs and the
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medullary dendritic cells express tissue-restricted antigens on their surface through a process
called promiscuous gene expression (PGE). PGE is carried out by the transcription factors AIRE
(60, 61) and Fezf2 (59); AIRE allows the transcription of genes from areas found in
heterochromatic regions of mTECs, whereas FezF2 binds directly to promoter elements of TRA
genes. These gene products will be translated into proteins, processed into smaller peptides, and
then packaged into the MHC molecules of the mTECs, mDCs and expressed on the cell surface.
The thymocyte TCR binds to the MHC: self-peptide complex represented on the APCs. Depending
on the binding affinity, the T-cell will either undergo apoptosis (binding too tightly) or go on to
the periphery to mount an immune response. This process ensures that the population of naïve Tcells that leave the thymus is self-tolerant and will not attack its own tissues. In figure 1.1 a
schematic diagram elucidating the different steps of T-cell development is demonstrated (130).
Apart from the αβ-lineage, the thymus is involved in development of other less abundant T-cell
populations, including γδ–T cells, regulatory T-cells and iNKT cells.
At the beginning of the T-cell development section, γδ-T-cells were mentioned. Unlike αβT-cell, γδ-T-cells act as the first line of defense. This cell population is mainly found in the
epithelial layer of tissues underlying internal and external surfaces of the body, such as the skin,
intestinal epithelium, lung, and tongue (131, 132). Γδ-T-cells recognize conserved non-peptide
antigens that are upregulated by stressed cells (132). One notable feature of the γδ-T-cells is that
these cells acquire a pre-activated phenotype associated with the upregulation of memory markers
during development. This phenomenon enables them to rapidly induce effector function, followed
by tissue stress detection (132).
To maintain a proper immune system, another class of T-cells can ablate an over-reactive
immune response. A unique subset of T-cells, called Tregs, can modulate the autoreactive T-cells
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by making them anergic. Tregs are defined as CD4+ CD25+ Foxp3+, with Foxp3 being the
definitive marker of a regulatory T-cell. CD4+ Foxp3+ Tregs are generated in the medulla
alongside the conventional αβ T-cells. It has been shown that a subset of CD4+ thymocytes can
give rise to CD4+ Foxp3+ cells. However, the mechanisms that govern the lineage that lymphoid
progenitors follow to become a CD4+ Foxp3+ cell is yet to be elucidated (133).
Apart from these cells, one more “unconventional T-cell” lineages arise from the αβ
lineage, namely the iNKT (invariant natural killer T) cells. The role of TECs in unconventional
lineage generation is only partially understood. Currently, it is known that this T-cell population
is developed in the cortex from the DP cells. iNKT DP progenitors are selected by CD1d
expressing cortical DP thymocyte. This cell population expresses NK1.1 and has a limited TCR
repertoire, and behaves more like innate cells, which can immediately respond to antigens and
secrete cytokines when activated (134).
1.4.2. THYMIC CROSSTALK
T-cells develop in sequential order through the help of specialized epithelial cells in the
thymus. As described above, several levels of selection occur to allow the development of selftolerant T-cells that can mount an appropriate immune response against a pathogen. These
selection processes are dependent on a properly organized thymic epithelial architecture (135).
The crosstalk between the thymocytes and the TECs allows the development of both thymocytes
and the TECs (136). During embryogenesis, until the first lymphoid progenitor appears in between
E11.5-E12.5, the thymic epithelial anlage starts to differentiate into the cortex and subsequently
the medulla. The need for thymic crosstalk is apparent when looking at knockout mouse models
that impede T-cell development. For example, SCID mice (thymocytes arrested at DN2) (135),
RAG-/- mice (arrested at DN3) (137), and CαKO mice (arrested at DP stage) (138) all have varying
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degrees of cortical cellularity and organization, and all lack fully formed medullas. When the DN
T-cells are taken from a wild type mouse and injected into the peritoneal cavity of any one of these
mouse models, both the cortex and the medulla develop similar to a wild-type thymus (138). These
rescue experiments demonstrate that the T-cells and the TEC development are intimately locked
together. Despite its critical role in the T-cell development, the thymus undergoes age-associated
atrophy, resulting in loss of functional TEC microenvironments, decreased T-cell production, and
naïve T-cells in the periphery capable of responding to infection.
1.5. THYMIC INVOLUTION
As opposed to its crucial role in maintaining an essential part of the adaptive immunity, the
thymus is one of the first organs to undergo involution. 3% of thymic tissue is estimated to be lost
per year at puberty and then at 1% per year in middle life (139, 140). The thymus also undergoes
increased atrophy due to malnutrition, infection, glucocorticoid treatment, chemotherapy, and
radiotherapy (141). These causal factors primarily affect the T-cell population. For example,
glucocorticoid treatment induced apoptosis of the DP thymocytes or chemotherapy and
radiotherapy to cause significant loss of hematopoietic cells, including T-cell at different
developmental stages. Acute loss of developing T-cell causes loss of thymic cross-talk, which in
turn causes premature thymic involution (142)
The mammalian thymus undergoes distinct morphological changes during involution,
which include loss of TEC population and thymic adiposity (143, 144). A decreased thymic
capacity for hemopoiesis accompanies thymic atrophy and adiposity. With progressive aging, the
thymus starts losing its epithelial cell populations, while the number of non-TEC thymic stromal
cells increases. Several studies have confirmed that both intrinsic and extrinsic factors play a role
in thymic involution. Some of these intrinsic factors include hematopoietic cytokines, including
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IL6, Leukemia inhibitory factor (LIF), Stem-cell factor (SCF), and Macrophage Colony
Stimulating Factor (M-CSF) (145). Elevated levels of IL6, LIF, M-CSF, and SCF mRNA
correlates with a decreased level of sjTRECs (single joint T-cell receptor excision circle) (145).
Levels of sjTRECs correlate with the thymus' functionality; that is, decreased levels of sjTRECs
represent reduced levels of naïve T-cell production in the aged thymus, which is directly attributed
to thymic atrophy (145). One of the extrinsic factors that contribute to the thymic involution is
elevated androgen and estrogen. Increased levels of sex-hormones cause atrophy of the thymus.
Castration can cause partial restoration of the size of the involuted male thymus (146).
It is known that thymic epithelial cells have a rapid turnover rate, i.e., they proliferate
extensively during the period of thymic growth. Gray et al. 2006 revealed that during aging, the
thymic epithelial cells' turnover rate decreases, suggesting that TEC proliferation might be the key
regulator of thymus size (147). This leads to the assumption that the decreased turnover rate of
TECs might be one of the factors of thymic atrophy during aging. In this study, it was also shown
that thymus involution could be reversed following sex steroid ablation. Seven to fourteen days
after castration surgery, an aged mouse can achieve an expansion of both thymocyte and TEC
numbers with an increased ratio of mTEC/cTEC (147). More recent work by Griffith et al. 2012,
has suggested that although the aging thymus size recovers transiently in response to castration or
androgen blockade, it maintains many functional characteristics of the aged thymus (7). Capacity
for thymic regeneration supports the presence of thymic epithelial progenitor cells in the adult
thymus, which are activated to regenerate the thymus following sex steroid ablation (146).
1.6. PLASTICITY OF BONE-MARROW DERIVED CELL POPULATIONS
Stem cells are a unique self-renewing cell population that can differentiate into one or more
mature cell types (148). Stem cell populations can differentiate into one or more mature cell types
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depending upon their differentiation potency. Embryonic stem cell populations are more
pluripotent than adult stem cell populations (149). An adult Stem cell population maintains many
self-renewing tissues like the skin, intestinal epithelium, liver, mammary gland, and hematopoietic
system (149). Two well-characterized adult stem cell populations include the hematopoietic stem
cell (HSC) and mesenchymal stem cell (MSC) populations. Both of these stem cell populations
are mainly found in the bone marrow.
Bone marrow is one of the two primary lymphoid organs. Bone marrow is a semi-solid
tissue located within bone. It consists of several distinct cell populations, including osteoblasts,
osteoclasts, adipocytes, endothelial cells, hematopoietic stem cells, and mesenchymal stem cells.
The rare population of self-renewing hematopoietic stem cells undergoes a tightly regulated
process of generating mature blood cells, hematopoiesis, in the unique microenvironment provided
by the bone marrow stroma throughout life (150). Hematopoietic stem cells are a wellcharacterized population of self-renewing cells that produce progenitors that differentiate into
every type of mature blood cell (150). Bone-marrow also contains mesenchymal stem cells. This
cell population was characterized as adherent cells and shown the ability to differentiate into
osteoblast, chondroblast, and adipocytes when treated with proper stimuli (151, 152).
Apart from these two stem cell populations, recent studies have revealed a unique
pluripotent population in adult bone-marrow that can undergo trans-differentiation and contribute
to different tissue. Jiang et al. 2002 have shown this population can be cultured in vitro in specific
growth media (153). They also showed that this population could differentiate into different cells,
including hepatocytes, neurons, and endothelial cells in vitro (153). This characteristic is unique
for an adult stem cell population. It is commonly believed that adult stem cells are tissue-specific,
and their main function is to maintain tissue homeostasis (8). But this new bone marrow-derived
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stem cell population can cross-lineage barriers and can transdifferentiate into other tissue-specific
cells. Apart from Jiang et al. 2002, several other studies showed that bone marrow-derived cell
populations could home to different organs (153-155). These studies (reviewed below) also
demonstrated that a BM-derived population could differentiate into mature hepatocyte (156, 157),
cardiac muscle (158), skeletal muscle cells (159), skin epithelial cells (160), air-way epithelial
cells (161), GI tract epithelial cells (162), pancreatic endocrine β-cells, uterus endometrial
epithelial cells(155), renal tubule epithelial cells (163), and neurons of the central nervous
system(154, 164).
1.6.1. BONE-MARROW DERIVED SKELETAL MUSCLE & CARDIAC MUSCLE
It was predominantly believed that satellite cells of muscle fibers are the primary mediator
of muscle regeneration. Still, Ferrari et al. 1998 demonstrated that regenerating muscles recruit
progenitor cells from the bone marrow (159). They showed bone marrow-derived cells could
migrate to degenerating muscle, differentiate into myocytes, and participate in the regeneration of
the damaged fibers. Later Bittner et al. 1999 and Gussoni et al. 1999, showed that during Duchene
muscular dystrophy, tissue-specific stem cell reservoir is exhausted to repair and maintain tissue
homeostasis. They demonstrated that both skeletal and cardiac muscles recruit cells from bone
marrow to repair the injured tissue. They demonstrated that when the Satellite cell (muscle stem
cell) reservoir is exhausted, both skeletal muscle and cardiac muscle recruit cells from the bone
marrow to contribute to the progenitor cell pool (165, 166). Their study also showed that bonemarrow-derived cells do not need to be injected locally for muscle engraftment, intravenous
injection works efficiently for bone marrow cell engraftment in dystrophic muscle fibers (165).
This study demonstrated under the condition of demand injected bone marrow cells can migrate
to injury locations and differentiate into tissue specific cell populations. Later LeBarge et al. 2002,
27

showed that when GFP expressing BM cells were transplanted in a total body irradiated non-GFP
recipient mice, GFP+ satellite cells are observed in the recipient's muscle tissue (167).
Apart from the skeletal muscle, BM-derived cells also contribute to the cardiac muscle.
Tomita et al. 19999 and Makino et al. 1999 showed the BM-derived stromal cells and
mesenchymal stem cells can differentiate into cardiac myocytes in vitro (158, 168). Later Jackson
et al. 2001 showed that bone-marrow-derived side population cells enriched in the hematopoietic
stem cell population (CD34–/low, c-Kit+, Sca-1+) when injected into the lethally irradiated mice,
can migrate to injured cardiac muscle and blood vessels and differentiate into cardiomyocytes and
endothelial cells (169). Orlic et al. 2001 injected Lin-c-kit+ BMC cells in the border zone of acute
infarcts and demonstrated that these cells could differentiate into myocytes and vascular structures
and increase the function of the infarcted heart (170). Kocher et al. 2001 showed that the adult
human bone-marrow contains endothelial precursors, which can be directly used for new blood
vessel formation and proliferation of existing vasculature after experimental myocardial infarction
(171).
1.6.2. BONE-MARROW DERIVED CELLS IN LIVER REGENERATION
BM-derived cells were also shown to contribute to liver regeneration (156, 157). It was
perceived that the liver is repaired and maintained by the proliferation of existing hepatocytes and
cholangiocytes as well as the proliferation and differentiation of bi-potent liver progenitors, oval
cells (8). Petersen et al. 1999 showed two weeks after BM cells from dipeptidyl peptidase IV
positive (DDPIV+) rats are injected into DDPIV null (DDPIV-ve) rats following hepatic injury
with 2-acetylaminofluorene (2-AAF), CCl4 DDPIV+ donor-derived oval cells and hepatocytes
developed (172). Their data showed that 0.76%-2.2% of the total hepatocytes were derived from
BM-derived cells (172). Theise et al. 2000 and Alison et al. 2000 showed that after BMT, human
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recipients developed BM-derived hepatocytes and cholangiocytes (157, 173). Lagasse et al. 2000
demonstrated that BM-derived hepatocytes' functionality using the metabolic liver disease
tyrosinemia type 1 mouse model (174). These mice are deficient in the enzyme
fumarylacetoacetate hydrolase (FAH) and need to be maintained on the drug 2-(2-nitro-4trifluoromethylbenzoyl)-1,3-cyclohexanedione (NTBC) to survive. When these FAH deficient
mice undergo BMT from wild-type FAH+ donors, three weeks after BMT when they were taken
off NTBC, the mice showed improved liver function (174). In an attempt to understand if a single
cell can give rise to cells at different organs, Krause et al. 2001 showed that lineage depleted cells
isolated from the bone marrow when transplanted into irradiated mice homed to bone marrow after
two days(154). These cells are then recovered from the recipient mouse. New irradiated hosts are
then re-transplanted with these recovered cells so that each host received just one cell. After 11
months, the long-term survivors have shown the presence of the transplanted cells in different
organs, including the liver, stomach, lungs, and skin. IHC studies showed that these cells had
differentiated into epithelial cells in multiple organs (154).
1.6.3. BONE-MARROW DERIVED CELLS IN GI TRACT REGENERATION
GI tract homeostasis is maintained by a multipotent intestinal stem cell population that can
give rise to all types of epithelial cells, columnar absorptive enterocytes, Paneth cells, goblet cells
enteroendocrine cells (8, 162, 175). But later, Krause et al. 2001, in their single-cell study,
demonstrated the presence of BM-derived intestinal epithelial cells (154). Also, Okamoto et al.
2002 showed that when four cancer patients who are demonstrating symptoms of GVHD, peptic
ulcer, and inflammation of GI tract underwent a BMT from a sex mismatched donor, donorderived epithelial cells were found in all sections of the GI tract, including the esophagus, stomach,
small intestine, and colon (176). They also performed karyotyping to rule out the possibility of a
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fusion of the BM-derived cells (176). Brittan et al. 2002, also showed that BMDCs could give rise
to intestinal myofibroblasts in both the mouse and the human small intestine and colon (165).
1.6.4. BONE-MARROW DERIVED CELLS IN SKIN REGENERATION
It has been shown that adult skin contains a multipotent stem cell population present in the
bulge region of hair follicles that can self-renew and differentiate into the epidermis, sebaceous
glands, and hair follicles (160, 177). Borue et al. 2004 argued that BMDCs could differentiate into
cytokeratin positive epithelial cells of the epidermis in response to skin injury(178). Additionally,
Korbing et al. 2002 demonstrated that when HSC from peripheral blood were transplanted into
human patients, biopsies of their liver, GI tract, and skin showed that 0-7% of the epithelial cells
in the histological section were derived from donor cells (179). Donor-derived cells were detected
in liver tissue as early as day 13 and as late as day 354 after transplantation (179).
1.6.5. BONE-MARROW DERIVED CELLS IN LUNG REGENERATION
Among the two types of surface epithelial cells of the alveoli, type I and type II
pneumocytes, type II pneumocytes have self-renewing properties (180). Type II pneumocytes are
responsible for alveolar tissue turnover. Type II pneumocytes can proliferate and differentiate into
type I pneumocytes in response to injury (180). A single BM cell transplantation study done by
Krause et al. 2001 showed that BM-derived cells could migrate to the lungs and differentiate into
type II pneumocytes in alveoli (154). Kotton et al. 2001 created alveolar tissue damage by using a
bleomycin injury protocol and showed that when plastic-adherent BMC cultured for ten days were
injected into the bleomycin-treated mice, the injected cells form a cluster of type I pneumocytes
30 days post-injection (161). Additionally, Theise et al. 2002 showed that within 5-7 days after
lethal irradiation and BMT, donor cells start to repopulate injured alveolar tissue, and within two
months, donor-derived cytokeratin expressing epithelial cells are observed in lungs (181). These
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data demonstrated that bone-marrow cells enriched in HSC could engraft into injured lung tissue
as pneumocytes (181). Interestingly, Davies et al. 2002 showed contradictory results in their study.
It was shown that after sex-mismatched BMT in humans, nasal brushing samples demonstrated
the presence of Donor-derived cells, but none of them were able to exhibit cytokeratin staining
(182). This result showed that bone marrow stem cells could not contribute to the healthy upper
respiratory tract's epithelial cell population. Later, Wong et al. 2007 showed that short-term
cultured bone marrow cells migrated to the naphthalene injured lung, localized there, and
differentiated into airway epithelial cells(183). They showed a unique population of cells in the
bone marrow, which express a marker of airway progenitors, Clara cell secretory protein (CCSP),
and the hematopoietic cell marker CD45 (183). Furthermore, they also demonstrated that this
population's frequency increases in response to lung injury (183). This cell population can migrate
to the lungs and differentiate into airway epithelial cells (183).
1.6.6. BONE-MARROW DERIVED CELLS IN REGENERATION OF PANCREAS
Ianus et al. 2003 found that BM-derived cells can also differentiate into pancreatic
endocrine β-cells when BMCs from wild-type mice are transplanted into lethally irradiated
mice(184). Donor-derived cells were observed in islets, and these cells expressed insulin and
transcription factors specific to B -cells (184). Hess et al. 2003 showed that when BMDCs express
c-kit in mice with streptozotocin-induced pancreatic damage, it reduces their hyperglycemia (185).
They demonstrated that the donor cells were mainly clustered in ductal and islet structures, which
induced endogenous cells' proliferation and produced insulin (185).
1.6.7. BONE-MARROW DERIVED CELLS IN KIDNEY REGENERATION
Poulsom et al. 2001 showed that lethally irradiated female mice receiving BMT from male
donors have kidney cells that co-stain with both the Y chromosome and the epithelial cell–binding
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lectin Ricinus communis, Lens culinaris, and Pisum sativum (186). This study also showed that
when male patients had been transplanted with kidneys from a female donor, their kidney biopsies
showed that a significant number of renal tubule epithelial cells were BM-derived (186). Kale et
al. 2003, showed that Lin–Sca-1+ cells from the adult mouse bone marrow are mobilized into the
circulation by transient renal ischemia and home specifically to injured regions of the renal
tubule(163). These BM cells differentiate into renal tubular epithelial cells in the renal tubule and
appear to constitute most of the cells present in the previously necrotic tubules (163). Loss of stem
cells following bone marrow ablation results in a more significant rise in blood urea nitrogen after
renal ischemia. In contrast, stem cell infusion after bone marrow ablation reverses this effect (163).
Later, Prodromidi et al. 2006 used a mouse model of autosomal recessive Alport syndrome. In this
model, podocytes fail to synthesize normal glomeruli causing progressive glomerular damage
leading to renal failure (187). In this study, female mice with Alport syndrome underwent BM
transplantation with whole BM from wild-type male mice. Twenty weeks of post-transplant kidney
function improved, and glomerular scarring decreased. They also observed donor-derived cells,
and some of those cells showed phenotypes of podocytes (187).
1.6.8. BONE-MARROW DERIVED CELLS IN UTERUS REGENERATION
In the uterus, during each menstrual cycle, endometrium regeneration takes place. The
Endometrial stem cells remain in the basalis layer and differentiate into endometrial cells. In search
of non-uterine endometrial stem cells, Taylor et al. 2004 revealed that bone marrow transplant
patients with mismatched HLA type showed the presence of 0.2%-48% donor-derived endometrial
cell (188). Later, Du et al. 2007 showed that after bone marrow cells from male mice were
transplanted into female mice, donor-derived BMCs were found in female mice's uterine
endometrium (189). They also demonstrated that <0.01% of the donor population differentiate into
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epithelial cells (189). Alawadhi et al. 2014 showed that BMDCs could engraft into the
endometrium under the condition of uterus injury (155). Liu et al. 2018 revealed that injection of
BMDCs rather than uterine-derived cells caused better uterine engraftment(190). This study also
elucidated the systemic administration of BMDCs causes more effective uterine engraftment than
a local intrauterine injection of BMDCs (190).
1.6.9. BONE-MARROW DERIVED CELLS IN REGENERATION OF THE CNS
Previously central nervous system cells were believed to be non-renewable (191). But
recent studies suggested that BMCs can differentiate into CNS cells, including neurons,
oligodendrocytes, and astrocytes, both in vivo and in vitro. In vitro studies on BMCs to CNS
plasticity focus on the stromal BMC population's capacity to self-renew and differentiate into
neuronal phenotypes. Mezey et al. 2000, showed that adult bone marrow cells could migrate to the
brain and differentiate into the cells that express neuron-specific antigens (192). Jiang et al. 2002
highlighted that Bone-marrow-derived cells could undergo morphological changes to evolve into
astrocyte-, oligodendrocyte-, and neuron-like cells in vitro when induced by cytokines (153). Hao
et al. 2003 demonstrated that when CD34+CD133+CD3– human fetal hematopoietic stem cells
are cultured in an astrocyte-conditioned medium, they differentiate into nestin and BMP-2
expressing neuronal progenitor-like cells(164). They also observed a similar result when the BMCs
are cocultured with astrocytes (164). Eglitis et al. 1997 showed that in vivo BM cells can
differentiate into GFAP (an astrocyte marker) expressing astrocytes in both gray and white matter
when bone marrow cells were injected into irradiated mice (193). Saski et al. 2001 and Akiyama
et al. 2002 showed that bone-marrow-derived cells could repair spinal cord injury by
remyelination. Moreover, they argued that in a demyelinating rat model, when myelination
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maintaining oligodendrocytes are destroyed with ethidium bromide injection followed by X-ray
irradiation, BMC administration causes remyelination on the neuronal axons (194, 195).
Taken together, these results suggest that adult bone marrow cells have more plasticity than
it was previously understood. Bone-marrow derived cells can differentiate into epithelial cells in
different organs. This capacity of bone-marrow-derived cells can be used for targeted cell
replacement therapy for different organs (8, 149).
1.6.10. CELL FUSION OR TRANSDIFFERENTIATION
Some studies have disputed the differentiation of BM-derived cells into other tissuespecific cells and argued that fusion rather than trans-differentiation is the source of bone marrow
plasticity(196-199). These studies were mainly performed in response to the study by Krause et
al. 2002, where they demonstrated that a single bone-marrow-derived stem cell can produce
progeny that migrate to different organs and differentiate into different epithelial cell populations,
including gut, lung, liver, and uterine epithelial cells (154). Interestingly, Ying et al. 2002, showed
that when mouse brain cells are cocultured with pluripotent embryonic stem cells (ESCs), the stem
cells spontaneously fuse with the brain cells and express brain cell markers (196). Karyotyping of
these cells revealed polyploidy (196). This data disputed all the previous results showing the
plasticity of bone marrow cells. Terada et al. 2002 showed that mouse BM mononuclear cells
from female transgenic mice expressing GFP and the puromycin-resistance gene when co-cultured
with male embryonic stem cells in an IL-3 containing growth media, within three weeks BM cells
started expressing embryonic stem cell-like properties, but further analysis showed polyploidy of
these cells (199). Previously Lagasse et al. 2000 demonstrated the functionality of BM-derived
hepatocytes by using metabolic liver disease tyrosinemia type 1 mouse model (174). In response
to that, Wang et al. 2003 showed that when they performed serial transplantation of bone-marrow34

derived hepatocytes, they found polyploidy in the bone-marrow-derived hepatocytes (197).
Additionally, Vassilopoulos et al. 2003 showed that when the Fah deficient mouse model was
injected with wild-type mice BM cells, the recipient mice liver was repopulated with liver cells.
But interestingly, these donor cells had both mutant and wild type Fah alleles, and these cells
exhibited polyploidy (198). These studies indicated the possibility that BMC plasticity is the result
of the fusion of hematopoietic cells to tissue-specific cells.
Herzog et al. 2003 suggested that newfound bone marrow plasticity can result from more
than one possible mechanism. One of the possibilities includes the presence of a unique pluripotent
stem cell population that is not part of the HSC population. Other possibilities include
transdifferentiation, where the hematopoietic stem cells can first dedifferentiate then follow the
alternative pathway to differentiate into completely different cell populations. Transdifferentiation
can also happen directly, where the HSC can directly differentiate into cell populations other than
hematopoietic cells. Lastly, fusion can also be one of the mechanisms where the HSC can
spontaneously fuse with nonhematopoietic cells to form polyploids with characteristics of both
donor and recipient cells (149). Figure 1.2 shows the schematics of these four mechanisms (149).
As explained in this section, bone marrow derived cells can differentiate into different adult
tissue-specific cell populations. Some of the studies demonstrating this newfound plasticity
exploited either the BM-derived HSC population (154, 183) or whole BM (165, 192). Some
studies also used more defined BM-derived subsets, for example, Lin-CD34+ BMCs (163). One
most prominent study by Krause et al. showed that a single bone-marrow-derived stem cell could
produce progeny that migrate to different organs and differentiate into different epithelial cell
populations, including gut, lung, liver, kidney, and uterine epithelial cells (154). Other studies also
demonstrated the contribution of bone marrow in the pancreas (184) and CNS (192). But
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interestingly, none of these studies examined the thymic stroma. This current study will assess if
bone marrow cells can contribute to the thymic epithelial microenvironment.

1.7. OVERVIEW OF WNT SIGNALING
Wnt proteins are a family of secreted signaling molecules. These evolutionarily conserved
proteins are pleiotropic and play a diverse but crucial role during cell development, differentiation,
migration, and proliferation in vertebrates and invertebrates (200-202). Gene sequencing has
revealed ~20 different evolutionary conserved Wnt proteins in various mammalian species,
divided into 12 subfamilies (203). Wnt genes encode secreted glycoprotein consisting of ~350
amino acids (201). This protein shows a conserved 23 cysteine residue pattern, and they undergo
lipid modification (201). Lipid modification (palmitoylation of the conserved Cysteine residues)
of the Wnt proteins is essential for their function. Wnt proteins also carry N-terminal signal
peptide, which is essential for Wnt protein secretion.
The Wnt signal transduction pathway is known to regulate cell fate, establishing the dorsal
axis, limb development, asymmetric cell division, progenitor-cell proliferation and survival, and
long-term memory formation (201, 204). Moreover, Wnt signaling also plays an essential role in
regulating hematopoietic and epithelial stem cells (205). This signaling pathway is tightly
regulated, and this pathway's misregulation can lead to cancer (203). For initiation of the Wnt
signal transduction pathway, Wnt proteins interact with the Frizzled (Fzd) family's seventransmembrane receptors (202, 205, 206). Higher vertebrates have at least ten frizzled proteins.
The Wnt-Frizzled complex can interact with different co-receptors, including LDL receptor
proteins, LRP 5, LRP 6, and the receptor protein tyrosine kinase ROR2 (206). There are three
different intracellular wnt signaling pathways present: 1) the canonical Wnt-β- catenin-dependent
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pathway, 2) the planar cell polarity pathway (PCP), or Wnt-Jun N-terminal kinase pathway, and
3) the Wnt-Ca2+ pathway. In the past, it was believed that certain types of Wnt proteins and frizzled
receptor activates specific pathways. Later, it came to light that such a specificity most probably
came from a specific combination of Wnt ligands, Fzd receptors, co-receptor,

and even

intracellular signaling components (206). But recently, redundancy of Wnt proteins in activating
different pathways or different pathways being activated to regulate each other was observed. This
new knowledge leads to the new idea about the Wnt signaling network. The canonical Wnt-βcatenin signaling pathway is the most studied Wnt pathway (205).
The canonical Wnt signaling cascade exists in two main phases, active and inactive. In the
inactive phase, the Wnt ligand does not bind to the frizzled receptor, which causes cytoplasmic
and nuclear β-catenin to be targeted for degradation by the proteasome through the actions of a
destruction complex (207). The destruction complex is composed of two scaffolding and tumorsuppressor proteins adenomatous polyposis coli (APC), axis inhibition protein 1 (AXIN1), and
glycogen synthase kinase 3β (GSK3β). When β-catenin binds to this destruction complex, it is
phosphorylated by the serine/threonine kinase 1 (CSNK1A1) and glycogen synthase kinase 3β
(GSK3β). CSNK1A1 phosphorylates β-catenin on Ser45, and then GSK3β phosphorylates βcatenin on Ser33, Ser37, and Thr41, creating recognition sites for β-transducin repeat-containing
protein (βTRCP1, and βTRCP2) (208). This βTRCP1 and βTRCP2 recognition site tags the βcatenin for ubiquitination dependent proteolysis(209). Meanwhile, in the nucleus, TCF assembles
a transcriptional repressor complex comprised of Groucho/Transducin-like enhancer (GRG/TLE),
C-terminal binding protein (CTBP), and histone deacetylases (HDACs) to silence Wnt target
genes(210). In the active phase, when the Wnt ligand bind to the Fzd receptor to initiate the Wnt
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signaling pathway, that disbands the destruction complex that causes stabilization and
accumulation of cytoplasmic β-catenin.
The initiation of canonical Wnt signaling results in the cytoplasmic stabilization and
accumulation of β-catenin, which subsequently translocate to the nucleus and coordinates
transcriptional activity(205). Wnt ligands bind to its Fzd receptor and its co-receptor, low-density
lipoprotein receptor-related protein 5 (LRP5) or 6 (LRP6), at the cell membrane to activate the
signaling cascade (211). LRP 5/6 are single-span transmembrane proteins. It is presumed that Wnt
may induce Fz-LRP 6 complex formation, which in turn activates the Wnt signaling pathway.
Disheveled (DVL) then binds to Fzd/LRP complex and promotes the phosphorylation of PPPSPxS
motifs within the LRP5/6 intracellular domain by CSNK1A1 and GSK3β. LRP5/6 then recruits
AXIN1 to the plasma membrane (212). In the meantime, DVL is also modified through CKIε,
which increases the affinity of GSK3β inhibitor GBP/FRAT and away from the destruction
complex in the cytoplasm (207, 213). Thus, the inhibition of β-catenin phosphorylation results in
the accumulation of β-catenin in the cytoplasm, which then translocates into the nucleus and
associates with the TCF/LEF family of transcription factors to activate β-catenin-dependent
responsive genes (214). Furthermore, both TCF/LEF and β-catenin interact with additional
proteins such as BCL9, Pygopus (PYGO), SWI/SNF, Pontin, and CBP/p300, to initiate
transcription(205). TCF/LEF and β-catenin complex activate gene expression Myc, Jun, Fra,
Cyclin D1(Figure 1.3).
The canonical Wnt signaling pathway is tightly regulated at many points to ensure proper
signaling. The Wnt signaling pathway's antagonists can be divided into two broad groups: the
secreted Frizzled related protein (Sfrp) group and the Dickkopf group (215). Sfrp group includes
the Sfrp family, Wnt inhibitory factor 1 (Wif-1), and Cerberus (215). Inhibitors in Sfrp group
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inhibitors can bind directly to the Wnt ligands in the extracellular membrane and prevent Wnt
signaling initiation, and this results in the unspecific inhibition of both canonical and noncanonical
Wnt signaling (215). On the other hand, Dickkopf group inhibitors specifically inhibit canonical
Wnt signaling by binding and blocking the LRP5/6 co-receptors (216). Negative regulation also
occurs in the nucleus by the cell-autonomous inhibitor of β-catenin and TCF (ICAT), which can
inhibit the nuclear interaction between β-catenin with TCF (217). TCF has at least eight isoforms
formed by alternative splicing and different promoter usage. All the isoform can bind to the Wnt
ligands at different extents and thus regulating cells' response to Wnt signaling (205).
The two non-canonical Wnt signaling pathways are still less understood. One of the two
noncanonical Wnt signaling pathways generates planar cell polarity (PCP) (218). The PCP
pathway results in Jun N-terminal kinase (JNK) activation, which mediates cell position and
shape(205). It is β-catenin-independent and does not include the Fzd co-receptors LRP5/6 or TCF
molecules. Wnt5a, Wnt11 initiates this pathway using frizzled and DVL (205). DVL associates
with the Disheveled-associated activator of morphogenesis (DAAM), which activates the RAS
homologue gene-family member A (RHOA) and Rho-associated coiled-coil-containing protein
kinase (ROCK) to facilitate cytoskeletal reorganization (205, 219). DVL also activates RAC1, and
both RAC1 and RHOA activate JNK, which leads to changes in cell adhesion and cell migration
by regulating cytoskeletal changes (205). It has also shown that non-canonical Wnt signaling can
inhibit canonical Wnt signaling in lymphocytes (220, 221).
A more recently recognized non-canonical Wnt pathway, the Wnt-Ca2+ pathway, is
hypothesized to influence both non-canonical and canonical Wnt signaling. It is presumed that
Wnt5a and Fzd-2 are the most probable components of the Wnt-Ca2+ pathway. Wnt ligand goes
through palmitoylation so that they can bond to a cognate Fzd receptor to initiate this signal
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transduction pathway(222). These lipid-modified proteins are chaperoned by heparin sulfate to
prevent clustering(223). The extracellular N-terminus of the Fzd receptor binds to the ligand. The
PDZ (Psd-95/dics large/ZO1)-binding domain in the intracellular part is responsible for all the
downstream process. Through a G protein, the Wnt-Fzd complex activates phospholipase C (PLC),
leading to the cleavage of phosphatidylinositol-4,5-bisphosphate (PtdIns (4,5) P2) to inositol
triphosphate (IP3) and diacylglycerol (DAG), which then activates protein kinase C (PKC). IP3
binds to its calcium channel receptor present on the endoplasmic reticulum and releases
intracellular calcium stores, and increases Ca2+ ion levels in the cytoplasm. Ca2+ ion levels are
normally kept low, and the increased Ca2+ concentration activates the calmodulin phosphatase
calcineurin and several calcium-dependent kinases, including calmodulin-dependent protein
kinase II (CaMKII)(224); whereas DAG activates PKC(225). Increased CaMKII and PKC have a
wide variety of effects but often triggers the nuclear factor of activated T cells (NFAT)(226).
Wnt/Fz interaction is also seen to activate phosphodiesterase 6 (PDE6) in a calcium-dependent
manner to decrease cyclic GMP(cGMP) level(227).
Wnt signaling is currently assumed to have three individual pathways. Others, however,
oppose this divisive approach and instead view all three pathways as a single Wnt signaling
network(206). It has been shown in vivo that different Wnt pathways simultaneously regulated
each other in the same cell type simultaneously—PCP signaling activation of JNK has been
reported to inhibit the canonical Wnt signaling pathway in addition to regulating cell movement.
Redundancy of the same molecule involved in different Wnt signaling pathways has also been
observed(206, 228). For example, Dejmek et al. 2006, Ma et al. 2006, Yamanaka et al. 2006 and
He et al. 1997, have shown that Wnt5a is capable of activating not only the noncanonical calcium
signal pathway and JNK pathway(229-231) but also the canonical β-catenin pathway when in the
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presence of human Fzd-5 in Xenopus embryos(232). Mikels et al. 2006 demonstrated mouse Fzd4 in HEK293 cells can activate the canonical β-catenin pathway via Wnt5a(233). In another study,
Tu et al. 2007 showed that Wnt3a could simultaneously activate canonical and non-canonical
pathways in the same cell type(234). Additionally, Boutros et al. 1998 and Sheldahl et. al 2003
showed the intracellular signaling pathway mediator DVL is involved in β-catenin-dependent
signaling, as well as PCP and Wnt-Ca2+ signaling(235, 236). Saneyoshi et al. 2002 has shown that
the Wnt/ Ca2+ pathway stimulated transcription factor NF-AT also involved in wnt mediated
dorsal-ventral patterning in Xenopus embryos indicating the involvement of Wnt/β catenin
pathway(237). Kani et al. 2004 has shown that atypical receptor tyrosine kinase ror2 is regulated
by CKIϵ, which is regulated by canonical wnt signaling(238). From all these experimental facts, it
is clear that Wnt signaling is extremely context-specific and, stimulation with a certain Wnt ligand
does not necessarily produce the same results for different cell types in the same species, or the
same cell type in different species, or even in the same cell type in same species but at different
time points. Therefore, it is important to view Wnt signaling as a vast, interconnecting network
rather than individual pathways because making assumptions about specific roles for certain
proteins can lead to invalid conclusions(206).
1.7.1. Wnt SIGNALING & TEC DEVELOPMENT
Several studies have shown that Wnt signaling has an extensive role in hematopoietic stem
cell self-renewal, maturation of dendritic cells, T-cell development, activation, and peripheral
migration of T-cells(205, 239-242). Previous studies have demonstrated that in the thymic stroma,
only thymic epithelial cells express Wnt ligand proteins(204), which regulates proliferation of DN
T-cell, survival, and positive selection of DP cells(205). Moreover, it has been shown before that
TCF-1, an effector of canonical Wnt-β-catenin signaling, is important for T-cell development. In
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addition to demonstrating TECs as the sole source of secreted Wnt ligand in the thymic stroma, it
has also been shown that TECs even express membrane-bound Fzd receptors. This data created
speculation that TECs can stimulate Wnt signaling cascades in themselves(204). However, it is
difficult to separate between Wnt signaling's effect on developing thymocytes and the effect of
wnt signaling on TEC development because of crosstalk present between developing thymocytes
and TECs.
Few studies attempted to reflect upon the direct relationships between individual Wnt
ligands and their Fzd receptors or the transcriptional targets Wnt signaling simulates in TECs.
Balciunaite et al. 2002 showed the presence of Wnt1, Wnt3, Wnt4, Wnt5, Wnt10b in thymic tissue.
They also demonstrated that fetal thymus Wnt expression depends on different developmental
stages of TECs and the presence of developing thymocytes, whereas, in adult TEC, some Wnt
ligands are expressed independently of developing thymocytes. Additionally, their study
highlighted that Wnt proteins play an essential role in fetal thymus development by regulating the
expression of FOXN1, the key regulatory transcription factor for TEC development(31). Later,
Kuraguchi et al. (2006) found that the mice with a FoxN1 specific deletion of APC can stabilize
canonical β-catenin-Wnt signaling. They also demonstrated that these transgenic mice are unable
to form a proper thymus(243). Later, Brunk et al. 2015, showed transgenic mice with FoxN1
conditional knockout for GPR177, a Wnt-specific cargo receptor required for secretion of Wnt
ligands, lose the capability of all Wnt secretion in TECs, including both canonical and noncanonical Wnt ligands(204). They demonstrated that without GPR177 close to birth, thymus size
is reduced along with TEC cellularity. Conditional knockout of GPR177 also causes reduction of
the peripheral T-cell number and The thymus hypotrophy sets in close to birth, and the number of
T-cells in the periphery reduces(204). These mice showed an increase in the ratio of mature
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mTEChi to immature mTEClo cell populations and an increase in the rate of apoptosis in
TECs(204). Besides that, the mutation does not affect TEC development, chemokine production,
or the differentiation of Aire+ mTECs. Furthermore, it does not alter the mTEC/cTEC ratio or
thymocyte development, but only the thymocyte frequency, which was less due to the reduced
TEC population(204). Other cell populations in the thymus do not compensate for the loss of Wnt
secretion(204). Together these studies propose a significant role for Wnt signaling in TEC
proliferation and survival rather than TEC development and differentiation.
Other studies tried to demonstrate the potential effect of β-catenin TEC development,
differentiation, and maintenance directly or indirectly. Balciunaite et al. 2002 showed that
constitutive the canonical β-catenin-Wnt signaling pathway in cTEC1-2, an established cortical
epithelial cell culture, upregulates FoxN1 expression(22). Later, other in vivo studies showed that
canonical β-catenin-Wnt signaling in TECs is a complex and tightly regulated process.
Overexpression or inhibition of β-catenin disrupts normal thymus development(244, 245). Kvell
et al. 2014 experimented with ICAT, a protein that disrupts the β-catenin/TCF interaction, which
then inhibits the expression of Wnt signaling pathway target genes. They demonstrated that the
fetal TECs transfected with ICAT reduces the expressions of FoxN1, MHC-II, and IL-7(245).
Zuklys et al. 2009 demonstrated that constitutive activation of Wnt-signaling via gain-of-function
mutation of β-catenin changes the earlier commitments of endodermal epithelial cells to a thymic
fate. This mutation also disrupts thymic stroma organization as well as thymocyte recruitment by
TECs (246). Osada et al. 2006 exhibited that Kremen1 (a Wnt antagonist) deficient mice showed
an increase in canonical β-catenin-Wnt signaling in TEC-derived cell lines. They also
demonstrated that these transgenic mice could not form properly developed thymic architecture,
lacking the defined cortex and medulla regions(5). These data altogether suggest that the
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stabilization of canonical β-catenin-Wnt signaling in TECs disrupts the thymic architecture and
creates a non-functional thymic microenvironment. Interestingly, Osada et al. 2010, also
demonstrated that inhibiting canonical β-catenin-Wnt signaling also disrupts the thymus
architecture(6). In this study, double transgenic (tetO-Dkk1) mice were used, which in the presence
of doxycycline produce high levels of Dkk1 in both mTECs and cTECs, which leads to the
inducible inhibition of canonical Wnt signaling. Overexpression of DKK1 causes a decrease in
TEC proliferation, reduction in all TEC subsets, and subsequently, premature thymic
degeneration(6). Consequently, because of their role in the creation of developing thymocyte
niches, Dkk1 inhibition of β-catenin-Wnt signaling also decreases the number of thymocytes(6).
Taken together, these studies indicate that precise regulation of canonical β-catenin-Wnt signaling
in TECs is indispensable for proper thymus development, and enhancing or diminishing canonical
β-catenin-Wnt signaling compromises the integrity of the thymic epithelia.
The expression of several secreted Wnt proteins has been identified in multiple TEC
populations, but the results vary (in part due to different experimental techniques as well as the
age, the sex, and the mice used) and most Wnt proteins detected in the thymus have unknown
roles. However, some studies were able to reveal the role of a few Wnt ligands in TEC
development and maintenance. For example, Wnt-4 has been extensively studied for its effect on
TEC-development. These studies revealed Wnt-4 plays an important role in proper TEC
development. Several studies have identified Wnt-4 expression in TECs at multiple time points
during thymus organogenesis, postnatal expansion, and adult homeostasis. Furthermore,
Balciunaite et al. 2002 and Kvell et al. 2014 both showed that Wnt-4 staining colocalizes with
EpCAM staining in both human and mouse embryonic TECs suggesting that Wnt-4 expression is
evolutionarily conserved(22, 245). Balciunaite et al. 2002 also demonstrated an abundant
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expression of Wnt-4 in the early thymus, highlights the significance of its absence in the aging
thymus. Balciunaite et al. 2002 and Mathieu 2006 also demonstrated that by E10.5, both the dorsal
and ventral aspects of the 3rd pp express the Wnt ligands, Wnt4, Wnt5b, but the expression pattern
was different for Wnt inhibitors Wif-1, Nkd1, Sfrp-2(22, 247). This implies that Wnt signaling is
spatiotemporally regulated within the 3rd pp and has potential roles in proper patterning and/or
differentiation of the epithelium in early thymus organogenesis(247). On a similar line, Mulroy et
al. 2002 and Swann et al. 2017 showed that Wnt-4 transgenic mice play a role in embryonic thymus
development and migration(17, 248). Mulroy et al. 2002 demonstrated that the TEC-specific Wnt4
overexpressing transgenic mice disrupts the TEC differentiation and causes abnormal thymus
migration(17). Interestingly, apart from the suppression of fetal and postnatal thymic expansion,
the same study also showed that Wnt 4 predominantly affected cTECs and reduced fetal cTEC
frequency and cell numbers; fetal mTEC numbers were similar to controls (though both cell
populations were decreased at later time points when compared to controls)(17). This implies that
Wnt-4 disrupts fetal TEC differentiation primarily through a cTEC dependent mechanism. Later
Brunk et al. 2015 demonstrated ways Wnt4 can trigger both the canonical-β-catenin-Wnt and noncanonical-Wnt singling in a context-dependent manner. They also showed it is the highest
expressed Wnt ligand in the 1-month old mouse thymus and expressed in both cTECs and
mTECs(204). Furthermore, Heinonen et al. 2011 showed that Wnt-4 stimulates multiple cell
populations in the thymus (249). They also explained how a PCP-like pathway involving Fzd-6,
RAC1, and JNK, Wnt-4 expands hematopoietic progenitor cells derived from bone marrow and
fetal liver(249). In another study, Heinonen et al. 2011 showed that both conventional and
conditional Wnt-4 KO mice suppress the fetal and postnatal thymic expansion. This mutation
causes a disproportionate loss of TEPCs an overall decrease in TEC numbers that alters the
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medullary-to-cortical TEC ratio(4). In the same study, Heinonen et al. 2011 showed that the Wnt4 transfected BM cells cultured with thymocytes expand ETPs and DN thymocytes and suggest
Wnt-4 can regulate thymocytes independent of TECs. Together these data indicate that Wnt-4
dynamically regulates thymic cellularity and promotes thymopoiesis in multiple cell
populations(4).
Additionally, St-Pierre et al. 2015 showed that Wnt-ligand production by wild-type mice
mTECs is significantly higher than the mTECs from Aire deficient mice(250). Wnt5a, Wnt7b, and
Wnt8b are all downregulated in the mTEChi cells of AIRE deficient mice compared to WT mTEChi
cells(250). Even though more conclusive evidence is still needed, this suggests a relationship
between Aire and Wnt signaling. Furthermore, this represents possible roles for Wnt signaling in
the differentiation of mature mTECs, the late processes of thymocyte development, and/or the
emigration of thymocytes from the thymus(250).
Previously several papers have shown that potential downstream Wnt target genes impact
thymus development. Röhrs et al. 2009 and Bredenkamp et al. 2014 have shown that K5 driven
expression of CCND1/2, a proposed target gene of Wnt signaling and FoxN1, in TEPCs causes
thymic hyperplasia, expands TEC numbers, and promotes thymus development(251-253). Wnt
proteins can regulate STAT3 in ESCs(254) and retinal epithelium(255). Subsequently, Lomada et
al. 2016 have highlighted that STAT3 signaling is known to induce survival and maintenance of
mTECs and the postnatal development of the thymic medullary regions(256). Hunziker et al. 2011,
have shown that RAC1 deficient mice increase the expression of c-MYC, another Wnt target gene
(though other pathways frequently regulate c-MYC), which results in thymic atrophy(257).
Together, these data highlight that potential downstream genetic targets of Wnt signaling
influences the TEC development.
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1.8. OVERVIEW & SIGNIFICANCE OF THE RESEARCH
1.8.1 OVERVIEW OF THE RESEARCH
The primary research project demonstrated the presence of a unique bone marrow
population that expresses both CD45, a hematopoietic cell marker, and EpCAM, a definitive
thymic epithelial cell marker. It will also demonstrate how these unique bone marrow derived cells
can migrate to the thymus and contribute to the thymic epithelial microenvironment under injury
conditions. Furthermore, it will show that this particular BMC population expresses epithelial stem
cell markers and that it is derived from the hematopoietic stem cell population of bone marrow.
The secondary research project will demonstrate that TECs are the primary source of Wnt
signaling in the fetal thymic stroma. This study characterized active Wnt signaling in different
thymic epithelial compartments during embryogenesis.
1.8.2. SIGNIFICANCE OF THE RESEARCH
Prior work has suggested that the adult thymus may not contain an epithelial progenitor
cell population, unlike other epithelial organs. In the fetal thymus, the endodermal layer of the
third pharyngeal pouch gives rise to a bi-potent TEC progenitor population, which subsequently
differentiates into cTECs and mTECs. More recent studies have identified some distinct nonhematopoietic self-renewable thymic stromal cell populations that differentiate into different TEC
lineages. Even though several studies have focused on identifying adult TEPCs, this population's
characteristics are not fully understood. Previous studies that have tried to identify the TEPC
population were mainly restricted to CD45 negative (non-hematopoietic) thymic stromal cell
populations. As explained in the previous section, recently, a large body of research has shown
that bone-marrow-derived cells can migrate to different organs and contribute to the different
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organ-specific cell populations. This study explores the newfound plasticity of a bone marrowderived cell population and identifies a subpopulation in the bone marrow that can migrate to the
thymus and contribute to the non-hematopoietic component of the thymic stroma.
Wnt proteins are a family crucial signaling molecule. This evolutionarily conserved protein
family plays a diverse and crucial role during the development, differentiation, cell migration, and
proliferation in both vertebrates and invertebrates (200-202). It is a well-known fact that Wnt
signaling plays an important role in T-cell development, and the thymic epithelial cells are a
primary source of wnt signaling, which regulates this process. Few studies have shown the role of
wnt signaling in TEC development, which is yet not fully understood. In my secondary research
project, I have characterized changes in active Wnt signaling in TECs during the development of
the fetal thymus using the TCF/LEF-H2BGFP Wnt reporter model.
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Figures & Figure Legends
Figure 1.1

Figure 1.1. Overview of T-cell development adapted from Anderson and Jenkinson(70).
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Figure 1.2

Figure 1.2. This figure is adapted from Grove et al. 2003, Mechanisms of differentiation. The 4
models shown in the figure above represent the mechanisms of differentiation from BM-derived
cells into an alternative nonhematopoietic phenotype (green). (A) Consistent with our existing
paradigm that cells always travel from a less differentiated to a more differentiated state, this model
predicts that there is a highly pluripotent cell (red) that has not yet committed to the hematopoietic
lineage and maintains the ability to differentiate into multiple diverse cell types. (B) With indirect
transdifferentiation, an HSC changes its gene expression pattern to that of an alternative cell type
through a dedifferentiation/redifferentiation pathway that presumably passes through an as yet
unidentified intermediate cell type, shown in white. (C) In direct transdifferentiation, an HSC may
be able to directly change its gene expression pattern from that of a hematopoietic stem cell to an
alternative cell type. (D) If fusion is the mechanism by which BMSCs acquire a nonhematopoietic
phenotype, a marrow-derived cell, perhaps a macrophage (blue), fuses with a nonhematopoietic
cell (yellow), and the nucleus of the marrow-derived cell takes on the gene expression pattern of
the nonhematopoietic cell type. The 2 nuclei do not have to fuse. Note that these models are not
mutually exclusive and may all reflect the in vivo mechanisms involved. These models apply
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equally well to MSCs and MAPCs, which may directly transdifferentiate into multiple cell types,
dedifferentiate through an intermediate cell type, represent highly pluripotent stem cells with the
ability to differentiate directly into multiple cells types or have the ability to fuse with different
cell types(149).
Figure 1.3

Figure 1.3. Schematic representation of the canonical Wnt/b-catenin signaling pathway. (a) In the
absence of Wnt signal, β-catenin is recruited into the APC/ Axin/GSK3β complex, and
phosphorylated by GSK3b at the N-terminal ‘destruction box’. The phosphorylated b-catenin
binds to β-Trcp of the proteosome machinery and is targeted for degradation. As the result, no free
β-catenin enters nucleus to form transcriptional complex with LEF/Tcf and to regulate downstream
gene expression. (b) Wnt binds to its Fz receptor and LRP5/6 co-receptor and activates Dvl,
leading to the inhibition of APC/Axin/GSK3β mediated β-catenin degradation. Stabilized βcatenin forms a transcriptional complex with LEF/Tcf and activates downstream targets such as cMyc. Negative regulators, such as Dkks, WIF and FRPs, inhibit the interactions between Wnt
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ligands and their receptors. There is crosstalk between Wnts and other signaling pathways, such
as growth factors that activate receptor tyrosine kinases. This figure is Adapted from Luo et al.
2007 (258).
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CHAPTER 2
EXPERIMENTAL METHODS

2.1. Preparation of adult Thymic epithelial cells (TEC)
Thymic lobes were extracted from humanely euthanized mice in ice-cold phosphate-buffered
saline (PBS). The thymic lobes were cleaned to remove fat and connective tissue and cut into four
smaller pieces and transferred into a new tube containing PBS. The cut pieces were gently agitated
using a glass Pasteur pipette to remove thymocytes. The remaining tissue was dissociated using
Collagenase D (1.8mg/ml) and DNase I (1X) in HBSS solution incubated in a 37oC water bath for
15 minutes with gentle agitation every 5 minutes using a Pasture pipette. The single-cell
suspension of digested tissue was washed with PBS and then filtered through a 100 μm strainer to
remove any clumps of tissue. Hematopoietic cells were removed from the single-cell suspension
using anti-mouse Thy1.2, CD11b, and CD19 antibodies and magnetic beads to enrich the TEC
population before sorting flowcytometric analysis.
2,2. Preparation of fetal thymic epithelial cells.
Time-pregnant mice were dissected to isolate pups from the embryonic sac. Then the fetuses are
used to extract thymic lobes from them. First, the thymic lobes were cleaned to remove fat and
subsequently was dissociated using Collagenase D (1.8mg/ml) and DNase I (1X) in HBSS solution
incubated in a 37oC water bath for 15 minutes with gentle agitation every 5 minutes using a Pasture
pipette. The single-cell suspension of digested tissue was washed with PBS. No depletion of the
hematopoietic cell was done from E13.5 to E 17.5 and directly used for flow cytometric analysis.
For E18.5 and E19.5, hematopoietic cells were removed from the single-cell suspension using anti53

mouse CD45 antibodies and magnetic beads to enrich for the TEC population before sorting or
flow cytometric analysis.
2.3. Isolation of Bone Marrow cells
Bone Marrow cells were isolated from mouse hind limbs, as previously described(259). The
resulting single-cell suspension was lineage depleted using biotinylated CD19, CD4, CD8, CD11b,
CD11c, B220, Ter119 antibody, and biotin-binder magnetic beads. The post-depletion cell
population was used for flow cytometric analysis
2.4. Flow cytometry
Cells were suspended in 106 cells/100 μl concentration in FACS staining buffer (FSB-5% fetal
bovine serum, 5 mM EDTA in PBS) and incubated with Fc- block (anti-mouse CD16/CD32
antibody) for 15 minutes in ice. After incubation, cells were washed and resuspended again in106
cells/100 μl concentration in FSB with appropriately diluted primary antibodies for 20 minutes on
ice in the dark. After washing, secondary antibodies appropriately diluted in FSB were added, and
the cells were incubated for an additional 20 minutes on ice in the dark. After washing, the cells
were resuspended in 500 μl of FSB for data acquisition. Data acquisition was performed using an
LSRII analyzer complete with three lasers (BD Bioscience), and cell sorts were performed using
a FACS Aria (BD Bioscience). FACS data were analyzed using Flow Jo software (Tree Star) or
FACS Diva software (BD Bioscience). For FACS analysis, we have routinely used the forward
Scatter (FSC) area versus Side Scatter (SSC) area analysis to discriminate the appropriate live cell
populations together with 7AAD staining. Doublet discrimination was performed by using SSC W
vs. SSC H followed by FSC W vs. FSC H. The single cells are then negatively selected for CD11b,
CD11c, CD19 staining to exclude thymic DCs, Macrophages, and B-cells from our population of
interest. To control for non-specific binding by the antibodies, gates for positive staining were set
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using isotype controls and/or one minus controls. To accurately set gates for GFP expression,
C56BL6 mice analysis controls stained with the same antibody cocktail were used. We
additionally used 7AAD staining for live-dead discrimination when we used irradiated C57BL6
mouse for our experiment to exclude the high proportion of radiation-induced dead cells.
2.5. RNA extraction and q-RT PCR from sorted cells
Cells were sorted as described above, and RNA was isolated using the Trizol method as directed
by the Qiagen RNA isolation mini-prep kit. Isolated RNA was used for cDNA synthesis using
Reverse transcriptase and random hexamers. The resulting cDNAs were used for q-RT PCR
analysis using Taqman probes for CD45 and EpCAM. The 18s RNA housekeeping gene was used
as a positive control to normalize the qPCR results.
2.6. Reaggregate Thymic Organ Cultures (RTOC)
EpCAM+CD45+ cells were isolated and sorted to greater than 95% purity from the bone marrow
and thymus-derived from Actin H2BGFP mice and placed in single-cell suspensions as described
above. The resulting highly purified EpCAM+ CD45+ GFP+ cells were mixed with dissociated
fetal thymic stromal cells from an E14.5 C57BL6 fetal thymus at a ratio of 1:10 to form a
reaggregate on a polycarbonate filter suspended over a trans-well plate. After 48 hours of culture,
these reaggregates were then surgically transplanted under Athymic Nude mice's kidney capsule
and grown for three weeks in vivo. After three weeks, the reaggregates were harvested and
sectioned for further IHC analysis.
2.7. Fetal Thymus Transfer Under Mouse Kidney Capsule
Fetal thymi were isolated from E14.5 C57BL6 or Actin H2BGFP mice, as stated, and 5-6 fetal
lobes were placed under the kidney capsule of either Actin H2BGFP mice or Rosa26 mRFP mice,
respectively. Following a time course of 3, 6, 9, or 12 weeks the kidneys were isolated, and most
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of the exogenous thymi were used for flow cytometric analysis, while the remaining lobes were
used for immunohistochemistry.
2.8. Hematopoietic stem cell transplant
For hematopoietic stem cell transplant, C57BL6 mice were subjected to total body irradiation with
1300 cGy using an X-ray irradiator. Total body sublethal irradiation cause hematopoietic cell
ablation. Simultaneously, linage-ve c-kit+Sca1+ positive hematopoietic stem cells are sorted from
ActinH2B GFP transgenic mice bone marrow. This Lineage-ve c-kit+Sca1+GFP+ sorted
cells(~200,000 cells) are then resuspended in 300µl PBS intravenously injected into sublethally
irradiated mice. Following a time course of 4, 5, 6, or 20 weeks these injected mice are sacrificed,
and their bone marrow and thymus were isolated for subsequent FACS analysis.
2.9. Systemic delivery of Bone marrow-derived cell
To induce partial injury to the mouse thymus, C57BL6 mice were subjected to total body
irradiation with 650 cGy using an X-ray irradiator. Simultaneously, linage-veCD45+EpCAM+
cells were sorted from ActinH2B GFP transgenic mice bone marrow. These linageveCD45+EpCAM+ GFP+ sorted cells(~50,000 cells) were then resuspended in 300µl PBS
intravenously injected into sublethally irradiated mice. Following a time course of 6 weeks, these
injected mice are sacrificed and their bone marrow and thymus were isolated for subsequent FACS
analysis.
2.10. Immunohistochemistry of Thymic Sections
Thymi were embedded in OCT compound from Tissue-Tek and snap-frozen using Liquid-N2. 8
µm sections were cut using a cryostat and mounted on coated slides. The slides were then air-dried
and fixed in 4% paraformaldehyde for 10 minutes, washed with PBS three times, then
permeabilized using acetone for 10 minutes, washed and blocked with complete normal donkey
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serum (1% Normal donkey serum in Bovine serum albumin). Appropriately diluted antibodies
specific to stromal subsets were added to the slides and then placed into a humid chamber at 4oC
overnight. Secondary antibodies were applied, if needed, and incubated in a humid chamber for
one hour at 37oC. After incubation, the slides were washed in PBS three times, mounted, then they
were sealed following the application of Prolong Gold antifade +DAPI reagent. Images were
acquired using a Zeiss LSM800 confocal microscope and LSM710 confocal microscope. Confocal
images were analyzed using LSM software (Zeiss).
2.11. Statistical Analysis
Data comparisons were performed using a non-parametric, unpaired, one-tailed T-test. All graphs
and statistical results were generated using Graph-pad Prism software. A P-value of <0.03 was
considered significant.
Table 1: A list of antibodies used in this study is given below.
Name

Specificity

CD45

Pan-hematopoietic marker

EpCAM

Thymic epithleial cell mamker

Pan-Keratin

Epithelial cell marker

FoxN1

Thymic epithelial cell marker

Dec205

Cortical thymic epithelial cell maker

BP1

Cortical thymic epithelial cell maker

UEA1

Medullary thymic epithelial cell maker

CD11b

Macrophage marker

CD11c

Dendritic cell marker

CD19, B220

B-cell marker
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Thy1.2, CD3, T-cell marker
CD4, CD8
Sca-1

Stem cell marker

CD49f

α6 integrin, epithelial stem cell marker

CD29

β1 integrin

FSP1

Fibroblast specific marker

MHCII

Thymic epithelial cell marker
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CHAPTER 3:
Bone Marrow-Derived Cells Contribute to the Maintenance of Thymic Stroma, including
Thymic Epithelial Cells
Title: Bone Marrow-Derived Cells Contribute to the Maintenance of Thymic Stroma, including
Thymic Epithelial Cells
Running Title: Bone-marrow derived CD45+EpCAM+cells Contribute to TECs.
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ABSTRACT
In paradox to critical functions for T-cell selection and self-tolerance, the thymus undergoes
profound age-associated atrophy and loss of T-cell function, which are further enhanced by cancer
therapies. Identification of thymic epithelial progenitor populations capable of forming functional
thymic tissue will be critical in understanding thymic epithelial cell (TEC) ontogeny and designing
strategies to reverse involution. We identified a new population of progenitor cells, present in both
the thymus and bone marrow (BM) of mice, that co-express the hematopoietic marker CD45 and
the definitive thymic epithelial marker EpCAM and maintains the capacity to form functional
thymic tissue. Confocal analysis and qRT-PCR of sorted cells from both BM and thymus
confirmed co-expression of CD45 and EpCAM. Grafting of C57BL/6 fetal thymi under the kidney
capsule of H2BGFP transgenic mice revealed that peripheral CD45+ EpCAM+ GFP-expressing
cells migrate into the developing thymus and contribute to both TECs and FSP1-expressing
stroma.

Sorted BM-derived CD45+EpCAM+ cells contribute to reaggregate thymic organ

cultures (RTOCs) and differentiate into keratin and FoxN1 expressing TECs, demonstrating that
BM cells can contribute to the maintenance of TEC microenvironments previously thought to be
derived solely from endoderm. BM-derived CD45+EpCAM+ cells represent a new source of
progenitor cells that contribute to thymic homeostasis. Future studies will characterize the
contribution of BM-derived CD45+EpCAM+ TEC progenitors to distinct functional TEC
microenvironments in both the steady-state thymus and under conditions of demand. Cell therapies
utilizing this population may prove useful for counteracting thymic involution in cancer patients.
Key points
CD45+ EpCAM+ TEC progenitor cells are found in mouse bone marrow and thymus.
Peripheral cells contribute to the thymic stroma, including TECs.
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Bone marrow-derived CD45+EpCAM+ cells contribute to TECs in RTOCs.
3.1. INTRODUCTION
The thymus serves as the primary lymphoid organ responsible for the development and
selection of a self-tolerant T-cell repertoire(33, 260). Thymic epithelial cells (TECs) are the most
significant component of the thymic microenvironment responsible for regulating T cell
development and selection(114, 260, 261). Thus, proper organization and maintenance of TECs
are critical for a properly functioning adaptive immune system(260-262). Despite the fundamental
importance of the thymus in the development of T cells, the thymus undergoes profound atrophy
relatively early in life(144, 263, 264). Thymus degeneration is physically evident in humans
starting at puberty, where the loss of functional thymic microenvironments contributes to a
progressively restricted naïve T cell repertoire, resulting in an immune system that is less capable
of responding to new immune challenges(144, 147). Thymic involution also severely restricts the
ability to generate long term, low morbidity tolerance to foreign transplants, including those of
stem cell origin(265). Understanding the signals and cell-to-cell interactions that control both the
development and postnatal maintenance of thymic epithelial cells is critical to design clinical
strategies to counteract age-associated involution while enhancing thymic recovery following
HSCT.
Structurally, the thymic stroma contains three compartments: 1) Cortex, 2) Medulla, and
3) Cortico-medullary junction(12). The cortex is composed of cortical thymic epithelial cells
(cTEC), defined by primarily keratin 8 expression as well as the surface expression of BP1 and
CD205, together with immature thymocyte subsets, and it is involved in positive selection and
MHC restriction during T-cell development(142). The thymic medulla is composed of medullary
thymic epithelial cells (mTEC), defined by primarily Keratin 5/Keratin 14 expression together
with UEA1 binding, and is involved in negative selection of mature single-positive (SP)
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thymocytes expressing autoreactive T-cell antigen receptors and development of FoxP3+Tregs(130,
142). The cortico-medullary junction is the perivascular space between the cortex and medulla,
which serves as the entry point of CD4-CD8-(DN) thymocytes to the thymus(266) as well as the
location where fully mature SP naïve T-cells exit to the peripheral blood vessels(142, 260, 262).
Most epithelial tissues are known to maintain tissue homeostasis throughout their adult life
through the action of progenitor or stem cell populations(267). Previous work has shown that TECs
of both the cortex and medulla develops from common progenitors during thymic organogenesis
(53, 92, 100, 106).

The presence of progenitors restricted to each lineage has also been

demonstrated(88, 100, 103, 104, 268, 269). Previous studies identified embryonic TEC
progenitors, expressing high levels of claudin-3 and claudin-4, that exclusively give rise to mature
mTECs(268).

Progenitors initially expressing cTEC lineage markers(270), including the

thymoproteosome subunit β5t(105, 108) and CD205(106), were shown to give rise to mTECS
during thymic organogenesis. However, the mechanisms responsible for the maintenance of
functional thymic microenvironments in the postnatal thymus remain unclear. Tissue maintenance
might be mediated through stem-cell-based regeneration similar to tissues with high turnover rates,
including hematopoietic, skin, and intestinal tissues(271). Alternatively, the thymus might be
maintained by replication of more differentiated cells, similar to tissues with lower turnover rates,
including the liver and pancreas(15). Previous studies revealed that TECs, particularly mTECs,
have much higher turnover rates than previously thought and are comparable with
keratinocytes(272), implying a stem-cell-based regeneration of at least mTECs. Embryonic
SSEA-1+ Cld3,4hi mTEC stem cells were shown to be capable of maintaining functional mTEC
regeneration, including mature mTECs and central T cell tolerance(1). The clonogenic activity of
these SSEA-1+ Cld3,4hi TECs was rapidly decreased after birth in wild-type (WT) mice but was
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maintaining in postnatal Rag2 deficient mice, suggesting that crosstalk previously thought to be
important in maintaining an appropriately organized thymus might inhibit maintenance of mTEC
stem cell activity(1).
The existence of bipotent TEPC in the postnatal thymus has also been demonstrated(100,
102, 104, 109), and they appear to be found within the cTEC population(273). The stem cell
characteristics of label retention and increased colony-forming capacity were identified within the
Sca-1hi MHCIIlo TEC subset(102, 109). In contrast, other studies demonstrated bipotent TEPC
potential within the PLET1+ MHCIIhi subset(104). These competing results suggest that more
work is needed to identify the bipotent epithelial progenitor phenotype and the mechanisms
responsible for postnatal TEC maintenance.
Hematopoietic stem cells (HSCs) give rise to a variety of hematopoietic cells found in the
thymus, including thymocytes, B cells, dendritic cells, and macrophages. Several recent studies
identified unexpected plasticity of bone marrow-derived hematopoietic stem cell populations(154,
183, 192, 274-276). These studies suggested that bone marrow-derived HSC can give rise to a
variety of different adult cell types. Previous work showed that BM-derived HSC, when
transplanted to irradiated hosts, home to and repopulate the bone marrow(154). Interestingly, it
was also shown that this cell population could migrate and differentiate into epithelial cells in the
lung, GI tract, and skin(154). BM-derived HSC can give rise to hepatocytes in both rodents and
humans was also demonstrated previously (156, 157). However, these studies were refuted by
showing that BM-derived populations begin expressing characteristics of non-hematopoietic
populations as a result of cell fusion rather than by trans-differentiation in the hepatocyte
system(197, 199). Later, by using a Cre-lox system to demonstrate that even though a small subset
of stem cells in the presence of somatic cells undergoes spontaneous fusion, there is a part of the
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HSC population that can undergo trans-differentiation to contribute to the keratinocyte expressing
epithelial cells in the skin during the process of wound healing(277). This study also showed that
BM-derived epithelial cells at the wound edges express Ki67, proving that these transdifferentiated cells are actively cycling(277). Bone-marrow-derived HSC was also shown to give
rise to lung epithelial cells under conditions of naphthalene-induced lung injury(276). Together,
these studies showed unexpected plasticity, with BM-derived HSC giving rise to epithelial cells in
different organs, but none of these studies suggested a contribution of BM-derived HSC to the
maintenance of thymic epithelial or other thymic stromal components.
In this study, we describe a unique population of CD45+EpCAM+ cells in both adult BM
and thymus that expresses both the definitive hematopoietic marker CD45 and the definitive
thymic epithelial marker EpCAM. Using both organ transplant and reconstitution thymus organ
culture, we show that this unique population of cells can contribute to the maintenance of nonhematopoietic components of thymic stroma, including keratin and FoxN1-expressing TECs.
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3.2. MATERIALS & METHODS
Mice
C57BL6 control, Actin H2BGFP transgenic, mRFP Rosa26 transgenic mice, and athymic
nude mice purchased from Jackson Laboratory were used for this study. The ages of the mice
ranged from 7-9 weeks. All mice were bred and maintained at the City College of New York
animal facility, and all experiments were performed with approval from the City College of New
York institutional animal care and use committee.
Antibodies
The following primary antibodies were used for experiments: CD45-PE Cy7, CD45-APC
Cy7, CD45 APC (clone 30-F11, BD Bioscience,Biolegend), Pan-keratin ( Polyclonal, Dako),
EpCAM-PE (clone G8.8, eBioscience),FoxN1(clone G-20, Santa Cruz Biotechnology)
FSP1(CloneS100A4 , Biolegend),Thy1.2(clone 30-H12, BD Bioscience), CD11b ( clone,
BioLegend), CD11b PerCpcy5.5 (clone M1/70, Biolegend) CD4- biotinylated(clone RM4-5 ,
BioLegend), CD8 -biotinylated (clone53-6.7, BioLegend), CD19 (clone1D3, Biolegend), Rabbit
anti-GFP (Life), , and CD205 (LY75/DEC-205)( clone HD30 (Millipore).We also used lineage
depletion panel containing B220. As control for EpCAM staining we used Rat IgG2a,κ Isotype
control(eBioscience). As control for CD45 staining we used Rat IgG2b,κ Isotype
control(Biolegend).
The following secondary reagents were used for experiments: donkey anti-rabbit IgGTRITC, donkey anti-rabbit IgG-Cy5, donkey anti-rabbit IgG-FITC, donkey anti-rat IgG-TRITC,
donkey anti-goat IgG-FITC, goat anti-rat IgM-TRITC (Jackson ImmunoResearch), anti-rat IgG2aFITC, anti-rat IgM-FITC, streptavidin-APC, streptavidin-APC Cy7, streptavidin-PerCP Cy5.5
(BD Bioscience) and streptavidin-TRITC (Southern Biotechnology Associate).
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TaqMan probes
All Taqman probes were purchased from Thermo-fisher Scientific, including CD45
(PTPRC), CD11c, EpCAM, and 18S rRNA.
Preparation of Thymic epithelial cells (TEC)
Thymic lobes were extracted from humanely euthanized mice in ice-cold phosphatebuffered saline (PBS). The thymic lobes were cleaned to remove fat and connective tissue and cut
into four smaller pieces, and transferred into a new tube containing PBS. The cut pieces were
gently agitated using a glass Pasteur pipette to remove thymocytes. The remaining tissue was
dissociated using Collagenase D (1.8mg/ml) and DNase I (1X) in HBSS solution incubated in a
37oC water bath for 15 minutes with gentle agitation every 5 minutes using a Pasture pipette. The
single-cell suspension of digested tissue was washed with PBS and then filtered through a 100 μm
strainer to remove any clumps of tissue. Hematopoietic cells were removed from the single-cell
suspension using anti-mouse Thy1.2, CD11b, and CD19 antibodies and magnetic beads to enrich
for the TEC population before sorting or flowcytometric analysis.
Isolation of Bone Marrow cells
Bone Marrow cells were isolated from mouse hind limbs, as previously described(259).
The resulting single-cell suspension was lineage depleted using biotinylated CD19, CD4, CD8,
CD11b, CD11c, B220, Ter119 antibody, and biotin-binder magnetic beads. The post-depletion
cell population was used for flow cytometric analysis.
Flow cytometry
Cells were suspended in 106 cells/100 μl concentration in FACS staining buffer (FSB5% fetal bovine serum, 5 mM EDTA in PBS) and incubated with Fc- block (anti-mouse
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CD16/CD32 antibody) for 15 minutes in ice. After incubation, cells are washed and resuspended
again in 106 cells/100 μl concentration in FSB with appropriately diluted primary antibodies for
20 minutes on ice in the dark. After washing, secondary antibodies appropriately diluted in FSB
were added, and the cells were incubated for an additional 20 minutes on ice in the dark. After
washing, the cells were resuspended in 500 μl of FSB for data acquisition. Data acquisition was
performed using an LSRII analyzer complete with three lasers (BD Bioscience), and cell sorts
were performed using a FACS Aria (BD Bioscience). FACS data were analyzed using Flow Jo
software (Tree Star) or FACS Diva software (BD Bioscience). For FACS analysis, we have
routinely used the forward Scatter (FSC) area versus Side Scatter (SSC) area analysis to
discriminate the appropriate live cell populations together with 7AAD or DAPI staining. Doublet
discrimination was performed by using SSC W vs. SSC H, followed by FSC W vs. FSC H. The
single cells are then negatively selected for CD11b, CD11c, CD19 staining to exclude thymic DCs,
Macrophages, and B-cells from our population of interest. Gates for positive staining were set
using isotype controls and/or one minus controls to eliminate false-positive results by non-specific
binding of the antibodies. To accurately set gates for GFP expression, C56BL6 mice analysis
controls stained with the same antibody cocktail were used. We additionally used 7AAD staining
for live-dead discrimination when we used irradiated C57BL6 mouse for our experiment to
exclude the high proportion of radiation-induced dead cells,
RNA extraction and q-RT PCR from sorted cells
Cells were sorted as described above, and RNA was isolated using the Trizol method as
directed by the Qiagen RNA isolation mini-prep kit. Isolated RNA was used for cDNA synthesis
using Reverse transcriptase and random hexamers. The resulting cDNAs were used for q-RT PCR
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analysis using Taqman probes for CD45 and EpCAM. The 18s RNA housekeeping gene was used
as a positive control to normalize the qPCR results.
Reaggregate Thymic Organ Cultures (RTOC)
EpCAM+CD45+ cells were isolated and sorted to greater than 95% purity from the bone
marrow and thymus-derived from Actin H2BGFP mice and placed in single-cell suspensions as
described above. The resulting highly purified EpCAM+ CD45+ GFP+ cells were mixed with
dissociated fetal thymic stromal cells from an E14.5 C57BL6 fetal thymus at a ratio of 1:10 to
form a reaggregate on a polycarbonate filter suspended over a trans-well plate. After 48 hours of
culture, these reaggregates were then surgically transplanted under the kidney capsule of athymic
Nude mice and grown for three weeks in vivo. After three weeks, the reaggregates were harvested
and sectioned for further IHC analysis.
Organ Transfer Experiments
Fetal thymi were isolated from E14.5 C57BL6 or Actin H2BGFP mice, as stated, and 5-6
fetal lobes were placed under the kidney capsule of either Actin H2BGFP mice or Rosa26 mRFP
mice, respectively. Following a time course of 3, 6, 9, or 12 weeks the kidneys were isolated, and
most of the exogenous thymi were used for flow cytometric analysis, while the remaining lobes
were used for immunohistochemistry.
Immunohistochemistry of Thymic Sections
Thymi were embedded in OCT compound from Tissue-Tek and snap-frozen using LiquidN2. 8 µm sections were cut using a cryostat and mounted on coated slides. The slides were then
air-dried and fixed in 4% paraformaldehyde for 10 minutes, washed with PBS three times, then
permeabilized using acetone for 10 minutes, washed and blocked with complete normal donkey
serum (1% Normal donkey serum in Bovine serum albumin). Appropriately diluted antibodies
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specific to stromal subsets were added to the slides and then placed into a humid chamber at 4oC
overnight. Secondary antibodies were applied, if needed, and incubated in a humid chamber for
one hour at 37oC. After incubation, the slides were washed in PBS three times, mounted, then they
were sealed following the application of Prolong Gold antifade +DAPI reagent. Images were
acquired using a Zeiss LSM800 confocal microscope and LSM710 confocal microscope. Confocal
images were analyzed using LSM software (Zeiss).
Statistical Analysis
Data comparisons were performed using a non-parametric, unpaired, one-tailed T-test. All
graphs and statistical results were generated using Graph-pad Prism software. A P-value of <0.01
was considered significant.
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3.3. RESULTS
Cells co-expressing both the definitive thymic epithelial marker EpCAM and the hematopoietic
marker CD45 are present in both the bone marrow and the thymus.
Presence of CD45+EpCAM+ cells in the thymus.
Using standard enzymatic digestion of thymic tissue in conjunction with CD45 magnetic
bead depletion to reduce the frequency of hematopoietic cells, we observed a persistent but rare
population of cells that co-expressed both CD45+ and EpCAM+ (DP), shown in Figure 3.1A. This
population has been described in several publications; however, they were identified as thymic
nurse cells, which are complexes of cTECs with internalized CD45+ thymocytes(50). Due to the
consistent presence of this DP population, even after very conservative doublet discrimination, we
set out to determine if this unusual population truly represented thymic nurse cells or was a unique
previously undescribed cell population expressing both CD45 and EpCAM. We enhanced the
isolation of this population by depleting hematopoietic cells in our enzymatically dissociated
thymic tissue using a cocktail of antibodies, including anti-Thy1.2, CD11b, CD11c, and CD19
together, rather than the usual anti-CD45 antibody. Figure 3.1 shows a representative FACS profile
demonstrating the increase in the frequency of the CD45+EpCAM+ population when anti-CD45
depletion was not utilized to deplete hematopoietic cells. Panel A shows that when anti-CD45
depletion was used to analyze the frequency of DP cells present in 8-month old C57BL/6 mice,
the CD45+EpCAM+ population represents only an average of 0.23% (+/-0.2%) of the total cells
present, whereas in panel B, when a cocktail of anti- Thy1.2, CD11b, CD11c, and CD19 was used
for depletion, the frequency of the CD45+EpCAM+ population in the total dissociated thymic cells
increased to an average of 1.14%. (+/-0.3%). Every set of experiments had four replicates. Our
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gating strategy, including stringent doublet discrimination, lineage-negative selection, along with
the isotype control for the EpCAM antibody, is shown in figure 3.11(H-M).
Thymic CD45+EpCAM+ cells co-express both CD45 and EpCAM at both the protein and
mRNA levels.
We reasoned that the apparent co-expression of CD45 and EpCAM, observed using flow
cytometry of dissociated thymic tissue, could be the result of epitope sharing caused by the close
association of thymocytes with thymic epithelial cells due to penetration of CD45 antibodies into
partially damaged TNC complexes or because of EpCAM expressing thymic dendritic
cells(DCs)(278). To confirm the presence of single cells co-expressing both CD45 and EpCAM,
CD45+EpCAM+ cells were sorted to high purity (~98% purity) using a FACS sorter from
dissociated thymic tissue using conservative doublet discrimination. Cells were also gated to
exclude hematopoietic cells using a cocktail of anti-Thy1.2, CD11b, CD11c, and CD19. To
confirm that the DP population expressed both the CD45 and EpCAM genes at the RNA level,
RNA was isolated from CD45+EpCAM+; CD45+; EpCAM+ cell populations sorted from thymic
tissue with high purity for and used for RNA isolation. For the CD45+EpCAM+ population, we
were able to achieve greater than 99% purity with the aid of back gating. For the CD45+EpCAMand CD45-EpCAM+ control populations, we achieved greater than ~96% purity. The sort purity
results are shown in Figure 3.12(A-E). We also sorted the lineage positive population to determine
the relative expression of CD11c to ensure that the DP population was not CD11C-expressing
thymic dendritic cells, which have been reported to express EpCAM(130). All RNA samples were
normalized to 5 ng/µl before performing qPCR. 18s rRNA was used as a housekeeping gene to
compare relative amounts of RNA expression (Fig. 3.2B-D). Isolated and normalized RNA was
analyzed using qRT-PCR with Taqman primers specific to EpCAM and CD45. Relative levels of
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RNA expression of both CD45 and EpCAM were normalized in each sorted population to the
levels of 18s rRNA to thoroughly rule out epitope sharing as the cause of this unique population.
Figure 3.2 shows the fold change in the expression level for both CD45 and EpCAM between the
two control populations (CD45+EpCAM-and CD45-EpCAM+) and the CD45+EpCAM+
population. Panel A shows the FACS representation of the sorted populations. Panel B shows the
relative CD45 expression in all three populations, where the CD45+EpCAM- population serves as
the positive control. As expected, the CD45+ control population has a high level of CD45
expression, whereas the EpCAM+ population has negligible (~98-fold lower) CD45 expression
compared to the CD45 only population. The DP population expressed ~80 fold more CD45 than
the CD45-EpCAM+ TEC population but only had a ~10-fold lower expression of CD45 than the
CD45+ EpCAM- population. Panel C shows the relative EpCAM expression in all three
populations, where the CD45-EpCAM+ population was used as a positive control. DP cells
exhibited ~37-fold higher EpCAM expression than the CD45+ population, while expression of
EpCAM was ~60- fold lower than that observed in the EpCAM only TEC positive control. As
expected, the CD45 only population has negligible EpCAM expression (~97 fold lower). The qRTPCR confirmed that the DP population co-expressed both CD45 and EpCAM mRNA. Analysis of
CD11c expression demonstrated a high level of CD11c expression in the lineage positive
population; however negligible CD11c expression (~96 fold lower) was observed in the lineage
depleted EpCAM-CD45+, CD45-EpCAM+, and CD45+EpCAM+ populations (Figure 3.2D). The
absence of CD11c mRNA expression in the CD45+EpCAM+ population showed that this new
population is not CD11C+EpCAM+ thymic DC and represents a previously undescribed subset.
Expression of both the CD45 and EpCAM surface proteins by sorted CD45+EpCAM+ cells was
verified using immunohistochemistry. CD45+ EpCAM- or CD45-EpCAM+ subsets were also
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sorted as controls and immediately imaged under a fluorescence microscope without further
staining to ensure that the antibodies were specific and that the CD45+EpCAM+ cells observed
using flow cytometry were indeed single cells co-expressing both CD45 and EpCAM surface
proteins. Figure 3.2 (E-S) shows the fluorescent microscopy imaging results obtained using the
sorted CD45+EpCAM+ population and the control CD45+ EpCAM- or CD45-EpCAM+
populations from C57BL6 thymus following Anti-CD45 antibody and anti-EpCAM antibody
staining. Combined CD11b, CD11c, and CD19 staining were performed on all sorted populations
to rule out Langerhans cells and thymic DCs that are known to co-express EpCAM(48-50) as well
as to rule out non-specific binding of the anti-CD45 and anti-EpCAM antibodies to FC receptors
on hematopoietic cells, leading to a false-positive result. The CD45+EpCAM- control cells showed
staining with only the anti-CD45 antibody (Fig. 3.2 E-I). The CD45-EpCAM+ control cells only
exhibited anti-EpCAM staining (Fig. 3.2 J-N). However, the CD45+EpCAM+ cells stained
strongly with both the anti-CD45 and anti-EpCAM antibodies while no staining with a cocktail of
anti- CD11b, CD11c, CD19 antibodies was observed (Fig. 3.2 O-S) and confirming that the
staining observed was not the result of non-specific FC-receptor binding. The inset of the merged
image of the sorted CD45+EpCAM+ population shows a single representative cell expressing both
CD45 and EpCAM. IHC results of the sorted cells confirmed protein co-expression of both CD45
and EpCAM on the CD45+EpCAM+ population.
To provide further evidence for this unique population's presence and to localize the cells
within the thymus, we sought to determine if the DP population could be seen within sections of
an intact adult mouse thymus. Within adult mouse thymus, CD45+ cells far outnumber and are
close to TECs. To better visualize the rare DP cells within the background of abundant CD45+
thymocytes, we performed intraperitoneal injections of dexamethasone on 6-week-old C57BL/6
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mice to specifically reduce the number of double-positive thymocytes, the most abundant CD45+
cells in the thymus. Three days following the dexamethasone injections, when the number of
thymocytes is most reduced, the mice were sacrificed, and their thymi were harvested, sectioned,
and stained with antibodies specific to CD45 (hematopoietic) and Pan-Keratin (epithelial) to
enable identification of thymic stromal cells co-expressing CD45 and EpCAM. Confocal imaging
of the stained sections revealed rare cells that share both hematopoietic (CD45+) and epithelial
(Pan Cytokeratin) characteristics in the intact thymus ( Figure 3.13). Together the IHC and qRTPCR results obtained with highly purified sorted cells from mouse thymus and IHC of sections of
intact thymus confirmed that the CD45+EpCAM+ cell population was observed in dissociated
thymic preparations truly co-express CD45 and EpCAM at both the protein and mRNA levels.
Further, these results suggest that we and others in the field may be losing a large percentage of
EpCAM+ cells by ignoring this CD45+ EpCAM+ population, including potential TEC
progenitors.
Rare CD45+ EpCAM+ Cells are present in the bone marrow.
Bone marrow-derived cells, including hematopoietic stem cells (HSCs), were previously
reported as contributors of epithelial cells for epithelial organs, including lung(276), gut, and
uterus through the process of trans-differentiation(154). Wong et al. showed that the BM-derived
CD45+CCSP+ cell population contributes to the alveolar epithelial cell population (CCSP is a
unique alveolar epithelial cell marker)(183, 276). As the DP population is expressing the
hematopoietic marker CD45, we wanted to determine if the CD45+EpCAM+ cells observed in the
thymus might be derived from a population in the BM. Bone marrow preparations were analyzed
for the presence of CD45+ EpCAM+ cells using flow cytometry. Multiple experiments with
C57BL6 bone marrow showed that bone marrow contains a low frequency (~0.1%-0.2%) of
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CD45+EpCAM+ cells (Figure 3.3A). Our gating strategy, including doublet discrimination,
lineage negative cell population selection along with isotype control staining for the EpCAM
antibody, is shown in figure 3.11(A-F). We have also shown the presence of the CD45+EpCAM+
cell population in athymic nude mice in figure 3.11 G. The presence of the CD45+EpCAM+ cell
population in nude mouse bone marrow confirms this population originates in the bone marrow
and does not migrate from the thymus to the bone-marrow. CD45+EpCAM+ cells could not be
identified in dissociated nude mouse thymus (data not shown).
To confirm that the population of CD45+EpCAM+ cells detected in flow cytometry
analysis represented a new population co-expressing both the CD45 and EpCAM proteins on their
surface and expressed at the mRNA level, we performed the same set of experiments shown above
for the thymic derived CD45+EpCAM+ population using sorted BM-derived cells.
CD45+EpCAM+ cells and CD45+EpCAM-cells (control) were sorted to high purity (~99%) from
a bone marrow preparation depleted of lineage-committed cells and stained with CD45 and
EpCAM antibodies. Bone marrow sort purity results are shown in figure 3.12 (F-I). The sorted
populations were subsequently analyzed using immunohistochemistry and qRT-PCR for
expression of CD45 and EpCAM for each of the sorted cell population.
To rule out epitope sharing as the cause of the bone marrow-derived DP population, we
determined the relative level of mRNA expression of both CD45 and EpCAM compared to the
housekeeping gene, 18s rRNA. All RNA samples isolated for these experiments were diluted to 5
ng/µL, to exclude differences in RNA amounts and normalized to 18s rRNA. The
CD45+EpCAM+ population was shown to express both CD45 and EpCAM mRNA using qRTPCR (Figure 3.3 B-C). Figure 3.3 panel B shows the relative CD45 expression in the
CD45+EpCAM+ population when compared with the CD45+EpCAM- positive control
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population. As expected, the CD45+ population has a high level of CD45 mRNA expression. The
DP population clearly expresses CD45 mRNA. However, it has a ~51-fold lower expression level
than the CD45+ EpCAM- control population. Panel C shows the relative EpCAM expression in
comparison to the CD45+EpCAM-, negative control population. The CD45+EpCAM+population
has a ~93- fold higher EpCAM mRNA than the CD45+EpCAM-control population.
The sorted DP and CD45 only populations in the BM were also analyzed using
immunohistochemistry for surface protein expression of CD45, EpCAM, and a mixture of CD11b,
CD11c, CD19 for each of the populations (Figure 3.3D-M). CD11b, CD11c, and CD19 combined
staining were done to rule out FC receptor binding to the CD45 and EpCAM antibodies leading to
a false-positive result as well as ensuring that the CD45+EpCAM+ cells observed were not CD11cexpressing DCs. The control CD45+EpCAM- cells only exhibited staining with the anti-CD45
antibody (3D-H). In contrast, the CD45+EpCAM+ cells were stained with both the anti-CD45 (3J)
and anti-EpCAM antibodies (3L) while no staining with the CD11b, CD11c, CD19 cocktail (3K)
was observed. The inset shows a higher magnification image of the DP cells (outlined by the box)
for every staining panel and demonstrates that the DP cells represent single cells expressing both
CD45 and EpCAM. Together these IHC results of sorted cells confirmed that single
CD45+EpCAM+ cells co-express both the CD45 and EpCAM proteins on their cell surface.
Isotype control staining was used to verify the specificity of the EpCAM and CD45 antibodies
(data not shown).
Collectively, these data show that there is a rare population of previously undescribed cells
in both the adult thymus and the bone marrow that co-express the hematopoietic marker CD45 and
the definitive thymic epithelial marker EpCAM. Further, we have demonstrated that in both adult
bone marrow and thymus, single cells express both the CD45 and EpCAM surface proteins and
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that highly purified sorted populations express mRNA for both genes confirming that this rare and
unique population exists. The absence of TNC complexes ensures that contrary to previous reports
when careful double discrimination is used, the DP cells are not TNCs, while the lack of CD11c,
CD11b, and CD19 surface protein expression allows exclusion of FC receptor binding to antibodies
or identification of Langerhans cells and thymic DCs which are known to express both CD11c and
EpCAM(278, 279).
CD45+EpCAM+ cells are recruited to thymic stroma from the periphery and contribute to
EpCAM+CD45- TECs.
E14.5 C57BL/6 fetal thymic lobes were transplanted under the kidney capsule of Actin
H2BGFP transgenic mice to understand if peripheral CD45+EpCAM+ cells can contribute to the
non-hematopoietic populations of the thymic stroma. The engrafted thymic lobes were then
harvested at different time points from 3 to 12 weeks following transplant and analyzed for the
presence of H2B-GFP-expressing cells that have migrated into and contributed to the growing fetal
thymi using both flow cytometry and immunohistochemistry. As a control, E14.5 C57BL/6 fetal
thymic lobes were transplanted under the kidney capsule of C57Bl6 mice and harvested after three
weeks for flow cytometric analysis to set up negative gating for GFP expression.
Figure 3.4A shows representative FACS analysis of dissociated transplanted thymic lobes
analyzed at different time points after transplant, Figure 3.4B shows the percentage of
CD45+EpCAM+GFP+ cells migrating into the C57BL/6 GFP-negative thymus, and 4C shows the
frequency of CD45-EpCAM+GFP+ TECs that are derived from peripheral sources. Bar graphs of
the mean percentages of peripheral CD45+EpCAM+GFP+ and CD45-EpCAM+GFP+ populations
found in the transplanted thymi are shown in Figure 3.4D-E.
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The flow-cytometric analysis revealed an influx of GFP+CD45+EpCAM+ cells into the engrafted
fetal thymic lobes. The presence of CD45-EpCAM+GFP+ TECs was detected at a later timepoint
in the C57BL/6 grafts (Figure 3.4). An influx of the peripherally derived CD45+EpCAM+GFP+
population was observed at every timepoint. The average frequency of the CD45+EpCAM+GFP+
population remained almost constant at week three, 17.88% (+/-7.3%), and week six, 18%
(+/7.9%). At week nine and week twelve, the average frequency of the CD45+EpCAM+GFP+
population increased to 26.53% (+/-19%) and 27.3%(+/-13%), respectively. An unpaired, nonparametric one-tailed T-test demonstrated that there was a significant increase in the frequency of
peripherally derived GFP+CD45+EpCAM+ cells within the C57BL6 fetal thymi that were
transplanted under C57BL6 kidney capsules when compared with C57BL/6 control thymi
transplanted under the kidney capsules of non-GFP expressing mice.
We compared each time point with the control. All the time points analyzed, when
C57BL/6 fetal lobes were transplanted under the kidney capsule of ActinH2BGFP mice, showed
a statistically significant number of CD45+EpCAM+GFP+ cells had migrated to the transplanted
thymi. Interestingly, a small but progressive increase in the frequency of CD45-EpCAM+GFP+
TECs was also observed, suggesting that true EpCAM-expressing TECs were also derived from
peripheral sources. The average frequency of GFP expressing TECs increased from 2.6% (+/2%) at week three to 4.4% (+/- 2%) at week six. At week nine, the average frequency of GFP
expressing TECs was 6.34% (+/- 4%) and increased to 7.4% (+/- 4%) at week twelve. C57BL/6
fetal thymi transplanted under the C57BL/6 kidney capsule were used as a control to allow gating
on true GFP-expressing cells in the engrafted thymus. When the frequency of EpCAM+GFP+ cells
in the engrafted thymi at each time points was compared to the control (using a non-parametric,
unpaired, one-tailed T-test), it showed significant numbers of EpCAM+GFP+ true TECs appearing
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in the transplanted thymic lobes. These results confirm that peripheral GFP+ CD45+EpCAM+
cells migrate into the thymus and that these peripheral cells then give rise to GFP-expressing
CD45-EpCAM+ thymic epithelial cells. This result is unprecedented, as it suggests that contrary
to previous models of thymic organogenesis, which suggested that all EpCAM expressing TECs
were derived from the third pharyngeal pouch endoderm and its derivatives, that in fact, up to 7%
of EpCAM only TECs may be derived from peripheral sources that migrate into the thymus.
Peripheral cells contribute to the pan-keratin and FoxN1 expressing epithelial cells in the
thymic stroma.
The engrafted thymi were also analyzed histologically in parallel experiments at the
previously indicated time points. Figure 3.5 shows the staining pattern of PanK (an epithelial cell
marker) and FoxN1 (a definitive thymic epithelial cell marker) in the transplanted thymic tissues
at different time points following transplant. These histological results showed the presence of a
PanK+ FoxN1+ H2B-GFP+ and PanK+FoxN1- H2BGFP populations in the engrafted fetal
thymus at week three and week six, and PanK+FoxN1+H2B-GFP+ cells appeared in higher
number at later time points (week nine and week twelve) shown in figure 3.5. Expression of PanK
on a GFP+ cell in the transplanted thymi indicates that peripheral cells can migrate into the thymus
and contribute to true TECs. At earlier time points, only PanK+FoxN1-GFP+ cells were observed,
while at later time points, PanK+FoxN1+GFP+ cells were observed. This sequential emergence of
two different populations of PanK+GFP+ cells that were initially FoxN1- followed by FoxN1+
cells with progressive age, indicates that first peripheral cells are recruited to the thymus and
differentiate into only PanK expressing TEC, and at a later time point more mature PanK+FoxN1expressing cells emerge. Images of 12th week transplanted fetal thymus staining for Pan-keratin
and DAPI at lower magnification (200x) is shown in figure 3.14 as a representative figure to show
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the morphology of fetal transplanted thymus. Figure 3.14 A-C shows week 12 images of the
transplanted fetal thymus. In this figure, the kidney is visible in the lower part of each image. This
figure clearly shows a properly developed transplanted thymus at week 12.
CD45+EpCAM+ cells can contribute to the thymic stroma in vivo.
To understand the differentiation potential of the CD45+EpCAM+ population in vivo, we
used reaggregate thymic organ culture (RTOC). GFP+CD45+EpCAM+cells were sorted to high
purity (greater than 96%) from Actin H2BGFP mouse bone marrow or thymus and reaggregated
with dissociated fetal thymic cells (E14.5) derived from GFP- C57BL6 mice. Reaggregates were
cultured for 48hrs on polycarbonate filters supported by trans-well plates and then engrafted under
the kidney capsule of athymic nude mice. The resulting ectopic thymic graft incorporated the
GFP+CD45+EpCAM+ population into the thymic stroma. At week three, we observed PanK and
FOXN1 expressing GFP+ cells in thymic stroma (Figure 3.6). RTOCs derived from bone marrow
had more GFP+ TECs, shown in figure 3.6 A-D, whereas thymus-derived RTOCs had a limited
GFP+ TEC population (figure 3.6 E-H). These results together showed that bone marrow and
thymus-derived CD45+ EpCAM+ cells could give rise to the thymic epithelium and prove that
peripheral cells contribute to the TEC component of the thymic stroma. Images of sections of
transplanted RTOCs stained for Pan-keratin and DAPI at lower magnification (200x) are shown
in figure 3.14. Figure 3.14 D-F shows BM RTOC, whereas panel G-I shows sections of thymic
derived RTOCs. In this figure, the kidney is visible in the lower part of each image. The figure
shows extensive Pan-keratin staining in both bone-marrow-derived and thymus-derived RTOCs,
indicating a properly developing reaggregate thymus at week 3.
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FSP1 expressing fibroblast cells in the thymus are derived from peripheral cells.
During our FACS and IHC analysis, we observed that apart from the CD45+GFP+,
CD45+EpCAM+GFP+, and CD45-EpCAM+GFP+ populations, there were a significant number
of GFP+ cells that did not express either CD45 or EpCAM. In addition to TECs, another nonhematopoietic contributor of the thymic stroma is fibroblasts. Recently, Fibroblast Specific
Protein-1 (FSP-1) expressing cells were shown to help to maintain medullary thymic epithelial
cells(280). Engrafted thymi were analyzed for FSP1 expression using IHC (Figure 3.7). Figure
3.7A-L shows a representative figure of FSP1 staining in the transplanted thymi at different
timepoints. The frequency of peripherally derived GFP+ cells found in the transplanted fetal lobes
that express FSP1 was calculated at the different time points post-transplant. At week three, the
percentage of GFP+ cells expressing FSP1 was 35% (+/- 8%), while at week six, it increased to
53 (+/-13). At week nine and week twelve, the percentage increased to 71.2% (+/-8%) and 71.4%
(+/-10%), respectively (figure 3.7 M). These results suggest that FSP1-expressing cells in the
thymic stroma are continuously derived from cells migrating into the thymus from peripheral
sources rather than through the expansion of stromal cells derived during embryonic development
of the thymus.
CD45+EpCAM+ cells can contribute to the FSP1 expressing fibroblasts in the thymic stroma
in vivo.
We next wanted to investigate whether the BM and thymic derived CD45+EpCAM+ cells
that contribute to TECs might also contribute to the peripheral populations giving rise to FSP1expressing
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CD45+EpCAM+H2BGFP+ BM or thymic cells mixed with non-GFP expressing fetal thymic cells
were sectioned and stained with FSP1 to investigate if CD45+EpCAM+ cells can contribute to the
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FSP1+ fibroblast population of the thymic stroma (Figure 3.8). We observed FSP1 expressing
H2B-GFP+ cells in the thymic stroma of RTOCs derived from both bone marrow and thymicderived CD45+EpCAM+ cells showing that CD45+EpCAM+ cells can also give rise to FSP1
expressing fibroblasts.
Peripheral derived CD45+EpCAM+H2BGFP+ and CD45-EpCAM+H2BGFP+ result from
trans-differentiation and not cell fusion.
Previous studies reported that HSC cells could give rise to epithelial cells in different
organs, including the liver, lung, GI tract, and skin, through trans-differentiation(154, 276).
However, these results were later disputed by Terada et al. and Wang et al., which suggested that
BM-derived cells do not transdifferentiate, but they spontaneously fuse with other cells and adopt
their characteristics(197, 199). The relatively high frequency of CD45+EpCAM+ cells observed
in both the thymus and BM suggested that they were not derived from fusion. To determine if the
H2BGFP-expressing TECs we observed in transplant experiments were the result of cell fusion
events or true trans-differentiation, we transplanted E14.5 fetal thymuses derived from Actin
H2BGFP time-pregnant mice under the kidney capsule of Rosa26 mRFP mice. If actin-H2BGFP+
EpCAM expressing CD45+EpCAM+ cells and the CD45-EpCAM+ true TECs shown in Figure
3.4 are the result of cell fusion, then in this double transgenic model, both GFP and RFP should be
expressed together on both the CD45+EpCAM+ cells and their resulting TEC progeny. However,
if the cells are genuinely derived from peripheral sources, then co-expression of both RFP and
GFP in the CD45+ EpCAM+ and EpCAM+ populations should not be observed. We analyzed the
transplanted thymi at two different time points 6 and 9 weeks after transplant. Analysis of
dissociated GFP-expressing fetal lobes using flow cytometry to identify RFP and GFP 6 and 9
weeks after transplant under the kidney capsule of Rosa26 mRFP mice revealed no co-expression
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of GFP and mRFP in either the CD45- EpCAM+, CD45+ EpCAM+ populations (Figure 3.9).
mRFP+ peripheral cells were observed in all the populations, including CD45-EpCAM+ TECs.
The CD45+EpCAM+ cell population had similar frequencies of peripheral mRFP+ cells at both
time points, 68% (+/-15%) and 66% (+/-15), respectively. The CD45-EpCAM+ population also
contained ~1% RFP + cells that were derived from peripheral mRFP cells migrating into the lobes.
This set of results showed that peripheral CD45+EpCAM+ cells that migrate to the thymus and
contribute to the thymic stroma are not the result of cell fusion and any H2BGFP+CD45+EpCAM+
cells observed as well as their H2BGFP+ CD45-EpCAM+ TEC progeny represent peripheral cells
migrating into the thymus and contributing to stromal components. There remains a slight
possibility that the CD45+ EpCAM+ cells observed in this experiment could be derived from an
earlier fusion event that occurred prior to the surgical transplant of the fetal lobes; however, we
argue that the complete absence of DP cells co-expressing RFP and GFP strongly supports that
they are not likely to be derived from cell fusion.
BM-derived CD45+EpCAM+ cells can migrate to the thymus and contribute to the thymusderived CD45+EpCAM+ and CD45-EpCAM+populations under the condition of the
radiation-induced injury.
Previously it was shown that the CD45+CCSP+ population in the bone marrow migrates
to the lungs and contributes to the alveolar epithelial population following naphthalene induced
lung injury(276). To understand if the CD45+EpCAM+ population found in the bone marrow can
contribute to the thymus under flowing radiation-induced injury, we partially irradiated (650cGy)
four-month-old C57BL6 mice and intravenous injected ~30,000 CD45+EpCAM+ cells sorted to
high purity (>95%) from Actin H2BGFP transgenic mice. Six weeks after injection, the mice were
sacrificed for further analysis. The presence of H2BGFP+ cells in the dissociated thymus of
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injected mice would indicate that the GFP labeled CD45+EpCAM+ population can migrate from
the bone marrow to the thymus. As a control, C57BL6 mice were irradiated with the same dose
X-rays and sacrificed within 48 hours, followed by thymic dissociation for FACS analysis. This
was done to enable accurate gating of the GFP+ cells migrating into the thymus from the
bloodstream or bone marrow. 7AAD staining was used to excluded radiation-induced dead cells
from the FACS analysis. Figure 3.10 shows representative FACS analysis of dissociated thymic
lobes. The lower panel of the figure shows the analysis of C57BL/6 control mice. Since the
irradiated C57BL/6 control mice were sacrificed within 48 hours, they show a higher frequency of
EpCAM only TECs than our experimental mice (due to less radiation-induced death), which were
analyzed 6-weeks after irradiation and CD45+EpCAM+cell injection. The upper panel of the
figure shows a representative image of irradiated C57BL/6 mice injected with H2B-GFPexpressing CD45+EpCAM+ BM-derived cells. The injected CD45+EpCAM+ H2BGFPexpressing cells were present in the thymus of the irradiated mice, where the frequency of
GFP+CD45+EpCAM+ cells averaged 15% (+/-10%). Interestingly we also observed a small but
consistent presence of GFP+CD45-EpCAM+ true TECS (2%), which could only have been
derived from the injected GFP-expressing CD45+EpCAM+ cells. These data show that the bonemarrow-derived CD45+EpCAM+ population can migrate to the thymus and contribute to nonhematopoietic components of thymic stroma under the condition of radiation-induced demand for
thymic recover
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3.4. DISCUSSION
In this study, we describe a unique, rare population in the postnatal bone marrow, which
can migrate to the thymus and contribute to the thymic epithelial cell pool. This bone marrowderived population expresses both the definitive thymic epithelial cell marker EpCAM and panhematopoietic cell marker CD45. This unique population was identified in dissociated thymic
tissue as well, supporting the idea that it migrates from the bone marrow to the thymus.
Immunohistochemistry and qRT-PCR results performed with highly purified sorted populations
of these CD45+EpCAM+ cells derived from both the bone marrow and thymus showed that these
cells express both CD45, EpCAM and no expression of CD11c at both the mRNA and protein
levels, confirming that they are not thymic nurse cells, or thymic DCs as previously reported(50)
or an artifact derived from enzymatic dissociation of closely associated TECs and thymocytes
(Figure 3.2 and Figure 3.3).
Several previous studies suggested that bone marrow-derived populations could contribute
to the epithelial cell populations of different organs, including lung, stomach, intestine, uterus(154,
156, 275, 276); however, these studies never identified a contribution to the thymus. In this study,
for the very first time, we are showing the presence of a potential thymic epithelial progenitor cell
population within the bone marrow. Analysis of C57BL6 fetal thymi, transplanted under the
kidney capsule of Actin H2BGFP mice, revealed that the CD45+EpCAM+ population can migrate
from the periphery to a growing fetal thymus and can contribute to non-hematopoietic components
of the thymic stroma (Figure 3.4). With progressive time after transplant, the frequency of the
CD45+EpCAM+GFP+ cell population increased and was followed by the subsequent emergence
of EpCAM+GFP+ TECs in the transplanted thymus.
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IHC analysis of the same tissue showed the presence of Pan-keratin and GFP expressing
cells in the transplanted tissues at all time points (Figure 3.5). Interestingly, Pankeratin+FoxN1+GFP+ cells also appear to emerge at later time points. Foxn1 is a crucial
transcription factor in TEC development and thymic function, and it is a well-established marker
for thymic epithelial cells. The sequential expression of FoxN1 leads us to believe that peripheral
cells can migrate to the growing thymus and can contribute to thymic stroma as PanK expressing
thymic epithelial cells, which later differentiate into more mature FoxN1 expressing TEC at later
time points(96, 97). The presence of relatively abundant GFP+ cells in grafted fetal thymic lobes
that did not bind the pan-keratin antibody, CD45, or Foxn1 led us to analyze the engrafted lobes
for the presence of other non-hematopoietic stromal components, including fibroblasts using FSP1
(a fibroblast marker). Recently it has been shown that FSP1 expressing cells are essential for the
maintenance of medullary thymic epithelial cells(280). FSP1 staining of the transplanted tissue
revealed the presence of a GFP expressing peripherally derived FSP1+ cell population (Figure
3.7). We also observed with the progressive time that the number of peripherally derived
GFP+FSP1+ cells increased (Figure 3.7M).
These results together showed that a peripheral CD45+EpCAM+ cell population could
migrate to the thymus and contribute to the non-hematopoietic components of the thymic stroma.
The CD45+EpCAM+ population appears to contribute to thymic stroma in two different ways: 1)
by directly giving rise to EpCAM and keratin expressing epithelial cells and 2) by giving rise to
an FSP1 expressing cell population, known to support the maintenance of the medullary thymic
epithelial cell population. Limitations in the availability of antibodies to sort FSP1-expressing cells
or co-localize both Keratin and FSP1 on the same populations post-RTOC precluded determining
whether they represented the same population or unique lineages derived from the
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CD45+EpCAM+ population. Future experiments will need to be performed to determine the
lineage relationship between FSP1+ GFP + peripheral cells and PanK+GFP+ peripherally derived
TECs.
Although several previous studies showed that bone-marrow-derived populations
including HSCs could contribute to tissue regeneration in epithelial organs, some of this work had
been refuted by subsequent studies which demonstrated that bone marrow-derived cells undergo
fusion, allowing them to take on characteristics of the recipient organs cell phenotype, instead of
genuinely transdifferentiating(197). Our results obtained when ActinH2BGFP fetal thymus was
transplanted under the kidney capsule of mRFPRosa26 mice clearly showed that the
CD45+EpCAM+ RFP+ cell population observed in the ActinH2BGFP thymus after transplant is
not the result of fusion (Figure 3.9) since no cells co-expressing RFP and GFP were observed. The
RFP+ CD45-EpCAM+ TECs observed in the transplanted thymi are derived from peripheral RFP+
cells migrating into the GFP-expressing fetal lobe.
When highly purified CD45+EpCAM+ GFP+ cells from the bone-marrow were
reaggregated with non-GFP fetal thymic stroma, the GFP+ bone-marrow-derived cells gave rise
to pan-keratin and FoxN1-expressing true thymic epithelial cells (Figure 3.6A-D), as well as FSP1
expressing fibroblast cells (Figure 3.8A-C). Similar results were obtained with reaggregates made
using the thymus-derived CD45+EpCAM+ population (Figure 3.6 E-H and Figure 3.8 D-F).
Together these results confirm that the CD45+EpCAM+ cell population from both bone marrow
and thymus can differentiate to Pan-Keratin expressing epithelial cells as well as FSP1 expressing
fibroblasts. Our results suggest that the thymus-derived CD45+EpCAM+ cells in RTOCs exhibit
less potential to differentiate into Pan-keratin expressing TECs than BM-derived CD45+EpCAM+
cells supported by the lower frequency of Pan-Keratin+ true TECs. This result leads us to
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hypothesize that the BM-derived cells have more potential to differentiate in Pan-Keratin
expressing TECs, whereas the thymus-derived CD45+EpCAM+ population might have lost some
of its potentials to differentiate into TECS, or some of the cells may be committed to a different
fate other than Pan-Keratin expressing epithelial cells.
Further, when highly purified CD45+EpCAM+GFP+ cells sorted from the BM of Actin
H2BGFP mice were intravenously injected into partially irradiated C57BL6 mice,
CD45+EpCAM+GFP+ cells were shown to migrate to the thymus under the condition of demand
induced due to injury and contribute to the CD45+EpCAM+ population in the recovering thymic
stroma (Figure 3.10). The frequency CD45+EpCAM+GFP+cells in the recovering thymus is
significant; however, the frequency of EpCAM+GFP+ cells remained low. Later timepoint
analysis is needed to understand if a longer time is needed to observe an increase in the
CD45+EpCAM+GFP+ population's contribution to the EpCAM expressing TEC population or if
the migration of this population decreases with the further recovery of the thymus.
In summary, this study demonstrates that a bone-marrow-derived population expressing
both CD45 and EpCAM can migrate and contribute to the thymic stroma and can give rise to two
different non-hematopoietic cell populations in the thymic stroma, including both FSP1expressing fibroblasts and keratin/FoxN1- expressing TECs under the condition of demand. It is
not clear whether the CD45+EpCAM+ cells are derived from HSCs or represent a distinct lineage
of BM cells. Future studies will also need to be performed to determine the lineage relationships
between the FSP1+ cells and the true keratin expressing TECs derived from the CD45+EpCAM+
population. They could represent distinct fates of the same population or steps in an undefined
ontogeny. It is also unclear how significant the CD45+EpCAM+ population and its progeny are
to TEC homeostasis or how they might contribute to self-tolerance or T cell selection. Previous
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work has suggested that the MHC background of the thymic microenvironment determines the
MHC restriction of developing T cells after BMTs(281). If BM-derived cells are migrating into
the thymus and contributing to the maintenance of TEC subsets, then it is surprising that they do
not influence the MHC restriction of developing thymocytes. Further studies needed to be done
to understand the ontogeny of this population and its contribution to distinct TEC subsets. If
migrating CD45+EpCAM+ cells only contribute to mTECs, then it is possible that they do not
influence MHC restriction but might contribute to self-tolerance through negative selection or the
development of Regulatory T-Cell (Tregs).
Despite the presence of a progenitor cell population in BM that can contribute to TECs, the
thymus still undergoes age-related involution. Understanding the lineage of the CD45+EpCAM+
BM population as well as the mechanisms responsible for the migration of this population to the
thymus and how they contribute to the maintenance of TEC number and organization will be
critical in counteracting age-associated involution, particularly in cancer patients, due to enhanced
degeneration in response to therapy. This study addresses a significant unmet clinical need for
thymus reconstitution by defining the contribution of bone-marrow-derived thymic epithelial
progenitor cells (TEPC) to the maintenance of TEC microenvironments in the postnatal thymus.
It should provide an additional target for overcoming thymic atrophy and hence, the development
of more strategic therapies for immunological-based diseases and cancer.
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Figures and Figure Legends:
Figure 3.1

Figure 3.1. An alternative hematopoietic cell depletion method reveals a previously unidentified
CD45+ EpCAM+ population in the thymus. FACS profiles show viable single cells gated on
CD11c-, CD11b-and CD19- cells. A- Shows the presence of only 0.091% of CD45+EpCAM+
cells present in dissociated thymic tissue when using the sheep-anti-CD45 antibody followed by
anti-sheep magnetic beads for the depletion of hematopoietic cells. B- Shows enrichment of the
CD45+EpCAM+ population to 1.5% derived from dissociated thymic tissue when a cocktail of
sheep anti-Thy1.2, anti-CD11b, and anti-CD19 antibodies followed by anti-sheep magnetic beads
was used in place of anti-CD45. All the experiments were done in three replicates.
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Figure 3.2

Figure 3.2. Single sorted thymic CD45+ EpCAM+ cells express both CD45 and EpCAM surface
proteins and their mRNA. CD45+ EpCAM+ cells were sorted to high purity and analyzed for
CD45 and EpCAM expression using immunofluorescence microscopy and qRT-PCR.
CD45+EpCAM-; and CD45-EpCAM+ cells were sorted as controls. A: FACS analysis
representation of the gating strategy used for cell sort. B: Shows relative CD45 expression level in
the thymus-derived CD45+EpCAM+ cells compared to the CD45+EpCAM- and CD45-EpCAM+
control populations; C: Shows the relative EpCAM expression level in the thymus-derived
CD45+EpCAM+ cells compared to the CD45+EpCAM- and CD45-EpCAM+ control populations.
D: Shows the relative CD11c expression level in the thymus-derived CD45+EpCAM+ cells
compared to the Lineage positive (CD11c+), CD45+EpCAM- and CD45-EpCAM+ control
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populations. E -I: DIC image, CD45 staining (blue), CD11b,CD11c,CD19 staining (green);
EpCAM staining (red) and Merged image respectively for CD45+EpCAM- control population ; JN: DIC image, CD45 staining(blue), CD11b,CD11c,CD19 staining (green); EpCAM staining
(red) and Merged image respectively for CD45-EpCAM+ control population; O-S: DIC image,
CD45 staining (blue), CD11b,CD11c,CD19 staining (green); EpCAM staining (red) and Merged
image respectively for the CD45+EpCAM+ experimental population. CD45+EpCAM+ cells of
interest are enlarged in the insets to show both proteins' colocalization and represent the cells
shown in the white boxes. The experiments were done in three replicates.
Figure 3.3

Figure 3.3. Single sorted bone marrow-derived CD45+ EpCAM+ cells express both the CD45 and
EpCAM genes and surface proteins. CD45+ EpCAM+ cells were sorted to high purity and
analyzed for CD45 and EpCAM expression using immunofluorescence microscopy as well as
qRT-PCR. CD45+EpCAM- cells were also sorted as a control. A: FACS profile of the gating
strategy used for sorting. B: Shows the relative CD45 expression level in the sorted BM-derived
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CD45+EpCAM+ cells compared to the CD45+EpCAM- control population; C: Shows relative
EpCAM expression level in the sorted BM-derived CD45+EpCAM+ cells compared to the
CD45+EpCAM- control population. D-H sorted CD45+EpCAM- controls (D) DIC image; (E)
CD45 staining (blue); (F) CD11b, CD11c, CD19 staining (green); (G) EpCAM staining (red); (H)
Merged. I-M shows immunohistochemistry results obtained with sorted CD45+EpCAM+ cells (I)
DIC image; (J) CD45 staining (blue); (K) CD11b, CD11c, CD19 staining (green); (L) EpCAM
staining (red) and (M) Merged image. CD45+EpCAM+ cells of interest are enlarged in the insets
to show the colocalization of both proteins and represent the cells shown in the white boxes. All
the experiments were done in three replicates.
Figure 3.4
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Figure 3.4. A peripheral population can contribute both CD45+ EpCAM+ cells as well as CD45EpCAM+ TECs in the thymus. C57BL6 fetal thymi were transplanted under the kidney capsule of
Actin H2BGFP mice and analyzed for the presence of GFP-expressing cells at four timepoints 3
to 12 weeks after transplant using FACS. A: The FACS representation of the lineage depleted cells
derived from dissociated engrafted thymi gated for CD45 and EpCAM. (B) The FACS
representation of the percentage GFP+ cells within the CD45+EpCAM+subset found in the grafted
thymus and (C) The FACS representation of the percentage GFP+ cells within the CD45-EpCAM+
population at the different time points after transplant under the kidney capsule. D. Bar graph
showing the mean percentage of the GFP-expressing cells found within the CD45+EpCAM+ cell
population at different timepoint (error bars represent SEM). E: Bar graph showing the mean
percentage of the GFP-expressing cells found within the CD45-EpCAM+ TEC population at
different time points (error bars represent SEM). "*" indicates a statistically significant difference
between control and any time point. P-values for each t-test analysis are given with the bar graph.
All the experiments were done in three-five replicates.
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Figure 3.5

Figure 3.5. A peripheral population can migrate into the thymus and contribute to PanK and FoxN1
expressing thymic epithelial cells. C57BL6 fetal thymi were transplanted under the kidney capsule
of Actin H2BGFP mice and analyzed for the presence of GFP-expressing peripheral cells 3-12
weeks after transplant using IHC. A-D: Week 3 transplanted thymic tissue sections showing
expression of PanK (A), GFP+ peripheral cells (B), FoxN1 (C), and Merged image (D). E-H: Week
6 transplanted thymic tissue section showing expression of PanK (E), GFP+ peripheral cells (F),
FoxN1 (G), and Merged image (H). I-L: Week 9 transplanted thymic tissue section showing
expression of PanK (I), GFP+ peripheral cells (J), FoxN1 (K), and Merged image (L). M-P: Week
12 transplanted thymic tissue section showing expression of PanK (M), GFP+ peripheral cells (N),
FoxN1 (O), and Merged image (P). GFP, Pank, and FoxN1 expressing cells of interest are enlarged
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in the insets to show colocalization of both proteins and represent the cells shown in the white
boxes. PanK+ FoxN1+ GFP+ cells and PanK+ FoxN1- GFP+ cells at all time points are indicated
by white and red arrows, respectively. All the experiments were done in three-five replicates.
Figure 3.6

Figure 3.6. Reaggregate thymic organ cultures show that both bone marrow and thymus-derived
CD45+ EpCAM+ cells can give rise to PanK+ FoxN1+ thymic epithelial cells. (A-D) Sections of
RTOC consisting of C57BL/6 fetal thymus mixed with sorted actin-H2BGFP-expressing bone
marrow-derived CD45+EpCAM+ cells. A representative RTOC section showing PanK expression
(A); FoxN1 expression (B) with GFP expressing cells derived from the CD45+EpCAM+ cells
sorted from adult GFP-expressing bone-marrow (C), (D) Merged image of PanK, FoxN1 and GFP.
(E-H) Sections of RTOC consisting of C57BL/6 fetal thymus mixed with sorted actin-H2BGFPexpressing thymic derived CD45+EpCAM+ cells. A representative RTOC section showing PanK
expression (E); FoxN1 expression (F) and; GFP expressing cells derived from actin H2B-GFPexpressing CD45+EpCAM+ cells sorted from the adult thymus (G); the Merged image of PanK,
FoxN1 and GFP (H). GFP, Pank, and FoxN1 expressing cells of interest are enlarged in the insets
to show co-expression of both proteins and represent the cells shown in the white boxes. All the
experiments were done in three replicates.
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Figure 3.7

Figure 3.7. Peripheral cells migrating into the thymus contribute to FSP1-expressing fibroblasts.
C57BL6 fetal thymi were transplanted under the kidney capsule of Actin H2BGFP mice and
analyzed 3-12 weeks after transplant using IHC. A-C: Week 3 transplanted thymic tissue section
showing the presence of GFP expressing peripheral cells (A), FSP1-expressing cells (B), and
Merged image for FSP1 and GFP expression (C). D-F: Week 6 transplanted thymic tissue section
shows the presence of GFP-expressing peripheral cells (D), staining pattern for FSP1 (E), and
Merged image for FSP1 and GFP expression (F). G-I: Week 9 transplanted thymic tissue section
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shows the presence of GFP expressing peripheral cell (G), staining pattern for FSP1 (H), and
Merged image for FSP1 and GFP expression (I). J-L: Week 12 transplanted thymic tissue section
shows the presence of GFP-expressing peripheral cells (J), staining pattern for FSP1(K), and
Merged image for FSP1 and GFP expression (L). GFP, FSP1 expressing cells of interest are
enlarged in the insets to show co-expression of both proteins and represent the cells shown in the
white boxes. Bar-Graph showing the mean of frequency of GFP expressing peripheral cells also
expressing FSP1 at different timepoints following transplant (error bars represent SEM). All the
experiments were done in three-five replicates.
Figure 3.8

Figure 3.8. Reaggregate thymic organ cultures show that both bone marrow and thymus-derived
CD45+ EpCAM+ cells can give rise to FSP1+ thymic stromal cells. (A-C) RTOC consisted of
C57BL/6 fetal thymus mixed with bone marrow-derived actin H2B-GFP-expressing
CD45+EpCAM+ cells. A representative RTOC section showing FSP1 expression (A), with GFP
expressing cells derived from actin H2BGFP expressing CD45+EpCAM+ cells sorted from adult
bone-marrow (B); the Merged image of FSP1 and GFP (C). (D-F) RTOC consisting of C57BL/6
fetal thymus mixed with thymus-derived actin H2B-GFP-expressing CD45+EpCAM+ cells. A
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representative RTOC section showing FSP1 expression (D); with GFP expressing cells derived
from CD45+EpCAM+ cells sorted from adult bone-marrow (E); the Merged image of FSP1 and
GFP (F). GFP and FSP1 expressing cells of interest are enlarged in the insets to show coexpression of both proteins and represent the cells shown in the white boxes. All the experiments
were done in three replicates.
Figure 3.9

Figure 3.9. The CD45+EpCAM+ and CD45-EpCAM+ TEC populations derived from peripheral
cells are not a result of cell fusion. Actin H2B-GFP fetal thymuses were transplanted under the
kidney capsule of mRFP ROSA26 mice and analyzed 6 and 9 weeks after transplant using FACS.
All the experiments were done in triplicate. A: The FACS representation of the lineage depleted
cells derived from dissociated engrafted thymi gated for CD45 and EpCAM B: The FACS
representation of the percentage of GFP+; GFP+RFP+; and RFP+ expressing cells within the
CD45+EpCAM- population at different time points; C: The FACS representation of the
percentage of GFP+; GFP+RFP+; and RFP+ expressing cells within the CD45+EpCAM+
population at different time points; D: The FACS representation of the percentage of GFP+;
GFP+RFP+; and RFP+ expressing cells within the CD45-EpCAM+ population at different time
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points. E. Bar graph showing the mean percentage of the CD45+GFP+RFP+ (potential cell
fusions) and CD45+RFP+ (peripheral cells) populations at different time points (error bars
represent SEM). F: Bar graph showing the mean percentages of the CD45+EpCAM+GFP+RFP+
(potential cell fusions); CD45+EpCAM+RFP+ (peripheral cells) populations at different
timepoint (error bars represent SEM). G: Bar graph showing the percentages of the
EpCAM+GFP+RFP+ (potential cell fusions); EpCAM+RFP+ (peripheral cells) cell populations
at different time points (error bars represent SEM). This experiment was done in three replicates.
Figure 3.10

Figure 3.10. Bone-marrow derived CD45+ EpCAM+ cells can migrate to the thymus and
contribute to the thymic CD45+EpCAM+ population, as well as CD45-EpCAM+ TECs under the
condition of the radiation-induced injury. CD45+EpCAM+ GFP+ cells were sorted to greater than
99% purity from Actin H2BGFP mouse bone-marrow and intravenously injected into partially
irradiated C57BL6 mice. The thymus was then dissociated and analyzed for the presence of GFPexpressing cells 6-weeks after transplant using FACS. (A) Representative FACS profile of the
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lineage depleted cells derived from dissociated irradiated and injected thymus showing the gating
strategy used analysis of live, lineage negative cells. (B) (A) The FACS representation of the
lineage depleted cells derived from dissociated irradiated and injected thymi gated for live and
lineage negative cells. (B) Representative FACS profile showing CD45 and EpCAM expression
within the viable lineage negative cells from A and the gating strategy used for the analysis of the
CD45+EpCAM+ and CD45-EpCAM+ subsets subsequently analyzed for GFP expression in
panels C and D. (C) Representative FACS profile showing the percentage of EpCAM+GFP+ cells
within the CD45+EpCAM+subset found in the thymus post-irradiation and injection of DP cells
and (D) Representative FACS profile showing the percentage of EpCAM+GFP+ cells within the
CD45-EpCAM+subset found in the thymus post-irradiation and injection of DP cells (E-F).
Identical analysis to that A-D above using dissociated thymus from irradiated control non-GFP
expressing C57BL/6 mice to allow proper gating on H2BGFP+ cells. E) Gating used for viable
lineage negative dissociated thymic cells. (F) Representative FACS profile showing CD45 and
EpCAM expression within the viable lineage negative cells from E and the gating strategy used
for the analysis of the CD45+EpCAM+ and CD45-EpCAM+ subsets subsequently analyzed to
allow proper gating for GFP expression in G and H. (G) The FACS representation of the control
gate for GFP expressing cells within the CD45+EpCAM+subset found in the irradiated thymus
and (H) The FACS representation of the control gate for GFP expressing cells within the CD45EpCAM+subset found in the irradiated thymus. Four replicates of these experiments were
performed.
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Figure 3.11

Figure 3.11. Gating strategy for FACs analysis of the lineage depleted bone-marrow and thymusderived CD45+EpCAM+ cell populations. A) Gating strategy for live cells in bone marrow
analysis: SSC A vs. FSC A. B) Gating for doublet discrimination of live cells: SSC W vs. SSC H;
C) Gating strategy for doublet discrimination of live cells: FSC W vs. FSC H; D) Gating for lineage
negative single cells using a cocktail of lineage antibodies including CD11b, CD11c, CD19; E)
The FACS representation of the lineage depleted cells derived from bone-marrow gated for CD45
and EpCAM. F) The FACS representation of the lineage depleted cells derived from bone-marrow
gated stained with CD45 together with the EpCAM using isotype control used to set the gate for
EpCAM staining. G) The FACS representation of the lineage depleted cells derived from the bonemarrow of nude mice gated for CD45 and EpCAM. H) Gating strategy for live cells in the analysis
of dissociated thymus: SSC A vs. FSC A. I) Gating for doublet discrimination of live cell: SSC W
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vs SSC H; J) Gating for doublet discrimination of live cell: FSC W vs FSC H; K) Gating for lineage
negative single cells using a cocktail of lineage antibodies including CD11b, CD11c, and CD19;
L) The FACS representation of the lineage depleted cells derived from dissociated thymus gated
for CD45 and EpCAM. M) The FACS representation of the lineage depleted cells derived from
dissociated thymus gated for CD45 and EpCAM using the isotype control for EpCAM staining to
allow proper gating of EpCAM expression. All the experiments were done in three-five replicates.
Figure 3.12

Figure 3.12. FACS representation showing the sort purity of Bone-marrow and thymus-derived
CD45+EpCAM+ cells and the other control cell populations used for RNA isolation. A) The FACS
representation of the pre-sort population and the gates used for sorting the CD45+EpCAM+cells
derived from the thymus. B) The FACS representation showing the live gating post sort purity
obtained for the thymus-derived CD45+EpCAM+ subset; C) The FACS representation showing
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the purity obtained for the thymus-derived CD45+EpCAM+ sorted subset; D) The FACS
representation showing the purity obtained for the thymus-derived CD45-EpCAM+ sorted subset;
E) The FACS showing the purity obtained after sorting the CD45+EpCAM-subset from the
thymus; F) The FACS representation of the gating strategy used for sorting the BM-derived
CD45+EpCAM+ and CD45+EpCAM- subsets; G-I) The FACS representation showing the purity
of the live gated (G) and BM-derived CD45+EpCAM+ (H) CD45+EpCAM- (I) subsets. All the
experiments were done in three replicates.
Figure 3.13

Figure 3.13. Presence of a CD45+Pan-keratin+ population in adult thymic sections.
Dexamethasone treated murine thymuses were sectioned and stained for CD45 and PanCytokeratin. Panel A showing a Maximum Intensity projection of CD45 staining; Panel B showing
Maximum Intensity projection of Pan-Keratin staining; Panel C showing Maximum Intensity
104

projection of DAPI staining. Panel D showing Maximum Intensity projection of merged CD45
and EpCAM staining. CD45 and EpCAM expressing cell of interest are enlarged in the insets to
show co-expression of both proteins and represent the cell shown in the white boxes. This
experiment was performed in three replicates.
Figure 3.14

Figure 3.14. Representative lower magnification image at week 12 post-transplant of a C57BL6
fetal thymus transplanted under the kidney capsule of an Actin H2BGFP mouse as well as both
BM and thymic RTOCs transplanted under a nude mouse kidney capsule stained with DAPI and
Pan- Keratin antibody to show the structure of the transplanted thymus. 200X images of sections
of transplanted C57BL6 fetal thymus transplanted under the kidney capsule of an Actin H2BGFP
mouse stained with DAPI (A), PanK (B), and the merged image (C). Sections of RTOC consisting
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of C57BL/6 fetal thymus mixed with sorted actin-H2BGFP-expressing bone marrow-derived
CD45+EpCAM+ cells. A representative 200x image of an RTOC section showing DAPI (D); PanK expression (E), and the merged image of PanK, and DAPI (F). The lower part of each image
clearly shows the presence of the kidney (D-F). Sections of an RTOC consisting of C57BL/6 fetal
thymus mixed with sorted actin-H2BGFP-expressing thymic derived CD45+EpCAM+ cells. A
representative RTOC section showing DAPI staining (G), Pan-keratin staining (H), and the merged
image of PanK and DAPI (I). The lower part of each image clearly shows the presence of a kidney.
(G-I) All the experiments were done in three replicates.
3.5. SUPPLEMENTARY INFORMATION
As an extension of this paper, we did some further analysis. Those results are explained below
Peripheral cells can differentiate into DEC205 expressing cTECs and UEA1 binding mTECs
in the thymic stroma.
Recently, evidence has been mounting that the scavenger receptor CD205 (DEC205) is
mainly expressed in cTEC, but recent studies have shown that the Dec205+ cell can also define
the TEPC population (282). Transplanted C57BL/6 fetal thymuses under Actin H2BGFP kidney
capsules were analyzed for UEA1 (an mTEC marker) and DEC205 (cTEC marker). The thymus
looked quite disorganized at weeks 3 and 6 ( figure 3.15 A-H), as expected due to the use of a fetal
thymus for engraftment. However, at weeks 9 and 12, the thymus looks like an adequately
organized adult thymus with distinct medullary and cortical areas, defined by UEA-1 and DEC205,
respectively(figure 3.15 I-P). Upon analyzing the data, there seems to be some GFP expressing
peripheral cells express DEC205 and/ or UEA1. But we observed more GFP+DEC205+ cells
rather than GFP+UEA1+ cells.
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Interestingly, at the 9th-week post-transplant, we observed a small number of peripheral
derived GFP-expressing cells that expressed DEC205 and UEA1 (Figure 3.16 A-D). From this set
of results, we hypothesize that the Dec205+UEA+GFP+ cell population represents a TEPC
population that can differentiate into mTEC and cTEC population.
Peripheral cells can not differentiate into DEC205 and UEA1 expressing cTEC and mTEC
in the thymic stroma in vivo
We next wanted to investigate whether the BM and thymic derived CD45+EpCAM+ cells that
contribute to TECs might also differentiate into DEC205 and UEA1 expressing cTEC and mTEC
in the thymic stroma. RTOCS composed of sorted CD45+EpCAM+H2BGFP+ BM or thymic cells
mixed with non-GFP expressing fetal thymic cells were sectioned and stained with DEC205 and
UEA1 to investigate if CD45+EpCAM+ cells can differentiate into cTEC and mTEC population.
In BM RTOC, we observed significant Dec205 staining but minimal UEA 1 staining. We also
observed an insignificant GFP+ DEC205+ cell in BM-derived RTOC. Similarly, in the thymusderived RTOC, we observed substantial Dec205 staining (Figure 3.17 A) but minimal UEA1
staining (figure 3.17 B). But no DEC205+GFP+ cells were observed in thymus-derived RTOCs (
Figure 3.17 E). This data set suggests that the BM-derived CD45+EpCAM+ cells differentiate
into DEC205 expressing cTEC or DEC205 expressing TEPC population three weeks posttransplantation. Different time points need to be analyzed for future experiments to observe if this
population can differentiate into UEA1 binding mTECs. But for RTOCs with thymus-derived
CD45+EpCAM+ cells after three weeks post-transplant CD45+EPCAM+ cells differentiated to
Keratin expressing TECs, but they are not further differentiated into DEC205+ or UEA1+
population. Analysis of further time points is necessary to observe if this population can
differentiate into Dec205+ and /or UEA1+ cells.
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Expression of FSP1 at mRNA level and protein level in both the thymus and BM-derived
CD45+EpCAM+ population.
In the previous section, we demonstrated that when we engrafted E14.5 C57BL6 fetal
thymus under the kidney capsule of Actin-H2BGFP mice, GFP-expressing cells from the periphery
migrated into the engrafted fetal thymus. Those GFP+ cells mainly contributed to
CD45+EpCAM+ cells, epithelial cells, and FSP1-expressing cells. We also demonstrated both the
BM-derived and thymus-derived CD45+EpCAM+ population could contribute to the FSP1
expressing thymic stroma in reaggregate thymic organ culture. We hypothesized that the
CD45+EpCAM+ population could migrate to the thymus and contribute both Pan-keratin
expressing TECs as well as the FSP1expressing fibroblast population. We wanted to understand if
the CD45+EpCAM+ cells express FSP1 before migrating to the thymus or acquiring FSP1
expression due to differentiation. We used flow cytometric analysis to understand if FSP1 is
expressed at the protein level in both the BM-derived and thymus-derived CD45+EpCAM+
populations. To detect FSP1 expression, we used ROSAmT/mG mice with FSP1 cre
mice. ROSAmT/mG mouse has a cell membrane-targeted, two-color fluorescent Cre-reporter allele.
Before Cre recombination, all the tissues express membrane-bound tdTomato, but Cre
recombinase expressing cells will express membrane-bound EGFP (mG) fluorescence expression
instead tdTomato expression. FSP1 cre is a transgenic mouse that expresses Cre recombinase
under the mouse FSP1 (s100A4) promoter's control. We crossed ROSAmT/mG mice with FSP1cre
to obtain offspring that express membrane-bound GFP in every FSP1 expressing cell. Then we
used the progeny mice for BM and thymus. FACS analysis of both bone marrow and thymus
showed a high percentage of the GFP expressing FSP1+ cells in the CD45+EpCAM+ population.
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89% of the BM-derived cell population express FSP1 on average (figure 3.18 A), whereas thymusderived CD45+EpCAM+population had an average of 93% FSP1+ cells (figure 3.18 B).
Next, we wanted to confirm FSP1 expression at the mRNA level using qRT-PCR and FSP1
primers to analyze the two CD45+EpCAM+ populations. For that purpose, CD45+EpCAM+ cells
from adult bone-marrow and thymus were sorted with high purity (~90%). We also sorted
CD45+EpCAM- cells from the BM and thymus and CD45-EpCAM+ cells from the thymus as
controls. We also sorted the CD45-EpCAM-PDGFRβ+ thymic fibroblast population as a positive
control, reasoning that we might expect strong FSP1 expression in this population. Relative levels
of RNA expression of FSP1 were normalized in each sorted population to the levels of 18s rRNA.
Interestingly, we observed that the BM CD45+EpCAM- the population had a 25-fold
higher expression of FSP1 (data not shown), whereas the thymic CD45+EpCAM- the population
has a 9-fold high level of FSP1 expression than the CD45-EpCAM-PDGFRβ+ cells. Österreicher
et al.’s findings that bone-marrow-derived and peritoneal macrophages have a high expression
level of FSP1 (283) can explain our data showing a high level of FSP 1 expression in CD45+ cells.
That means CD45+ cells also contain macrophages, which can have a high level of FSP1
expression. The BM-derived DP population has 70-fold lower FSP1 expression than the control
population. The thymus EpCAM, only the TEC population, has a 0.3-fold higher expression level
than the control thymic PDGFRβ population. Interestingly, the thymus DP population has 0.1fold
higher expression of FSP1 than the control population (Figure 3.18 C).
These results suggest that the CD45+EpCAM+ cell population already express FSP1 in the
bone marrow. But it seems that after migration to the thymus, these cells have an increased level
of FSP1 expression. From this unique result, we can hypothesize that when CD45+EpCAM+ cells
with a low FSP1 expression migrate from the bone marrow to the thymus and undergo an
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upregulation of FSP1 expression. A small subset of this population can lose FSP1 expression and
commit toward Pan-keratin expressing TEC differentiation in the thymus. In contrast, most of this
population retain their FSP1 expression and contribute to the FSP1+ fibroblast population known
to regulate mTEC development.
Figure 3.15

Figure 3.15. A peripheral population can migrate into the thymus and contribute to Dec205 and
UEA1 1expressing thymic epithelial cells. C57BL6 fetal thymi were transplanted under the kidney
capsule of Actin H2BGFP mice and analyzed for the presence of GFP-expressing peripheral cells
3-12 weeks after transplant using IHC. A-D: Week 3 transplanted thymic tissue sections showing
expression of Dec205 (A), UEA1 (B), GFP+ peripheral cells (C), and Merged image (D). E-H:
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Week 6 transplanted thymic tissue section showing expression of Dec205 E), UEA1 (F), GFP+
peripheral cells (G), and Merged image (H. I-L: Week 9 transplanted thymic tissue section
showing expression of dec205 (I), UEA1 (J), GFP (K), and Merged image (L). M-P: Week 12
transplanted thymic tissue section showing expression of Dec205 (M), UEA1s (N), GFP (O), and
Merged image (P). All the experiments were done in three-five replicates.
Figure 3.16

Figure 3.16. A peripheral population can migrate into the thymus and contribute to Dec205 and
UEA1 1expressing thymic epithelial cells. C57BL6 fetal thymi were transplanted under the kidney
capsule of Actin H2BGFP mice and analyzed for the presence of GFP-expressing peripheral cells
3-12 weeks after transplant using IHC.A-D Week 9 transplanted thymic tissue section showing
expression of dec205 (A), UEA1 (B), GFP (C), and Merged image (D). E-H: Week 12 transplanted
thymic tissue section showing expression of Dec205 (E), UEA1s (F), GFP (G), and Merged image
(H). GFP, Dec205, and UEA1 expressing cells of interest are enlarged in the insets to show both
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proteins' colocalization and represent the cells shown in the white boxes. All the experiments were
done in three-five replicates.
Figure 3.17

Figure 3.17. Reaggregate thymic organ cultures show that both bone marrow and thymus-derived
CD45+ EpCAM+ cells can give rise to DEC205+ thymic stromal cells. (A-C) RTOC consisted of
C57BL/6 fetal thymus mixed with bone marrow-derived actin H2B-GFP-expressing
CD45+EpCAM+ cells. A representative RTOC section showing DEC205 expression (A), UEA1
staining, (B) with GFP expressing cells derived from actin H2BGFP expressing CD45+EpCAM+
cells sorted from adult bone-marrow (C); the Merged image of DEC205, UEA1 and GFP (D). (EH) RTOC consisting of C57BL/6 fetal thymus mixed with thymus-derived actin H2B-GFPexpressing CD45+EpCAM+ cells. A representative RTOC section showing Dec205 expression
(E); UEA1 staining, (F) with GFP expressing cells derived from CD45+EpCAM+ cells sorted
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from adult bone-marrow (G); the Merged image of DEC205, UEA1 and GFP (H). All the
experiments were done in three replicates.
Figure 3.18

Figure 3.18. FSP1 is expressed in both the BM-derived and thymus-derived CD45+EpCAM+
populations. Panel A shows FSP1 expression in the BM-derived CD45+EpCAM+ population
Panel B shows FSP1 expression in the thymus-derived CD45+EpCAM+ population. Panel C
shows the fold change in FSP1 mRNA expression in both BM and thymus Derived
CD45+EpCAM+ population. All the experiments were done in three replicates.
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CHAPTER 4
Characterizing the CD45+EpCAM+ Bone Marrow derived Thymic Epithelial Progenitor
Cell Population
4.1. INTRODUCTION
Stem cells are a unique self-renewing population of cells that can differentiate into one or
more mature cell types (148). The tissue-specific adult stem cell populations maintain tissue
homeostasis for many self-renewing tissues such as the skin, intestinal epithelium, liver, mammary
gland, and hematopoietic system(149). Recently it has come to light that adult stem cell
populations can overcome tissue and lineage barriers and differentiate into different cell types(8,
149). Adult bone marrow cells are one of the most prominent examples of the newfound plasticity
of adult stem cell populations. Adult bone marrow cells have been shown to contribute to skeletal
muscle(284), cardiac muscle, skin, hepatocytes (156, 157), lung epithelial cells(183, 276), GI tract
epithelial cells, renal tubular epithelial cells, the endometrium of the uterus, endocrine cells of the
pancreas and the central nervous system. Additionally. Krause et al. 2001 have shown that a single
bone-marrow-derived stem cell can produce progeny that migrate to various organs and
differentiate into different epithelial cell populations, including gut, lung, liver, and uterine
epithelial cells(154). Interestingly, most of these studies showed that BM cells contribute to
different organs in response to injury(8, 154). In the previous chapter we showed evidence of a
unique BM-derived population that can contribute to the thymic epithelial microenvironment as
well as a critical FSP-1-expressing fibroblast population known to be important in the maintenance
of mTECs responsible for self-tolerance.
Thymic epithelial cells create a unique microenvironment in the thymus that supports and
regulates the self-tolerant naïve T-cell population's development. Paradoxically thymus undergoes
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age-related involution, where thymic epithelial cells are transformed into adipose tissue by
epithelial-mesenchymal transition (EMT)(144). Apart from age-related involution, the thymus can
also undergo stress-induced atrophy(285). Because of this age and stress-related involution, it was
believed that the adult thymus did not maintain an epithelial stem/progenitor cell population,
unlike many epithelial organs and tissues. However, in recent years, few studies have demonstrated
the thymic epithelial progenitor cell population's presence in the adult thymus(100). Osada et al.
2013 and later, Wong et al. 2014 defined the thymic epithelial progenitor population with an
EpCAMloMHCIIloSca1+CD49f+CD29+ phenotype (102, 109). Osada et al. 2013 also demonstrated
that the EpCAMlo TEC population exhibited mesenchymal stem cell-like multipotency(109).
Interestingly, Ulcheyanko et al. 2016 later defined the EpCAM+ UEA-BP1+PLET1+ MHCIIhi
population as adult bipotent TEC progenitors (104). These contradictory phenotypes may represent
different developmental stages of the thymic epithelial progenitor cell population or different
populations of cells that, under different experimental conditions, maintain the potential to
differentiate into both cortical and medullary TECs. These contradictory results suggest the need
for future research to identify the adult thymic epithelial progenitor cell population. Furthermore,
it is crucial to locate and fully characterize TEPCs to open up potential avenues for clinical therapy
to reverse stress and/or age-induced thymic involution and the subsequent loss of thymic function.
While all the previous TEPC studies were mainly focused on the CD45-EpCAM+ subpopulation,
this research probed into the CD45+ subpopulation in the search for the adult TEPC for the first
time.
Previously we identified the CD45+EpCAM+ population present in bone marrow and
thymus and demonstrated its capacity to be a potential thymic epithelial progenitor cell population.
This study demonstrated that the CD45+EpCAM+ population is derived from hematopoietic stem
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cells in the BM using adoptive transfer. Additionally, we examined this population's dynamics
during progressive aging and characterized changes in their stem cell-like surface marker
expression. Finally, we characterized this population's chemokine expression profile to understand
how this population can home to the thymus and contribute to the thymic stroma.
4.2. RESULTS
Bone-marrow CD45+EpCAM+ cells are derived from hematopoietic stem cells.
The bone-marrow contains two types of stem cell populations: hematopoietic stem cells
and mesenchymal stem cells. Previous studies have shown that BM-derived cells can differentiate
into different tissue-specific populations. A few papers showed the plasticity of the BM-derived
HSC population (154, 183). In contrast, other studies used whole BM (165, 192) or other more
defined BM subsets (163). We first hypothesized that the bone-marrow-derived TEPCs are from
the hematopoietic lineage because this population expresses the pan-hematopoietic cell marker,
CD45. However, we wanted to determine the lineage of the CD45+EpCAM+ cells to see if they
are genuinely derived from HSCs or some other stem cell population of the bone marrow. To
determine if the CD45+EpCAM+ progenitor cells were derived from the HSCs, we sublethally
irradiated C57BL6 mice with, 1300 cGY using an X-ray irradiator. Subsequently, the HSC
population was sorted from Actin H2BGFP transgenic mice. Before sorting, the BM cells were
lineage depleted for CD11b, CD11c, CD19, B220, Ter119 and CD3. Lineage depleted cells were
further negatively selected for CD11b, CD11c, and CD19-expressing cells. Subsequently, the HSC
population is defined as c-Kit+Sca1+ in the lineage negative bone marrow cells. 100,000 GFPexpressing HSCs were sorted to greater than 95% purity and intravenously injected to irradiated
C57BL6 mice. Later, these mice were analyzed at different time points from 5- 20 weeks after
transfer for the presence of GFP-expressing donor derived cells. Irradiated C57BL6 mice were
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used as a control to determine the GFP gating strategy (see figure 4.1). FACS analysis showed the
presence of GFP+ cells in both the bone marrow and thymus of these mice after BM transplant.
At the 5th week post-transplant, the lineage depleted bone marrow had an average frequency of
75% GFP expressing cells, subsequently the average frequency of GFP+ cells were 58% at the 6th
week post-transplant bone marrow. At the 20th week post-transplant, the average frequency of the
donor cell cells in the bone marrow was 66%. The different frequencies of the donor cells at
different time points in the bone marrow represent the extent of chimerism in the bone marrow.
Further analysis revealed that the GFP+ donor cells were mainly localized in the CD45+ and the
CD45+EpCAM+ cell population.
First, we analyzed the presence of GFP+CD45+ cells in the recipient bone marrow. First,
the frequency analysis of GFP+ CD45+ cells at different time points revealed that at the 5th week
post-transplant, the CD45+ population had an average frequency of 80% GFP expressing cells. At
the 6th week, the average frequency of GFP+ cells was 56 %. At the 20th week post-transplant, the
average frequency of donor cells in the CD45+ population was 88%. These different frequencies
of the donor-derived GFP+ cells at different time points in the CD45+ population reflect the extent
of chimerism in each replicates.
FACS analysis showed that a very small frequency of the CD45+EpCAM+ cells are
present in the bone marrow post-transplant, and the frequency gradually increases with progressive
time points. At the 5th week post-transplant, the average frequency of the CD45+EpCAM+
population was 0.1%, whereas, at the 6th week time-point, the average frequency increased to
0.23%. At the 20th week, the average CD45+EpCAM+ frequency increased to 0.5%. These data
suggests that the CD45+EpCAM+ population is radiation sensitive. At an earlier time point, the
frequency is lower due to radiation-induced injury, but the frequency increased as the bone marrow
117

recovers. The CD45+EpCAM+ population in the bone marrow showed the presence of GFP+
donor cells at all time points. A gradual increase in the number of CD45+EpCAM+GFP+ cells
was observed in progressive time following the adoptive transfer. At five weeks post-transplant,
the average frequency of the GFP+ donor cells in the CD45+EpCAM+ population was 33.7%,
which increased to an average of 41% at the 6th week post-transplant. , A high frequency of GFP+
cells were observed in the 20th week replicates, with an average of 86% in the CD45+EpCAM+
population. A representative FACS profile of the frequency of CD45+EpCAM+GFP+ cells at
different time points is shown in Figure 4.1B. Even though a gradual increase in the frequency of
GFP+ donor cells was observed, it was important to understand whether this change in the
frequency only reflects the extent of chimerism in the bone marrow or the donor cell frequency
indeed increases with the advancing time points. For that purpose, we normalized the frequency
of GFP+CD45+EpCAM+ cells to the frequency of total GFP+ cells in the bone marrow. This
normalization revealed that the average ratio of the GFP+CD45+EpCAM+: GFP+ cells increased
from 0.4 at the 5th week to 1.4 at the 20th week. This result clearly demonstrates that the
CD45+EpCAM+ cells are derived from HSC. The CD45+EpCAM+ cells of the bone marrow are
radiation-sensitive, and this population recovers gradually post-transplantation. These data also
revealed a steady increase in the ratio of CD45+EpCAM+GFP+ cells relative to the total GFP+
cells, suggest that more donor-derived HSC population differentiate into the CD45+EpCAM+
population with progressive time following adoptive transfer.
CD45+EpCAM+ thymic epithelial progenitor cells are derived from the hematopoietic stem
cells.
Next, the goal was to understand if the transplanted HSC can migrate to the thymus and
give rise to the thymic CD45+EpCAM+ population, as well as the EpCAM+ TEC population. For
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analysis of the thymic stroma, the same set of mice used for the bone marrow analysis was used.
The bone marrow analysis described previously proved that adoptive transfer had been successful
and that the BM CD45+EpCAM+ population was derived from the GFP-expressing HSCs. But to
determine whether the donor HSC derived CD45+EpCAM+ cell population can migrate to the
thymus, we analyzed the frequency of GFP+CD45+ cells in the recipient’s thymus. FACS analysis
of the dissociated thymus showed a substantial presence of donor GFP+ cells in the CD45+
population at all time points. With progressive time point, the frequency of GFP+CD45+ cells
increase in the thymus. At the 5th week, the thymic CD45+ population showed an average
frequency of 56% GFP+ donor cells, followed by an average frequency of 53% at the 6th-week
analysis. At the 20th week, an increased frequency of CD45+GFP+ cells, with an average of 72%,
was observed.
Additionally, we normalized the thymic GFP+CD45+ cells' frequency to the frequency of
the total GFP+ cells in the bone marrow. This normalization revealed that the average ratio of the
GFP+CD45+: GFP+ cells remained almost the same at both the 5th week and 6th-week time point,
with an average ratio of 0.75 and 0.77, respectively. But in the 20th week, this ratio increased to
1.1. These results suggest that the HSC derived CD45+ cells can migrate to the thymus. The bar
graph representation of the GFP+CD45+EpCAM+: GFP+ cells shown in figure 4.2G. FACS
representation of CD45+GFP+ cells at different time points are demonstrated in Figure 4.2D.
Next, FACS analysis of the CD45+EpCAM+ cell population also showed the presence of
GFP+ cells at all time points. At the 5th week, GFP+ had an The average frequency of GFP+ donor
CD45+EpCAM+ population was 38%-39% 5 and 6 weeks after adoptive transfer of GFPexpressing HSCs. A sharp increase in the frequency of GFP+CD45+EpCAM+ donor derived cells
was observed in the 20th week with an average of 68%. Additionally, we normalized the thymic
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GFP+CD45+ EpCAM+ cells' frequency to the frequency of the total GFP+ cells in the bone
marrow. This normalization revealed that the average ratio of the GFP+CD45+EpCAM+cells:
GFP+ cells remained almost the same at both the 5th week and 6th-week time point, with an average
ratio of 0.5 however, this ratio dramatically increased to 1 in the 20th week, clearly demonstrating
that donor derived HSCs contribute significantly to the thymic CD45+EpCAM+ subset.
A small number of donor-derived GFP+ CD45-EpCAM+ TECs were also observed at all
the time points. The frequency of the GFP+ EpCAM+ cells remained at 1-4% at all time points.
The ratio of GFP+EpCAM+cells: GFP+ cells remained very low at all time points. But at the 20thweek analysis, a small increase in this ratio, with an average of 0.1, was observed.
This set of data indicates that thymic CD45+EpCAM+ cells are HSC derived, and HSC
derived cell population can differentiate into thymic epithelial cells. Taking both the bone marrow
and the thymus FACs analysis together, it can be hypothesized both the bone marrow-derived and
thymus-derived CD45+EpCAM+ populations increase with advancing time point. The steady
frequency of GFP+ donor cells in the thymic epithelial cell population suggests HSC derived cells
can migrate to the thymus and differentiate into the thymic epithelial cells.
The CD45+EpCAM+ population is found in the fetal thymus both before and after bone
marrow formation.
Previous studies have suggested that the fetal TEPC population does not retain its self renewing properties in the adult thymus (107). We wanted to understand if the CD45+EpCAM+
positive population is exclusively an adult TEPC population. Additionally, it is important to
understand if this cell population is derived from only BM-derived HSCs or if CD45+EpCAM+
cells are found in the fetal thymus before bone marrow formation. During fetal development, the
first hematopoietic stem cells are found in the fetal liver, and the bone marrow is formed around
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E17.5. The first wave of early T-cell progenitors is derived from the fetal liver and arrives in the
fetal thymus at embryonic day E12.5 prior to BM development. Therefore, we chose three different
embryonic days E13.5, E15.5, and E18.5, to understand whether the CD45+EpCAM+ cells are
derived only once the BM is formed or if the fetal HSCs in the fetal liver also contribute this
population to the developing thymus. For future analysis, fetal liver HSC should be isolated to
confirm the presence of CD45+EpCAM+ cells in fetal HSC.
CD45+EpCAM+ population frequency first increases, then achieves a steady-state with
advancing embryonic days. At E13.5, the fetal thymus showed the lowest frequency of the
CD45+EpCAM+ cells, with an average of 0.48%(+/-0.05%). E15.5 and E18.5, both the time points
had the same frequency of CD45+EpCAM+ population with an average of 0.6%(+/-0.5%). FACS
representation of the frequency of CD45+EpCAM+ cells in the fetal thymus is demonstrated in
Figure 4.3.
Additionally, we analyzed the CD45+EpCAM+ for expression of a well-established HSC
marker, as well as postnatal TEPC marker, Sca1 expression. Sca1 analysis revealed earlier time
point CD45+EpCAM+ cells in E13.5 thymus had a lower frequency of Sca1+ cells with an average
of 33%, whereas both E15.5 and E18.5 have the same frequency of Sca1+ cells (an average of
41%, +/-5%). These data suggest the CD45+EpCAM+ population found in the fetal thymus
expresses TEPC markers. It was interesting to note that the level of Sca1 expression within the
CD45+EpCAM+ population was lower in the fetal thymus than that observed in adults. Lower
Sca1 expression in the fetal CD45+EpCAM+ population suggests that this population might
represent this population's immature stage. Postnatally this population matures farther and gains a
higher Sca1 expression level. Additionally, the presence of CD45+EpCAM+ cells in the fetal
thymic stroma at early embryonic time points indicates that this population is already present in
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the fetal thymus and is likely recruited from the fetal liver similar to T cell progenitors before BM
formation and may contribute to the development of fetal thymic epithelial microenvironment.
CD45+EpCAM+ cells from Thymus Express TEC Progenitor Characteristics
Many epithelial tissues maintain a reservoir of tissue somatic stem cells that can repair or
regenerate those tissues. Several studies have demonstrated that epithelial stem cell populations
are stored in a unique protective niche and signaled when necessary to proliferate and differentiate.
Most of these tissue-specific stem cell populations express Sca1 and other stem cell-specific
markers. Kim et al. 2005 identified CD45-Sca+ cells as the bronchoalveolar stem cell
population(286). Additionally, Burger et al. 2005 showed prostatic stem cells express Sca1, and a
fraction of that Sca1+ positive population also had high expression of the α6 integrin/ CD49f(287).
Jones et al. 1993 and Tani et al. 2000 characterized the skin stem cells with CD49fhi CD29hi
expression(288, 289). Stingl et al. 2006 showed that the mammary stem cell population is
characterized by a Sca1loCD49fhiCD29hi phenotype (290). Later, Osada et al. 2013 demonstrated
that a stem cell-like population exists within the postnatal thymic stroma, which can differentiate
into multiple mesenchymal lineages, including adipocytes, chondrocytes, and osteoblasts, as well
as TECs in vivo(109). This TEC progenitor/mesenchymal stem cell-like population was
characterized by the expression of an EpCAMloMHCIIloSca1hiCD49f+CD29+ phenotype(109).
Later Wong et al. showed that the adult thymic epithelial progenitor population could also be
defined with the EpCAM+MHCIIlo Sca1+CD29+CD49fhi phenotype (102). Interestingly,
Ulcheyanko et al. 2016 later defined the EpCAM+ UEA-BP1+PLET1+ MHCIIhi population as adult
bipotent TEC progenitor(104). This contradictory result showed that both MHCIIhi and MHCIIlo
subpopulations could have stem cell-like properties.

122

We wanted to understand if the CD45+EpCAM+ TEPC population expressed the stem cell
markers described by Osada et al. 2013. The previous sections described that this population is
present in the fetal thymus, and it expresses Sca1. Next, we also demonstrated that the mouse
thymus of all ages has the CD45+EpCAM+ population. This section aims to determine whether
the CD45+EpCAM+ population found in the thymus possessed the same tissue-specific stem celllike properties shown by Osada et al. 2013(109). Like other TEC progenitors described, the
thymus-derived CD45+EpCAM+ population expressed Sca1, CD49f, and CD29 providing support
for their potential as a unique population of TEC progenitors (Figure 4.4).
Figure 4.4 shows the representative Sca1, MHCII, CD49f, CD29 expression pattern in
C57BL6 male mice at different time points (4-month, 8-month, 10-month, and 12-month) for the
CD45+EpCAM+ population. This data set shows that the CD45+EpCAM+ cells contain two
distinct MHCII expressing populations, MHCIIhi, and MHCIIlo subsets, depending upon MHCII
expression's intensity. These two MHCII subsets were present at all time points analyzed, even
though the MHCIIlo subset was more abundant than the MHCIIhi subset. Our data revealed at
different time points, both MHCIIlo and MHCIIhi cell frequency remained almost the same. The
MHCIIlo population had an average frequency of 55% (+/-10), whereas the MHCIIhi population
had an average frequency of 23% (+/-6) at all time points. Both the MHCIIhi and MHCIIlo subsets
exhibit high levels of Sca1 expression. Again, our data demonstrated higher frequency Sca1+ cells
in the MHCIIlo population than the MHCIIhi population at all the time points. Additionally, this
data also revealed that the frequency of Sca1+ cells in both the MHCIIlo and MHCIIhi subsets
increases with progressive age. In a 4-month-old thymus, the frequency of the MHCIIloSca1+
population was 68% (+/-10%). Subsequently, the MHCIIloSca1+ frequency increased to 94% (+/2%) at ten months old and remained the same at 12 months old, with an average frequency of 91%,
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+/-10%). Next, we analyzed the MHCIIhi population for the frequency of Sca1+ cells at different
time points. The average frequency of the MHCIIhiSca1+ population in the thymus was 52% (+/13%) in 4-month-old mice. This population's frequency increased to an average of 80% (+/-8%)
in 8-month-old mice.

All the later time points maintained an average of 80% (+/-10)

MHCIIhiSca1+ cells.
Next, we wanted to compare the CD49f+CD29+ frequency at all time points in both the
MHCIIhiSca1+ and MHCIIloSca1+ populations. Both the MHCIIhiSca1+ and MHCIIloSca1+ cells
showed the presence of CD49f+CD29+ cells at every time point. Interestingly with progressive age,
both populations showed a decreasing frequency of the CD49f+CD29+ subset associated with
progenitor capacity. For the MHCIIloSca1+ population, the CD49f+CD29+ frequency was
maintained in 4-10 month-old mice, with an average of 55% (+/- 15) in the 4-month-old thymus,
52% (+/-7) in the 8-month-old thymus, and 57% (+/-7) in the 10-month-old thymus. Interestingly,
in the thymus of 12-month-old mice, the frequency of the CD49f+CD29+ population decreased
significantly to an average of 38%(+/-18). In case of the MHCIIhiSca1+ population, the
CD49f+CD29+ frequency decreased gradually from 63% (+/-20) to 49% (+/-25%) with progressive
age. Another population, expressing only CD29, was also observed at all timepoints. However,
unlike the CD49f+CD29+ population, this population maintained a low frequency for all time
points (14%-25%).
Additionally, the thymus-derived CD45+EpCAM+ population was analyzed for stem cell
marker expression in the regenerated thymus (Figure 4.4E i-vi). This set of data revealed that the
CD45+EpCAM+ population has an average of 54% of MHCIIlo cells. Analysis of the MHCIIlo
population showed an abundance of Sca1+ cells, with an average of 86% (+/-9). When we analyzed
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the MHCIIloSca+ population for CD49f and CD29 expression, we observed a very small frequency
of CD49f+CD29+ cells with an average of 4.3% (+/-5).
CD49f is an evolutionary biomarker for several stem cell populations. It has been
previously shown that CD49f or α6 integrin plays a vital role in tethering the stem cell population
to their protective niche(291). Tumbar et al. 2004 showed that CD49f and CD29 help skin stem
cells remain quiescent in their niche (292). Other studies have demonstrated that tight regulation
of CD49f/CD29 in stem cell populations is essential for maintaining the pluripotency of stem cells
and remaining quiescent in their niche(291). Another study highlighted that a single CD49f+
human HSC could generate a long-term multi-lineage graft (293). Additionally, they identified
that the loss of CD49f expression in HSC causes only temporary engraftment of this population if
used in the adoptive transfer (293). Keeping these previous findings in mind, it is possible that in
the aged thymus, the CD45+EpCAM+ population loses its CD49f expression, which reduces the
differentiation capability of this population and augments involution. Furthermore, the further loss
of CD49f expression in the castration recovered thymus may be responsible for only a temporary
recovery of the thymic epithelial cellularity. This hypothesis can be tested using the reaggregate
thymic organ culture system. MHCIIloSca+CD49f+CD29+ population can be sorted from both
young and old mouse thymus and be used in the formation of separate RTOCs. If the hypothesis
is correct, then the CD45+EpCAM+Sca1+CD49f+CD29+ population from the young mouse
thymus would be expected to differentiate more readily than the same population derived from old
mice.
CD45+EpCAM+ cells from the Bone Marrow Express TEC Progenitor Characteristics:
We wanted to determine whether the BM-derived CD45+EpCAM+ cells express the adult
TEC progenitor phenotype. Figure 4.5 shows the representative expression pattern for adult TEC
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progenitor markers Sca1, CD49f, and CD29 within the BM-derived CD45+EpCAM+ cells in
C57BL6 mice at different time points (4-month to 12-month). We observed that the BM DP cells
are enriched in Sca1 expression, with an average frequency of 90% for all the time points.
Interestingly the majority of the Sca1 expressing cells only expressed CD29 rather than both
CD49f and CD29. We noticed that the Sca1+CD29+CD49f- population undergoes a gradual
decrease in frequency with progressive age (from an average frequency of 91% for 4-month-old
to 75% in 12-month-old mice). Our FACS analysis showed that the Sca1+ population has a small
frequency of cells that expresses both CD49f and CD29. All the time points had an average of 12%
CD49f+CD29+ cells within the CD45+EpCAM+Sca1+ population.
Additionally, the BM-derived CD45+EpCAM+ population was analyzed for stem cell
marker expression in the regenerated thymus (Figure 4.5 M-O). Analysis of the CD45+EpCAM+
population showed an abundance of Sca1+ cells, with an average of 90% (+/-9). When we analyzed
the Sca+ population for CD49f, and CD29 expression, a very small frequency of CD49f+CD29+
cells with an average of 0.075, (+/- 0.01) and CD49f-CD29+ cells, with an average of (0.4,+/-0.1)
was observed.
Previous studies have shown that CD29/β1intergrin expression is prominent in several
tissue-specific and mesenchymal stem cell populations (294). Later, it was identified as a
hematopoietic stem cell homing regulator(295). Previous studies demonstrated that CD29
expressing cells are responsible for maintaining the stem cell niche, maintaining a stable stem cell,
and tightly regulating the balance between stem cell renewal and differentiation(294). Such studies
provide a possible explanation of the unique result that BM-derived CD45+EpCAM+ cells have a
high frequency of CD29+ cells and the CD29 expression is important for cell migration via blood
as well as for maintenance of the stem cell population. This result and previous studies together
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indicate that the abundant CD29+ cell in the BM-derived CD45+EpCAM+ population is important
for CD45+EpCAM+ cell migration to the thymus.
The BM-derived CD45+EpCAM+ population expresses CD34
CD34 is a well-established hematopoietic stem cell marker and a mesenchymal stem cell
marker(296). Blanpain et al. 2004 demonstrated that the skin epithelial stem cell population also
expresses CD34(297). The BM-derived CD45+EpCAM+ cell population expresses other
epithelial stem cell markers, as shown in figure 4.6. Next, we wanted to confirm if this population
expresses CD34, a marker found in both HSCs and mesenchymal stem cells. Figure 4.6 shows the
representative data for CD34 expression at different time points. Our data showed that a significant
number of CD45+EpCAM+ cells was CD34+ (on average 70%, +/-10%). Our data also revealed
a gradual decrease in CD34 expression with progressive aging. However, in the 12 month-oldmice, a sharp decrease was observed (8%, +/-5%) (figure 4.6H). These data suggest that with
progressive aging, the BM-derived CD45+EpCAM+ population loses its stem-cell-like
characteristics. Analysis of CD34+ cells present in the bone marrow of castrated mice revealed
that the CD45+EpCAM+ population loses CD34 expression (Figure 4.6 J). From this set of results,
it can be hypothesized that loss of stem-cell-like properties of the CD45+EpCAM+ population
with progressive aging may play an instrumental role in age-related thymic involution.
Contribution of CD45+EpCAM+ cells to the maintenance of TEC microenvironments with
progressive age
It has been observed that with advanced age, the mammalian thymus undergoes distinct
morphological changes, which include thymic atrophy and thymic adiposity (147, 298). A
decreased thymic capacity for thymopoiesis accompanies thymic atrophy and adiposity. With
progressive aging, the thymus starts losing its epithelial cell populations while the number of non127

TEC thymic stromal cells increases. We hypothesized that if the thymus undergoes age-related
involution even though this bone marrow-derived TEPC population is present, it indicates a major
change in this population, which causes the inhibition of migration of the BM-derived
CD45+EpCAM+ population to the thymic stroma. Another possibility is that this CD45+EpCAM+
steady flow in the thymic stroma contributes to the TECs and FSP1 expressing fibroblast and
maintaining the thymic medulla throughout life. A preliminary study was done to analyze the
frequency of these populations with progressive aging. For this purpose, C57BL6 male mice of
different ages from 2-months old to 12-months old were used for FACS analysis of the bone
marrow and dissociated thymus. Analysis of the absolute number of BM-derived CD45+EpCAM+
cells per animal at different time points revealed a gradual increase in the BM number. (Figure
4.7A), whereas the absolute number analysis of thymus derived CD45+EpCAM+ cells per lobe at
different time points revealed a gradual decrease in this population with progressive age (Figure
4.7B). Other studies have shown that the frequency of HSCs in the bone marrow increases
significantly with age but interestingly, the self-renewing capacity and pluripotency decreases
(299-301). Liang et al. 2005 demonstrated that the homing efficiency of HSC in old mice was at
least 3-fold lower than in young mice (302). It also has been shown that HSC differentiation gets
more skewed towards myeloid progenitors rather than lymphoid progenitors (303). These previous
findings can provide a possible explanation as to why the aged bone marrow derived
CD45+EpCAM+ population increases in number. It might also be possible that the BM
CD45+EpCAM+ population loses its capacity to differentiate and/or home to thymus, thus
explaining why we observed a decreasing number of CD45+EpCAM+ cells in thymus with age.
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BM-derived CD45+EpCAM+ can play a role in castration induced recovery of the thymus
It is known that thymic epithelial cells have a rapid turnover rate, i.e., they proliferate
extensively during the period of thymic growth. It has been demonstrated that the turn-over rate of
thymic epithelial cells decreases with thymic aging, suggesting that TEC proliferation might be
the key regulator of thymus size. These data led to the hypothesis that the decreased turnover rate
of TECs might be one of the factors contributing to thymic atrophy during aging (147). This study
also showed that sex steroid ablation could reverse thymic involution. Seven to fourteen days after
castration surgery, an aged mouse can achieve an expansion of both thymocyte and TEC numbers
with an increased ratio of mTEC/cTEC (143, 147). More recent work by Griffith et al. 2015, has
suggested that although the aging thymus size recovers transiently in response to castration or
androgen blockade, it still maintains many functional characteristics of the aged thymus (304).
They also demonstrated androgen blockade or castration recovery does not restore the complexity
of medullary islets or tissue-restricted antigen expression (304). The previous section showed that
the CD45+EpCAM+ cells migrate to the thymus in response to radiation-induced injury, and this
population is present during thymic organogenesis. It was essential to understand if the BMderived CD45+EpCAM+ population can migrate to the regenerating thymus in response to
castration induced thymic recovery. We hypothesized that this population could migrate to the
aged thymus following castration and contribute to the involuting thymic stroma's maintenance.
We also hypothesized that this population loses its capacity to migrate to the thymus and augment
the thymic involution during aging.
It was important to decipher how castration affects the frequency and distribution of the
CD45+EpCAM+ TEPC subset. The frequency and the absolute number of CD45+EpCAM+ cells
in the BM and thymus of young (4month old) and old (12-month-old) and regenerating thymus
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were analyzed to determine how thymic recovery impacted the frequency in 12-month-old
C57BL6 mice two weeks after they were surgically castrated. It has been previously demonstrated
that the thymus has the lowest cellularity within four days after castration, followed by restoration
of thymic cellularity by day 20. However, such restoration was not permanent and by the 4th-week
post castration, the restored thymus loses its cellularity (304, 305). It was important to analyze the
regenerating thymus before it starts to degenerate again. That’s why the castrated thymus was
analyzed at the 2nd-week post castration. FACS data showed that following castration, the number
of the CD45+EpCAM+ cells increased significantly in the thymus ( figure 4.8 B) but decreased in
the BM (Figure 4.8 A). This analysis showed that CD45+EpCAM+ cell number increased by ~2
fold in the regenerated thymus (an average of 2367,+/-160) then the aged thymus (an average of
1156, +/- 262). It is important to note that even though this population increased in number post
castration, it was still not as abundant as that observed in the young thymus (an average of 3631,
+/-1011). Analysis of the CD45+EpCAM+ population of bone marrow revealed a small decline in
number from the aged bone marrow (an average of 14504, +/-809) when compared to the castrated
mouse bone marrow (an average of 11652,+/-306)
This set of results suggests that castration induces the CD45+EpCAM+ cells in the bone
marrow to migrate towards the thymus, which results in a higher frequency of CD45+EpCAM+
cells in the thymic stroma. It was previously demonstrated that the HSC population loses its
differentiation capability with age. Even though CD45+EpCAM+ cells migrate to the thymus and
contribute to the thymic reconstitution, this recovery is not durable. To confirm this hypothesis,
we need to perform RNA-sequencing of this population from the aged thymus, castration recovery
thymus, and young thymus and see which genes are being upregulated and/or down-regulated.
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The CD45+EpCAM+ population expresses both chemokines and chemokine receptors.
The results presented in the preceding sections demonstrated that the CD45+EpCAM+
cells could migrate to the thymus from bone marrow. It was also shown that CD45+EpCAM+ cells
migrate to the thymus during castration recovery and irradiation-induced tissue repair. We next
wanted to determine how the migration of the CD45+EpCAM+ population from the BM to the
thymus might be facilitated. Early thymic progenitors or T-cell precursors express chemokine
receptors, which direct the migration from the bone marrow to the thymus that expresses the
corresponding ligands in thymic epithelial cells. Apart from T-cell precursors, BM stromal cells
also express a distinct set of chemokines essential for B-cell development. Wright et al.2002
demonstrated that the HSC population expresses chemokine receptors CXCR4, CCR3,
CCR9(306). Plotkin et al. 2003 have previously shown that the CXCL12/CXCR4 signaling axis
plays a vital role in the migration of T-cell precursors to the thymic cortex. The early progenitors
express CXCR4, and its ligand Cxcl12 is only expressed in stromal cells of the cortex(36). Other
studies have shown that stem cells express CXCR4, and they respond chemotactically to CXCl12
expressing cells. The CXCl12-CXCR4 axis plays an essential role in hematopoiesis(307). Even
though it is well established that the HSC population expresses chemokine receptors, Ciriza et al.
2010 did an extensive study on the chemokine and chemokine expression in a pattern of BMderived Lineage-Sca1+c-Kit+ (LSK cells) at different developmental stages (308). They showed
that adult BM-derived LSK cells express chemokine receptors, but they also express a set of
chemokine ligands, including Ccl4 and Ccl9 (308).
When BM-derived cells' newfound plasticity was discovered, a few studies were conducted
to understand how the BM cells migrate from bone-marrow toward other tissues. Inokuma et al.
2006 demonstrated that CCl27 is the primary regulator for migration of BM-derived keratinocytes
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precursors from BM to the skin. They showed CD34+ BM cells express CCR10, the receptor for
Ccl27(309). Ishiada et al. 2012 showed BM-derived endothelial progenitor cells express CCR5.
CCR5/CCL5 helps endothelial progenitor cells to migrate from the bone marrow and help in
neovascularization (310). Hu et al. 2013 showed that the CXCL12/ CXCR4 axis regulates
mobilization of mesenchymal stem cells from bone-marrow towards tissue injury and promotes
tissue repair (311). Sordi et al. 2005 showed that human bone-marrow-derived mesenchymal stem
cells express the chemokine receptors CXCR4, CX3CR1, CXCR6, CCR1and CCR7(312).
To identify the chemokine/chemokine receptor expression patterns in both the thymic and
BM CD45+EpCAM+ populations, a chemokine and chemokine receptor RT2 qPCR array from
Qiagen (PAMM-022Z) was used. Both BM-derived and thymus-derived CD45+EpCAM+ cells
were sorted to high purity and utilized for RNA isolation, followed by cDNA synthesis prior to
performing analysis using the qPCR array. As a control, we used the BM CD45+ population. These
results were then analyzed using Qiagen's Geneglobe, RT2 profiler PCR array analysis tool. Data
analysis revealed a set of upregulated genes in BM-derived and thymus-derived CD45+EpcAM+
cells compared to the BM CD45+ population.

The results of the comparison of the BM

CD45+EpCAM+ cell with the BM CD45 cells' is shown in table 1, while the comparison of the
thymus CD45+EpCAM+ cell with BM CD45 cells is shown in Table 2. We found that CXCL12
is expressed in both the BM-derived and thymus-derived CD45+EpCAM+ populations. CXCL12
is essential for maintaining the hematopoietic stem cell niche. Orlic et al. 2001 demonstrated that
CXCL12 helps in the mobilization of BMCs in response to heart injury (170). CXCL12 also
mobilizes BM-derived CD34 expressing mesenchymal cells towards burn injury to initiate wound
healing (311). Additionally, FACS analysis showed a small subset of the BM-derived
CD45+EpCAM+ population express CD34, and PCR array results indicated upregulated
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expression of CCR10 in both the BM-derived and thymus-derived CD45+EpCAM+ populations.
It has been previously demonstrated that CD34+ expressing BM cells express CCl27 receptor
CCr10. The same study also highlighted that the CCR10/CCl27 axis helps mobilize BMCs toward
the injury site to contribute to tissue repair (309). It is interesting to observe that this population
expresses both chemokines as well as chemokine receptors. Expression of CCR7 and CCR9 was
also observed and suggested that the CD45+EpCAM+ cells might be using the same chemokinechemokine receptor axis used by early T-cell progenitors to migrate from the BM to the thymus.
It has been shown previously that CCL20 and CCL22 both interact with regulatory T-cells
(Tregs) (313, 314). CCL20 interacts with non-promiscuous chemokine receptor CCR6, which is
expressed is expressed in B-cell, T-cells, and dendritic cells. CCL20 is mainly expressed in the
intestine, and upregulation of this chemokine is observed in response to an inflammatory stimulus.
CCL20 receptor is mainly expressed in Tregs and TH17. This ligand and its receptor play an
important role in mucosal immunology. Interestingly, this ligand is also expressed in T-helper cells
(TH17) (313). CCL22 is highly expressed in different lymph nodes. CCL22 is also expressed by
dendritic cells. It has been demonstrated before that CCL22 deficient mice are more susceptible to
inflammatory disease. Interaction of dendritic cells with Tregs is promoted by CCL22-CCR4
interaction (314). Interestingly apart from chemokine receptors, both the BM and thymus-derived
CD45+EpCAM+ populations also express some chemokine ligands like CCl20 and CCL22. These
results indicate that this cell population might have some role in Treg activation. The
CD45+EpCAM+population is expressing the chemokine ligands that are expressed by intestinal
stroma, it is possible that apart from thymus this population might migrate to the intestine and
contribute to intestinal epithelial cells. As a follow up experiment, it will be interesting to see after
intravenous injection of this population of cells can migrate to intestine or other organs as well.
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4.3. DISCUSSION
We described the identification of a unique postnatal bone-marrow-derived thymic
epithelial progenitor cell population. This population expressed both the hematopoietic cell marker
CD45 and epithelial cell marker EpCAM. We also identified this population in the thymus and
showed that these cells could migrate into the thymus from the bone marrow and differentiate into
Pan-keratin and Foxn1, expressing true thymic epithelial cells as well as stromal cells that express
FSP1, a fibroblast specific marker.
In the current study, we performed hematopoietic stem cell transplantation to determine
the lineage of the CD45+EpCAM+ population. HSCT data revealed the presence of donor cellderived CD45+EpCAM+ cells in both bone marrow and thymus. This set of experiments revealed
an increased frequency of donor cells in both the CD45+EpCAM+ and EpCAM+ populations in
the thymic stroma with progressive time following HSCT. These results confirm that the
CD45+EpCAM+ cells are derived from HSCs and suggest that the CD45+EpCAM+ cells which
appear in the BM, then migrate towards the thymus under the condition of radiation-induced injury
and contribute to thymic tissue repair. It will be interesting to analyze earlier time-points to observe
the serial migration of this population and see if this population travels towards bone marrow first
or if they migrate towards both BM and thymus at the same time.
Next, analysis of dissociated fetal thymus at E13.5-E18.5 was performed to determine if
the CD45+EpCAM+ population is only present after the bone marrow is formed or might also be
present in the fetal liver and contribute to the early fetal thymic stroma prior to BM formation. We
used three embryonic days for our analysis, E13.5, E15.5, E18.5. At E13.5 and E15.5,
hematopoiesis and early thymic progenitors are dependent on HSCs present in the fetal liver (315).
At E17.5, fetal bone marrow is fully developed. The CD45+EpCAM+ population present in the
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E18.5 fetal thymic stroma is likely derived from fetal bone marrow. From these results, we can
hypothesize that the CD45+EpCAM+ population found in the fetal stroma might play an important
role in fetal TEC development.
Next, we analyzed mice at different ages for the presence and surface characteristics of the
CD45+EpCAM+ subset to understand the effect of progressive age on its frequency and stem celllike properties. A time point analysis from (4 months to 12 months) of the CD45+EpCAM+
population in both bone marrow and the thymus revealed that the CD45+EpCAM+ population
increased in number with progressive age in the BM, whereas the number of CD45+EpCAM+
cells decreased in the thymus with increasing age. It is well established that with advancing age,
HSC number in the bone marrow increases, but the cells lose their pluripotency and self-renewal
capacity (299-301). In line with these findings, it is also established that BM cells lose homing
efficiency with advancing age (302). These previous findings might explain why an increase in the
number of CD45+EpCAM+ cells were observed in the BM while, at the same time, it declines in
the thymus. The CD45+EpCAM+ population in the BM may lose its differentiation and homing
capacity leading to a reduced capacity to home to the thymus with increasing age. It is also possible
that this decline in the CD45+EpCAM+ cells may contribute to the progressive loss of mTECs
and promiscuous gene expression observed during thymic involution. We have shown that
CD45+EpCAM+ cells give rise to FSP1-expressing cells in the thymus and maybe the main source
of the FSP1 expressing fibroblast population in the thymic stroma. Sun et al. have demonstrated
that FSP1 expressing cells play a critical role in medullary thymic epithelial cell maintenance in
the adult thymus (need reference here). We have also shown that the CD45+EpCAM+ cell
population also contributes to the TEC population. Loss of CD45+EpCAM+ cells with progressing
age may cause loss of FSP1+ cell population, which plays a crucial role in mTEC maintenance in
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the postnatal thymic stroma. Loss of this TEPC population with progressive age might be
instrumental in losing thymic epithelial cellularity in the aging thymus and contributing to ageassociated thymic involution.
Given that we are proposing that the CD45+EpCAM+ subset represents a progenitor or
stem cell population, we wanted to know if they express surface characteristics used to define stem
cells. Osada et al.2013 and Wong et al. 2014 have previously characterized the TEPC population
as EpCAM+MHCIIloCD49f+CD29+ (102, 109). We analyzed thymus-derived and bone marrow
CD45+EpCAM+ cells for the same set of markers, as shown by Osada et al.2013 (109) and Wong
et al. 2014 (102) at different time points (4-month to 12-month-old). This analysis revealed that
both of these populations express the same set of markers. This data indicates the TMSC
population defined by Osada et al. 2013, might arise from the CD45+EpCAM+ population. With
progressive age, the frequency of the CD49f+CD29+ subset decreases in the MHCIIloSca1+
population. CD49f and CD29 are regularly expressed on stem cells and play an essential role in
the maintenance of the stem cell niche. CD49f is an evolutionary biomarker for several stem cell
populations. It has been demonstrated that CD49f or α6 integrin plays a vital role in tethering the
stem cell population to their protective niche (291). Tumbar et al. 2004 showed that CD49f and
CD29 help skin stem cells remain quiescent in their niche (292). Other studies have demonstrated
that tight regulation of CD49f/CD29 in the stem cell population is essential for maintaining the
stem cell's pluripotency and remaining quiescent in its niche (291). Notta et al. 2011 showed that
a single CD49f+ cell could generate a long-term multi-lineage graft (293). Additionally, they
identified that the loss of CD49f expression causes transient engraftment of multipotent
progenitors (293). Our result shows that the CD45+EpCAM+ population expresses thymic
epithelial stem cell markers MHCIIloSCA1+CD49f+CD29+, but with progressive age, this
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population loses expression of these markers. It is probable that the loss of these stem cell markers
decreases the differentiation capability of this population and contributes to involution.
Some studies demonstrated that the bone marrow derived cells can be mobilized towards
different epithelial organs and contribute to those epithelial tissues only in response to injury. For
example, Wong et al. 2009 showed that BM-derived cells migrate to the naphthalene-induced
injured lung tissue and contribute to the alveolar epithelial cell population. In our study, we used
two different thymic injury models (183, 276).
BM-derived CD45+EpCAM+ cells were analyzed for expression of Sca1, CD49f, CD29,
and CD34. Like the thymus-derived DP population, our analysis revealed that the Sca1 expression
remained almost the same at all time points. Interestingly the CD45+EpCAM+Sca1+ population
mainly had CD49f-CD29+ cells rather than the CD49f+CD29+ subpopulation observed in the
thymus. Additionally, we observed that the CD49f+CD29+ population remained almost the same
throughout the time point, whereas the CD49f-CD29+ population showed a gradual decrease in
number with progressive aging. This result revealed that a subset of the BM-derived
CD45+EpCAM+ population expresses thymic epithelial stem cell markers, which strengthens our
hypothesis the thymus-derived CD45+EpCAM+ population is derived from the bone marrowderived CD45+EpCAM+ cells. It is possible that the BM-derived CD45+EpCAM+ cell has a high
frequency of CD29+ cells, as CD29 expression is important for cell migration via blood, as well
as for maintenance of stem cell populations. We hypothesized that CD29 expression regulates the
migration of the CD45+EpCAM+ population to the thymus.
It has been previously demonstrated that the CD34+ bone marrow cells can contribute to
the repair of the heart after myocardial infarction in the heart as well as to the hepatocyte of the
liver. Another study also demonstrated that the CD34+ BM population could be mobilized in
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response to skin injury. They also found that this population contributes to injury repair. In this
study, CD34 expression was examined in the BM-derived CD45+EpCAM+ cells with age. It was
found that a high frequency of CD45+EpCAM+ cells express CD34 in young mice; however, the
CD34+ frequency decreases significantly in the 12-month-old bone marrow. One possible
explanation of this result is that with progressive age, the BM-derived DP population loses its stem
cell-like properties.
To understand whether the CD45+EpCAM+ population is mobilized when thymic
reconstitution is necessary, we used castrated mice to analyze the effect of thymic reconstitution
on CD45+EpCAM+ cells. Our data demonstrated that following castration, the number of the
CD45+EpCAM+ cells increased significantly in the thymus but decreased in the BM (Figure 4.5).
We also observed a significant loss of stem cell markers, CD49f, and CD29 expression in these
two populations. This set of results indicates that castration induces migration of the
CD45+EpCAM+ cells from bone marrow to the thymus, resulting in the higher frequency of
CD45+EpCAM+ cells observed in the thymic stroma following castration induced thymic
reconstitution. Subsequently, the further loss of CD49f expression following castration recovery
in the thymus may be responsible for the temporary recovery of thymic epithelial cellularity.
To understand how BM-derived cells migrate to the thymus, we analyzed both the BM and
thymic derived CD45+EpCAM+ populations for their chemokine and chemokine receptor
expression using a qPCR array. These results revealed that both CD45+EpCAM+ populations
analyzed express both chemokines and their receptors, which is unique. Both the BM and thymusderived CD45+EpCAM+ populations express CCR7 and CCR9, indicating that this population
might be using the same chemokine ligand-receptor axis as used by immature thymocytes.
Interestingly, we also found that both CD45+EpCAM+ populations express CCR10 and CXCL12.
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CXCL12/CXCR and CCL27/CCR10 axis are important for HSC migration. Previous studies have
demonstrated that CD34+BM cells express CCR10. CCR10 plays an essential role in the migration
of the BM-derived stem cells toward injured tissue and contributes to tissue repair (309). CXCL12
is important for the mobilization of BM cells towards tissue injury(170). It will be interesting to
investigate which chemokines or chemokine receptors will be upregulated under the injury
condition. Future study will be interesting to analyze how the chemokine ligand and chemokine
receptor expression patterns of the CD45+EpCAM+ population change with progressive age.
To summarize, the CD45+EpCAM+ population is HSC derived unique stem cell-like
population found in both the bone marrow and thymus. However, with progressive age, both the
thymic and bone marrow CD45+EpCAM+ population lose their stem cell-like properties. The loss
of stem cell-like properties by these potential progenitor populations might explain why even after
this population is present in the thymus, the thymus still undergoes age-related involution and why
thymic reconstitution is transient. Analysis of mice following hematopoietic stem cell
transplantation revealed this population is mobilized in response to radiation-induced thymic tissue
injury. These results indicate that the CD45+EpCAM+ population may play an important role in
thymic repair.
Further analysis of the CD45+EpCAM+ population is necessary to understand if this
population can migrate to other epithelial organs and contribute to tissue maintenance. Even
though our chemokine and receptor array analysis revealed upregulation of several chemokines
and chemokine receptors, it is important to understand which chemokine ligand-receptor pair is
important for the migration of these cells and if this chemokine and chemokine receptor expression
pattern remains the same with advancing age. As explained in the previous chapter, the
CD45+EpCAM+ population in RTOC is mainly found in the cortical region, but not enough
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evidence was gathered to understand if this population can differentiate into cTECs and /or
mTECs. But the fetal thymus engraftment experiment showed that at later time points, this
population could express DEC205, a TEPC marker. Taking these two results into consideration,
a future study should be conducted to understand if this population can contribute to both cTEC
and mTEC or give rise to only one of the TEC population.
Figures & Figure legends:
Figure 4.1

Figure 4.1. The CD45+EpCAM+ population in the bone marrow is derived from HSCs. The
representative figure shows the presence of GFP+ donor cells in the thymus after hematopoietic
stem cell transplant at different time points (5 weeks – 20 weeks). Panel A-C shows the analysis
140

of thymus 5 weeks post-transplant: A) shows the frequency of the CD45+EpCAM+population; B)
Donor cell frequency in CD45+EpCAM+ cells, C) Donor cell frequency in CD45+EpCAM-cells
Panel D-F) shows the analysis of thymus 6 weeks post-transplant: D) shows the frequency of the
CD45+EpCAM+population; E) Donor cell frequency in the CD45+EpCAM+ cells, F) Donor cell
frequency in CD45+EpCAM-cells; Panel G-I) shows the analysis of thymus 20 weeks posttransplant: G) Shows the frequency of the CD45+EpCAM+population; H) Donor cell frequency
in CD45+EpCAM+ cells, I) Donor cell frequency in CD45+EpCAM- cells; Panel J-K) compare
the absolute number of GFP-expressing donor cells in different subsets following BMT, including
the CD45+EpCAM+ population (J); the CD45 population (K). Error bars represent SEM. "*"
indicates a statistically significant difference between any two time points. All the experiments
were done in 3-4 replicates.
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Figure 4.2

Figure 4.2. The thymic CD45+EpCAM+ population is derived from HSCs. The representative
figure shows the presence of GFP+ donor cellsin the thymus at various times (5 weeks – 20 weeks)
following hematopoietic stem cell transplant. Panel A-D shows the analysis of thymus 5 weeks
post-transplant: A) shows the frequency of the CD45+EpCAM+population; B) Donor cell
frequency in CD45+EpCAM+ cells, C) Donor cell frequency in CD45-EpCAM+ cells; D) Donor
cell frequency in CD45+EpCAM- cells; Panel E-H) shows the analysis of thymus 6-weeks posttransplant; E)shows the frequency of the CD45+EpCAM+population;F) Donor cell frequency in
CD45+EpCAM+ cells; G) Donor cell frequency in CD45-EpCAM+ cells; H) Donor cell frequency
in CD45+EpCAM- cells; Panel I-L) shows the analysis of thymus 20 weeks post-transplant; I)
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shows the frequency of the CD45+EpCAM+population; J) Donor cell frequency in
CD45+EpCAM+ cells; K) Donor cell frequency in CD45-EpCAM+ cells L) Donor cell frequency
in CD45+EpCAM- cells; Panel M-O) compare the absolute number of GFP-expressing donor cells
in different subsets following BMT, including the CD45+EpCAM+ population (M); the EpCAM+
population (N); and the CD45+ population(O). All the experiments were done in 3-4 replicates.
Error bars represent SEM. "*" indicates a statistically significant difference between any two time
points.

143

Figure 4.3

Figure 4.3. CD45+ EpCAM+ cells are found as early as embryonic day 13.5 and persist throughout
gestation. Panel A-B shows CD45+EpCAM+ cell frequency (A) and their Sca1 expression level
in the CD45+EpCAM+ population(B) at E13.5. Panel C-D shows CD45+EpCAM+ cell frequency
(C) and their Sca1 expression level in the CD45+EpCAM+ population(D) at E15. Panel E-F shows
CD45+EpCAM+ cell frequency (E)and their Sca1 expression level in the CD45+EpCAM+
population (F) at E18.5. All the experiments were done in three replicates.
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Figure 4.4

Figure 4.4. The thymic CD45+EpCAM+ population expresses adult the TEC progenitor markers,
Sca1, CD49f, and CD29. Representative figure showing expression of the adult TEC progenitor
markers MHCII, Sca1, CD49f, and CD29 in the thymus-derived CD45+EpCAM+ population at
different time points (4 month – 12-month). Panel A (i-vi) stem cell expression profile of
CD45+EpCAM+ population in 4-month-old thymus. Panel B (i-vi) stem cell expression profile of
CD45+EpCAM+ population in 8-month old thymus; Panel C (i-vi) stem cell expression profile of
CD45+EpCAM+ population in 10-month old thymus; Panel D (i-vi) stem cell expression profile
of CD45+EpCAM+ population in 12-month old thymus; Panel E (i-vi) stem cell expression profile
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of CD45+EpCAM+ population in CD45+EpCAM+population in post-castration regenerated
thymus. All the experiments were done in three to five replicates.

Figure 4.5

Figure 4.5. The bone marrow CD45+EpCAM+ population expresses the adult TEC progenitor
markers, Sca1, CD49f and CD29. Representative figure showing expression of the adult TEC
progenitor markers MHCII, Sca1, CD49f, and CD29 in the bone marrow-derived CD45+EpCAM+
population at different time points (4 month – 12-month) Panel A -C) Bone marrow analysis of 4
month old mouse A) CD45+EpCAM+ frequency, B) Sca1 frequency in CD45+EpCAM+ cells, C)
CD49f and CD29 expression in CD45+EpCAM+Sca1+ population. Panel D -F) Bone marrow
analysis of 8 month old mouse D) CD45+EpCAM+ frequency, E) Sca1 frequency in
CD45+EpCAM+ cells; F) CD49f and CD29 expression in CD45+EpCAM+Sca1+ population;
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Panel G -I) Bone marrow analysis of 10 month old mouse G) CD45+EpCAM+ frequency; H) Sca1
frequency in CD45+EpCAM+ cells; I) CD49f and CD29 expression in CD45+EpCAM+Sca1+
population; Panel J-L) Bone marrow analysis of 12 month old mouse J) CD45+EpCAM+
frequency, K) Sca1 frequency in CD45+EpCAM+ cells, L)CD49f and CD29 expression in
CD45+EpCAM+Sca1+ population;Panel M-N) Bone marrow analysis of 2 weeks old post
castration of 12-month-old mouse; M) CD45+EpCAM+ frequency; N) Sca1 frequency in
CD45+EpCAM+ cells; O) CD49f and CD29 expression in CD45+EpCAM+Sca1+ population. All
the experiments were done in three to five replicates.
Figure 4.6

Figure 4.6. The bone marrow CD45+EpCAM+ population expresses the adult thymic
mesenchymal stem cell marker CD34. Representative figure showing expression of the adult TEC
progenitor markers CD34 in the bone marrow-derived CD45+EpCAM+ population at different
time points (4 month – 12-month) Panel A -B) Bone marrow analysis of 4 month old mouse A)
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CD45+EpCAM+ frequency, B) CD34 frequency in CD45+EpCAM+ cells; Panel C- D) Bone
marrow analysis of 8 month old mouse C) CD45+EpCAM+ frequency; D) CD34 frequency in
CD45+EpCAM+ cells; Panel E -F) Bone marrow analysis of 10-month-old mouse E)
CD45+EpCAM+ frequency, F) CD34 frequency in CD45+EpCAM+ cells; Panel G-H) Bone
marrow analysis of 12-month-old mouse G) CD45+EpCAM+ frequency, H) CD34 frequency in
CD45+EpCAM+ cells. Panel I-J) Bone marrow analysis of 2 weeks old post castration of 12month-old mouse G) CD45+EpCAM+ frequency; H) CD34 frequency in CD45+EpCAM+ cells.
All the experiments were done in three to five replicates.

Figure 4.7

Figure 4.7. Change in CD45+EpCAM+ population frequency with progressive age. A. Graphical
representation of the absolute number of BM-derived CD45+EpCAM+ cells/lobe at different time
points. B. Graphical representation of an absolute number of thymus-derived CD45+EpCAM+
cells/animal at different time points. All the experiments were done in three to five replicates. Error
bars represent SEM. "*" indicates a statistically significant difference between any two time points.
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Figure 4.8

Figure 4.8 A. Graphical representation of the absolute number of BM-derived CD45+EpCAM+
cells two weeks after castration of 12-month-old C57BL6 mouse; B. Graphical representation of
the absolute number of thymus-derived CD45+EpCAM+ cells/lobe after castration of 12-monthold C57BL6 mouse. All the experiments were done in three to five replicates. Error bars represent
SEM. "*" indicates a statistically significant difference between any two time points.

Table 2: Genes over-expressed in BM-derived CD45+EpCAM+ population relative to the BM
derived CD45+ control population.
Gene

Fold

Position Symbol

Regulation

A02

Ackr2

5.31

A03

Ccl1

5.52

A04

Ccl11

45.81

A05

Ccl12

3.95

Comment

A
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A08

Ccl2

4.05

A09

Ccl20

3.17

A10

Ccl22

8.44

A11

Ccl24

6.35

B01

Ccl26

70.53

B02

Ccl28

98.14

B07

Ccl7

12.46

B08

Ccl8

6.96

B11

Ccr10

136.05

B12

Ccr1l1

288.98

C03

Ccr4

43.67

C05

Ccr6

8.09

C06

Ccr7

11.72

C07

Ccr8

3.03

C08

Ccr9

2.56

C09

Ackr4

2.81

C10

Ccrl2

2.08

C11

Cmklr1

41.32

C12

Cmtm2a

13.04

D02

Cmtm4

3.57

D03

Cmtm5

6.62

D04

Cmtm6

12.57

A

D05

Cx3cl1

3050488.75

A

A

A
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D07

Cxcl1

66.21

D08

Cxcl10

46.29

D09

Cxcl11

3.06

D10

Cxcl12

12.19

D11

Cxcl13

25.45

D12

Cxcl14

14.27

E01

Cxcl15

4.51

E02

Cxcl16

3.70

E03

Cxcl2

6.81

E04

Cxcl3

64.03

E05

Cxcl5

136.05

E06

Cxcl9

14.47

E07

Cxcr1

4.15

E11

Cxcr5

106.66

F01

Ackr3

3389.94

F04

Gpr17

5.62

F05

Hif1a

5.37

G04

Ppbp

2.02

G05

Slit2

2.49

G10

Tymp

6.69

H02

B2m

14.68

H05

Hsp90ab1

2.94

A

A

C

A
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Table 3: Genes over-expressed in the thymus-derived CD45+EpCAM+ population compared BMderived CD45+ control population.
Gene

Fold

Position Symbol

Regulation

Comment

A02

Ackr2

2.55

A03

Ccl1

5.37

A04

Ccl11

5.75

A05

Ccl12

13.03

A06

Ccl17

6.91

A07

Ccl19

10.42

A09

Ccl20

7.77

A10

Ccl22

13.42

A12

Ccl25

19.17

B02

Ccl28

4.09

B07

Ccl7

21.30

B08

Ccl8

16.36

B11

Ccr10

131.45

B12

Ccr1l1

131.46

C03

Ccr4

7.65

C05

Ccr6

16.28

A

C06

Ccr7

27.50

A
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C07

Ccr8

5.22

C08

Ccr9

25.13

C09

Ackr4

2.70

D05

Cx3cl1

3.70

D07

Cxcl1

20.49

D08

Cxcl10

10.47

D10

Cxcl12

2.96

D12

Cxcl14

7.21

E02

Cxcl16

14.09

A

E04

Cxcl3

27.71

A

E05

Cxcl5

74.51

E06

Cxcl9

7.99

E11

Cxcr5

6.96

F01

Ackr3

216.18

F04

Gpr17

4.45

G09

Tnf

2.28

G10

Tymp

5.04

G11

Xcl1

2.84

A

A: This gene's average threshold cycle is relatively high (> 30) in either the control or the test
sample

and

is

reasonably

low

in

the

other

sample

(<

30).

These data mean that the gene's expression is relatively low in one sample and reasonably detected
in the other sample suggesting that the actual fold-change value is at least as large as the calculated
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and

reported

fold-change

result.

This fold-change result may also have greater variations if the p value > 0.05; therefore, it is
important to have a sufficient number of biological replicates to validate the result for this gene.
C: This gene's average threshold cycle is either not determined or greater than the defined cut-off
(default 35), in both samples meaning that its expression was undetected, making this fold-change
result erroneous and un-interpretable.
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Chapter 5
Characterization of Active Canonical Wnt Signaling in the Fetal Thymic Stroma During
Embryogenesis & in the Regenerated Thymic Stroma
5.1. INTRODUCTION
The thymus is a three-dimensional framework of epithelial cells and fibroblasts essential
for developing a functional adaptive immune system (111, 316). It generates the naïve, selftolerant T-cell population from hematopoietic stem cells. T-cell lineage commitment and
development is heavily dependent on the interaction with the two distinct epithelial
microenvironments found in the thymic stroma: the cortex and the medulla. Early thymocyte
progenitors commit to T-cell fate in the cortex and undergo molecular processes to express
functional T-cell receptors (260). Cortex is also responsible for T-cell lineage ( CD4+ and CD8+
SP T-cells) determination. The thymic medulla is responsible for the negative selection of SP Tcell to develop a self-tolerant T-cell repertoire (260).
The development of thymic epithelial microenvironments from the third pharyngeal pouch
endoderm is a complex process and is still not fully understood. Organogenesis of the thymus is
linked to the parathyroid gland (86). The co-expression of a group of transcription factors that
consists of homeobox A3 (Hoxa3), paired box gene 1 (Pax1), Pax9, eyes absent 1 homologue
(Eya1), and sine oculis-related homeobox 1 homolog (Six1) are crucial for the formation and
patterning of the thymus/parathyroid rudiment from the 3rd pharyngeal pouch endoderm (317).
Additionally, proper separation of the thymus and parathyroid primordia from the common
bilateral primordium is driven by two transcription factors, Gcm2 (glial cells missing homolog 2)
and FoxN1 (Forkhead family transcription factor). Gcm2 was expressed in the pharyngeal
endoderm's parathyroid specific region, whereas the thymus specific region expressed FoxN1
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(Forkhead family transcription factor) (13).

Apart from separation from the parathyroid

primordium, FoxN1 is also important for the thymus' proper development (96). Previous studies
demonstrated that FoxN1 expression in thymic primordia is regulated by the Wnt signal
transduction pathway (31).
The canonical Wnt signaling pathway also plays an important role in the development and
proliferation of thymic stroma (245). Wnt ligands are evolutionarily conserved glycoproteins that
regulate cell fate, polarity, migration, and growth (206). The canonical Wnt signaling pathway is
activated when the Wnt ligands interact with Frizzled (Fzd receptors) and co-receptors, lowdensity lipoprotein receptor-related protein (LRP )- 5 or -6. The destruction complex, which
comprises adenomatous polyposis coli (APC), Axin, and glycogen synthase kinase-3β (GSK-3β),
releases Axin from the destruction complex. By inhibiting the phosphorylase activity of GSK-3β,
β-catenin is no longer phosphorylated and marked for degradation. After accumulating in the
cytoplasm, it is eventually imported into the nucleus and is able to form a complex with
transcription factors LEF-1 (Lymphoid Enhancer Factor) and T cell factors such as TCF-1, TCF3, or TCF-4 (200, 205). The binding of β-catenin to the TCF and LEF transcription factors activates
the expression of β-catenin-dependent responsive genes (214).
Canonical Wnt Signaling plays an essential role in thymocyte development. Tcf1−/− mutant
mice show a severe reduction of thymic cellularity. This transgenic mouse also shows a partial
block in CD4+CD8+ double-positive (DP) thymocyte production (318). Tcf1−/− mice showed a
severe decrease in thymocyte proliferation capability (319). Several studies have shown that the
Wnt signaling has an extensive role in hematopoietic stem cell self-renewal, maturation of
dendritic cells, T-cell development, activation, and peripheral T-cell migration (205, 239-242).
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Apart from its role in thymocyte development, Wnt signaling also has a role in developing
and maintaining the thymic epithelium. Lymphostromal crosstalk is essential for the development
and maintenance of the thymic epithelial architecture. For instance, the absence of Wnt4 ligand
down-regulates fetal thymic expansion, which causes a decrease in TEC numbers, early thymic
progenitor cells, and DN2 thymocytes (320). Another study found that mice with a FoxN1 specific
deletion of APC can stabilize canonical β-catenin-Wnt signaling. They also demonstrated that
these transgenic mice are unable to form a proper thymus (243). It has been previously shown that
the constitutive activation of Wnt-signaling via a gain-of-function mutation of β-catenin changes
the earlier commitments of the endodermal epithelial cells to thymic fate (246). This mutation also
disrupts the thymic stroma organization as well as thymocyte recruitment by TECs (246).
Our lab previously demonstrated that inhibiting canonical β-catenin-Wnt signaling also
disrupts the thymus architecture (241). In this study, double transgenic (tetO-Dkk1; K5rtTA) mice
were used, which in the presence of doxycycline produce high levels of Dkk1 in both mTECs and
cTECs, which leads to the inducible inhibition of the canonical Wnt signaling, and subsequently a
decrease in the TEC proliferation. Inducible inhibition of canonical Wnt signaling also causes a
reduction in all the TEC subsets (including the K5+K8+DP TECs thought to contain TEPCs) and
a rapid premature thymic degeneration similar to that observed in very old mice.
Thymic involution is the biggest paradox of immunology. Thymic involution is roughly
characterized by loss of the thymic size, decreased TEC number, adipogenesis, and loss of thymic
function. Inducing regrowth, albeit transient, is possible by castration, which has long been
considered a possible intervention in age-related degeneration of the thymus (146). However, the
regrown thymus' qualitative nature is far more similar to an aged thymus than a young thymus (7).
Most importantly, the canonical Wnt signaling pathway is the most significant pathway
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characterized by down-regulated genes in both aged and regenerated cortex compared to a young
cortex (7). Some studies demonstrated that the suppression of β-catenin-Wnt signaling is one of
the parameters involved in the complex process of thymic involution (6). This supports a vital role
for Wnt signaling in the maintenance of the thymus.
Despite the knowledge of thymic organogenesis and the role of canonical Wnt signaling in
the maintenance of the adult thymus and its role in the degeneration of the aged thymus, the role
and significance of canonical WNT signaling in fetal thymic development is unknown. Moreover,
no mapping of active Wnt signaling has been performed in either the postnatal, fetal or regenerated
thymus.
This study aims to use a relatively novel Wnt reporter mouse model, TCF/LEF: H2B-GFP,
to identify cells undergoing active WNT signaling. The TCF/Lef: H2B/GFP Wnt transgenic
reporter mouse has six copies of a TCF/Lef responsive element and an hsp68 minimal promoter in
front of a fluorescent protein fusion comprising human histone H2B fused to GFP. Nuclear-βcatenin and its transcriptional co-activators, TCF/Lef, interact with the TCF/Lef responsive
elements to initiate GFP expression (321). This transgenic model affords the ability to assess realtime changes in canonical Wnt signaling in individual cells in the thymic stroma. Preliminary
analysis using this model identified active canonical Wnt signaling in the postnatal thymus. It
showed that Wnt signaling is primarily restricted to the thymic medulla characterized by
UEA1+K14+ mTECs in addition to Aire-expressing mTECs essential for self-tolerance (data not
shown). These results suggest a previously unknown role for canonical Wnt signaling in the
development of this critical TEC subset. Thus, this study aims to identify specific cell types
undergoing active Wnt signaling during fetal development at specific timepoints and in the
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regenerated thymus. This study provides a roadmap of active Wnt signaling during fetal thymus
development.
5.2. RESULTS
This study utilized the TCF/Lef: H2B/GFP Wnt transgenic reporter mouse to characterize
which cells were undergoing canonical Wnt signaling during crucial stages during the fetal thymic
stroma development.
Canonical Wnt Signaling in the Fetal thymic stroma.
We wanted to understand whether Wnt signaling plays a role in mTEC development in the
fetal thymus or whether the Wnt signaling that is mostly restricted to mature mTECs in adult mice
represents a postnatal phenomenon. Given the critical role of mature mTECs in PGE and selftolerance, it is important to understand what role Wnt signaling might play in the initial development or
maintenance of Aire and Fezf2 expressing mTECs. We used the fetal thymus from embryonic day

13.5 (E13.5) to embryonic day 19.5 (E19) for flow cytometric analysis to focus on the time where
the TECs transition from bipotent progenitor cells at E13.5 to defined cortical and medullary
regions with mature mTECs and Aire-expressing cells beginning at E16.5-19.5. In the FACS
analysis of fetal thymic stroma, thymic epithelial cells were identified as the CD45, a
hematopoietic cell marker, negative, and EpCAM, a well-established thymic epithelial cell marker,
positive population. Nuclear H2B-GFP expression identified the cells undergoing canonical Wnt
signaling. C57BL6 mouse fetal thymus was used as a control for GFP expression in the Wnt
reporter mice.
To analyze whether the fetal thymic stroma undergoes Wnt signaling, the frequency and
absolute number of GFP expressing cells in single-cell suspensions derived from enzymatically
dissociated thymic stroma was analyzed using flow cytometry. Analysis of the E13.5-E19.5 fetal
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thymus revealed that the overall frequency of cells undergoing Wnt signaling in the fetal thymic
stroma decreases with progressive embryonic age. We analyzed both the frequency and absolute
number of GFP expressing cells in the fetal thymic stroma (includes both EpCAM+ and EpCAMpopulation) at different time points. At E13.5 and E14.5, the average frequency of cells undergoing
Wnt signaling in the thymic stroma remained 14% (+/-2.9). The GFP frequency started to decrease
from E15.5, with an average of 5.0% (+/-2) followed by an average of 1.8% (+/-1.2) at E16.5. At
E17.5, GFP expression frequency decreases further with an average of 0.74%(+/ 0.1). At E18.5
and E19.5, the average frequency of GFP expressing cells was observed to remain the same, 0.4(+/.2). Even though the frequency of cells undergoing Wnt signaling decreased with advanced fetal
age, the absolute number of those cells per lobe revealed a different pattern. The absolute number
of GFP expressing cells increases from an average of 947(+/- 105) at E13.5 to an average of
7575(+/-2212) at E16.5. Interestingly, from E17.5, the number of GFP expressing cells starts to
decline to show an average of 7066(+/-1112). The cell number remained almost the same, with an
average of 966 (+/-365) at E18.5 and 996 (+/-468) at E19.5. From this result, it is evident that
during embryonic day E13.5 -E15.5, a large frequency of TECs undergo active Wnt signaling, but
the number rapidly decreases from E16.5. It has been previously demonstrated that during the
E16.5-E19.5 developmental period, a defined cortical and medullar region with mature mTECs
and Aire-expressing cells started to appear. So, we hypothesized that Wnt signaling is essential for
thymic epithelial cell patterning. The bar graph representing the number of cells undergoing Wnt
signaling per thymic lobe at different time points is shown in Figure 5.1X. In the CD45-expressing
hematopoietic cells, the GFP expression was negligible (data are not shown). This result suggests
that the Wnt reporter gene is not expressed within the thymocyte subset or that active Wnt signaling
does not occur in the fetal thymocytes.
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Next, the frequency of EpCAM+ thymic epithelial cells in the thymic stroma at different
embryonic days was analyzed. This analysis showed that from E13.5 to E17.5, TEC frequency
decreased gradually. At E13.5, the average TEC frequency was 11% (+/-5), which subsequently
reduced to an average of 1.1% ( +/-0.3) at E17.5. But at E18.5 and E19.5, the TEC frequency
increased to an average of 4% (+/-1.5) (Figure 5.1). With progressive embryonic age, the thymus
is populated with an increasing number of thymocytes. Because of the rising number of
thymocytes, the epithelial cell frequency decreases. At E18.5 and E19.5, the CD45+ population
was depleted to enrich the thymic epithelial cell population resulting in an increase in the frequency
of EpCAM+ cells at those time points.
Additionally, the absolute number of thymic epithelial cells per lobe was also analyzed. As
expected, the total number of thymic epithelial cells increases with the progressive embryonic day.
The thymus dramatically grows during fetal development, ranging from an average as low as 950
(+/-355) cells at E13.5 to an average of as high as 7085(+/-3700) cells at E19.5. The Bar graph
representation of the absolutes number of Epithelial cells per lobe at different time points is shown
in Figure 5.1V.
Next, we analyzed both the frequency and the absolute number of GFP expressing TECs
in the thymic stroma at different time points. At E13.5 and E14.5, the average frequency of TECs
undergoing active Wnt signaling was 78.65% (+/-15.1). The GFP frequency started to decrease
gradually from E15.5. At E18.5 and E19.5, a sharp decrease in the frequency of GFP expressing
cells was observed. At E18.5, GFP+ cell frequency had an average of 16.83% (+/-6.7), and at
E19.5, the average frequency was 17.14% (+/-4.1). But when the absolute number of TECs
undergoing Wnt signaling was analyzed, it gradually increased with progressive timepoint from
an average of 958 (+/-221) cells at E13.5 to an average cell number of 6615 (+/-2500) at E16.5.
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The number of EpCAM+cells undergoing Wnt signaling started to decrease from an average of
5088, +/- 1116 cells at E17.5 to an average of 2023, +/-937 cells at E19.5. From this analysis, it
is evident that, like the total stromal cells undergoing Wnt signaling, active Wnt signaling in the
TECs first increases in the early embryonic stage (E13.5-E16.5) followed by a decrease in the late
embryonic stage (E17.5-E19.5). This result indicates TECs are the primary source of Wnt
signaling in the fetal thymus. FACS representation of EpCAM+ GFP+ population at different
embryonic days are shown in the second column of figure 5.1. Figure 5.1 W shows the bar graph
representing the number of epithelial cells undergoing Wnt signaling at different time points.
Next, we wanted to understand which TEC population undergoes active Wnt signaling
during fetal thymus development. In the adult thymus, active Wnt signaling was primarily
observed in the medulla, specifically in the AIRE expressing mature mTEC. In the fetal thymus,
the AIRE expressing mature mTECs appear during late embryogenesis (from E16.5). Few studies
have demonstrated that mature mTECs are developed from the bi-potent TEPCs (92, 106). Bipotent TEPCs are observed in the thymic stroma as early as embryonic day 11. A previous study
has shown that at E12.5, the fetal thymus has a homogeneous population of TECs. They also
demonstrated that if a single TEC from the E12.5 thymic stroma is transplanted in the fetal thymus,
it differentiates into cTECs and mTECs (92). Later, other studies explained that in the early stages
of thymic development, at E11.5-E12.5, a subpopulation of FoxN1 expressing TEPCs express
CD205, a cTEC marker. At a later embryonic day, E13.5, this CD205+ population upregulates
expression of mTEC marker CD40. This distinct population at E13.5 expressing both cTEC and
mTEC marker undergoes a further change of phenotype in the following embryonic days. At
E14.5, a subset of this population mentioned above downregulates CD205 expression and only
express CD40. These CD40+ mTEC progenitor cells then interact with SP thymocyte to develop
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into mature mTECs in later embryonic days. CD205+CD40+ progenitor cells in E14.5 get further
differentiated into mature cTECs. Interaction between DN thymocytes and immature
CD205+CD40+ immature cTECs is necessary for cTEC maturation. We wanted to understand at
what point during the crosstalk dependent stages of fetal development that result in the formation
of distinct functional regions of the thymic stroma, and Wnt signaling became restricted to mTECs.
For that purpose, FACS data of the fetal CD45-EpCAM+ TEC population was further analyzed to
distinguish between cortical and medullary TECs, by using BP1 as a cTEC marker and UEA1 as
an mTEC marker. The BP1 and UEA1 staining pattern of the EpCAM+ TECs revealed the
existence of four distinct populations:1) BP1+UEA1- (cTEC), 2) BP1-UEA1+(mTEC), 3)
BP1+UEA1+, and 4) BP1- UEA1-. Previous work by others analyzing TECs using these two
markers has shown these four populations but have not discussed their significance.
Active Wnt signaling is first observed in EpCAM+BP1-UEA1- population
First, we analyzed both the frequency and the absolute number of the EpCAM+BP1UEA1- population. We observed a decrease in the frequency of the EpCAM+BP1-UEA1-cells
with advanced embryonic age. At E13.5, BP-UEA1- cells had the highest frequency, with an
average of 85% (+/-16.5). The EpCAM+BP1-UEA1- population's frequency gradually decreased
to an average of 10.54% (+/-3) at E16.5. But from E17.5 to E19.5, the frequency of the
EpCAM+BP1-UEA1- population remained the same, with an average of 14.8% (+/- 5). Next, the
EpCAM+BP1-UEA1- cell number revealed that at E13.5 and E14.5, the highest number of BP1UEA1- cells were present, with an average of 4128, +/-1200, and the number gradually decreased
till E16.5, with an average of 963 (+/- 655). Interestingly, beginning at E17.5 BP1-UEA1- cell
numbers started to increase again. At E19.5, the BP1-UEA1- cell number increased to an average
of 2157,+/-1138 cells/lobe (figure 5.3A). From these results, it can be hypothesized that even
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though from E17.5 to E19.5, the frequency of BP1+UEA1+ population remained the same, the
absolute number of this population increased because the overall thymic epithelial cellularity
increased with progressive embryonic age (figure 5.2).
Next, the GFP expression in these cells was analyzed. At E13.5, an average of 590, +/-227
cells in this population express GFP, followed by an increased average of 3332, +/-519 at E14.5.
But at E15.5, the GFP+ cell number decreased, showing an average of 1476, +/-289 cells. From
E16.5 to E19.5, the number remains very low and almost the same. FACS representation of
GFP+BP1-UEA1- cells at different time points are shown in figure 5.2 v(A-G). The Bar graph
representation of total BP1-UEA1- cells undergoing Wnt signaling is demonstrated in Figure 5.3E.
The frequency of GFP+ cells in the BP1-UEA1- population was also analyzed. We observed an
average of 70% (+/-11) GFP+ cells at E13.5 and E14.5. From E15.5, the frequency of GFP
expressing cells within the BP1-UEA1- population decreased gradually. At E19.5, this population
had an average of 9.46% (+/-8.33) GFP+ cells.
To summarize, this analysis revealed that the EpCAM+BP1-UEA1- population had the
highest frequency of cells undergoing Wnt signaling at early embryonic days E13.5 and E14.5,
and this frequency decreased with progressive embryonic days. As explained before, EpCAM+
cells of the early fetal thymus differentiate into both cTECs and mTECs. The EpCAM+BP1UEA1- population in this study might represent the same thymic epithelial progenitor population.
From this result, it can be hypothesized that the EpCAM+ thymic epithelial progenitor population
undergoes active Wnt signaling at the early stage of thymic organogenesis. This population
becomes rare later, and these cells stop undergoing Wnt signaling as more defined TEC lineages
started to appear.
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Cortical thymic epithelial cells undergo active Wnt signaling in the fetal thymic stroma
BP1 vs. UEA1 staining in FACS analysis revealed that EpCAM+ cells were mainly BP1UEA1- at E13.5 and E14.5. But from E15.5 majority of the EpCAM+ cells started to express BP1,
shifting the cell density toward BP1+ cTECs (figure 5.2 i). So, the BP1+ cTEC population was
analyzed for cells undergoing active Wnt signaling. Frequency analysis of the GFP+ cells in the
EpCAM+BP1+UEA1- cTEC population revealed that from E13.5 to E16.5, an average of 61.67%
(+/-10.87) was maintained (Figure 5.2 ii (A-D)). From E17.5, the frequency of GFP+ cTECs
started to decrease with advancing embryonic age. E19.5 had the lowest frequency of GFP+
cTECs, with an average of 21.81(+/-9.4) (Figure 5.2 ii (E-G)). When the number of GFP
expressing cTECs was analyzed, a gradual increase of the absolute cell number was observed with
progressive embryonic age. At E13.5, GFP+ cells had an average of 49, +/- 20. GFP+ cells
gradually increased to an average of 3936, +/-491 at E17.5. But the number started to decrease
with an average of 1916, +/-965 at E18.5, followed by an average of 1562, +/-970 at E19.5(figure
5.3F).
The frequency and the absolute number of cTECs were also analyzed. We observed that
with advancing embryonic day, the frequency of the BP1 expressing cTEC population increased
gradually, from an average of 9.1% (+/-5) at E13.5 to an average of 80%(+/-5) at E19.5. Additional
analysis of the BP1+ cell number revealed that from E13.5 to E19.5, BP1+ cTECs increased in
number with progressive embryonic age (figure 5.3B).
Baik et al. showed that at E11.5- E12.5, the fetal thymic epithelial progenitor cell
population expresses CD205. At E13.5 this CD205-expressing population also starts expressing
CD40, an mTEC marker (106, 270, 322). Additionally, another study has shown that a subset of
CD205+ cells also express BP1 during fetal development. We hypothesized that the BP1+ cTEC
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population also represents at least in part the CD205+ TEPCs. The shift of frequency in the FACS
data showed that the BP1-UEA1- population progresses toward the BP1+ cortical epithelial cell
population. Interestingly, in the early stages of thymic organogenesis (E13.5 to E16.5), this
population has a high frequency of cells undergoing active Wnt signaling (~61%), which then
started declining from E17. It is worth noting that during this period ( E13.5-E16.5) of thymus
development, the first wave of thymocytes undergoes their developmental process,(315). It has
been demonstrated previously that interactions with DP T-cells play a critical role in cTEC
development (269). Taking our result and previously found information together, we can
hypothesize that Wnt signaling might play a crucial role in the lymphostromal interaction essential
for thymus development. It has been previously demonstrated that in response to inhibition of Wnt
signaling, specifically Wnt4 expression, fetal and early postnatal thymic expansion is suppressed.
Wnt4 suppression also decreases TEC numbers, early thymic progenitor cells, and thymocytes in
the DN2 stage (320). It has also been demonstrated that suppression of canonical Wnt signaling
disrupts thymic epithelial architecture (6). Keeping these previous findings in mind, it can be
hypothesized that Wnt signaling in cortical thymic epithelial cells from E13.5 to E16.5 might be
important for driving thymic epithelial progenitor cell differentiation toward different TEC
lineages, particularly cTECs.
Medullary thymic epithelial cells undergo active Wnt signaling in the fetal thymic stroma.
Preliminary analysis using the TCF/LEF H2BGFP Wnt reporter model identified that
active canonical Wnt signaling is primarily restricted to the thymic medulla characterized by
UEA1+K14+ mTECs in addition to Aire+ mTECs essential for self-tolerance in the postnatal
thymus. It is crucial to understand whether the Wnt signaling expression pattern changes in the
fetal thymus to regulate mTEC development.
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To analyze Wnt signaling during mTEC

development, medullary thymic epithelial cells were analyzed to identify mTECs undergoing
active Wnt signaling in the fetal thymus. The mTEC population was defined as the EpCAM+BP1UEA1+ subset of TECs (figure 5.2 i). Analysis of both the frequency and the absolute number of
EpCAM+BP1-UEA1+ cells revealed that this population expanded gradually with progressive
embryonic age. It should be noted that this population emerged beginning at E15.5. Analysis of
the frequency of GFP+ mTECs revealed that it increases with progressive embryonic age. At
E13.5, mTECs had the lowest frequency of GFP+ cells, with an average of 24% (+/-27), followed
by a gradual increase to an average frequency of 51% (+/-13) at E16.5 (figure 5.2 iii). From E16.5
to E19.5, the frequency of GFP+ mTECs remained the same, with an average of 52% (+/-16).
Furthermore, when we analyzed the absolute number of GFP+ cells in the mTEC population, we
observed that with progressive embryonic age, the number of GFP expressing mTEC increased
gradually. At E13.5, very few GFP+ mTECs were observed. But with the progressive embryonic
age, the number of GFP+ mTECs increased to an average of 555, +/-290 at E19.5 (figure 5.3G).
Apart from the BP1-UEA1+ population, another UEA1 binding population, BP1+UEA1+,
was observed in the fetal thymic stroma. Frequency analysis of this small population revealed this
population fully appeared from E15.5, with an average of 1.5% (+/-0.8), and this population
maintained a steady frequency from E17.5-E19.5, with an average of 6% (+/-1). Frequency
analysis of GFP+ cells in the BP+UEA1+ population revealed that this population maintains a
steady frequency of GFP+ cells at all embryonic days, with an average of 25% (+/5). Additionally,
the GFP+ cell number in the BP1+UEA1+ population revealed a gradual increase with progressive
embryonic age. Previous work by others analyzing fetal TECs using BP1 and UEA1 has shown
the presence of this population, but its significance was never discussed in detail before. Thymic
epithelial cells expressing both cTEC and mTEC markers have been considered as TEPC
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population before. Klug et al. showed the presence of this population in the MTS24+ fetal thymic
stromal cell population, and they hypothesized the BP1+UEA1+ population represents potential
TEPCs. But no further studies have been performed to confirm the validity of this hypothesis. Our
result demonstrated that this population appeared around the same time the BP1-UEA1+ mTEC
population started to emerge. It is important to note that this population undergoes active Wnt
signaling at the late embryonic stage along with the BP1-UEA1+ population. Additionally, both
this population maintained a steady frequency of GFP expressing cells from E16.5 to E19.5.
Keeping this data in mind, we hypothesized BP1+UEA+ population might represent an immature
mTEC population. We also hypothesized the small frequency of GFP+BP1+UEA1+ cells is
undergoing active differentiation to contribute to the BP1-UEA1+ population. In future
experiments, the BP1+UEA1+ population needs to be investigated more thoroughly to decipher if
this population truly represent mTEC progenitor cells.
To summarize the FACS analysis of changes in active Wnt signaling in the four TEC
population defined by UEA1 and BP1, GFP expression is first observed in the EpCAM+BP1UEA1- and EpCAM+BP1+UEA- populations at E13.5 and E14.5. At E15.5, the GFP+ cell
frequency decreased in the BP1-UEA1- population and increased in the BP1+UEA1-, cTEC
population. At E16.5, the GFP+ cTEC frequency started to decline, and the GFP+ BP1-UEA1+,
mTEC, and GFP+BP1+UEA1+ cell frequency reached a steady state. Comparison between GFP+
cTECs and GFP+ mTECs revealed that during the early stage of embryogenesis, at E13.5-E15.5,
the cortical epithelial compartment had a higher frequency of cells undergoing Wnt signaling than
the medullary epithelial population (Figure 5.4). Previous studies have shown that EpCAM1+ cells
of E12 thymic stroma represent the TEPC population. The EpCAM+BP1-UEA1- population in
this analysis likely represent the same population mentioned above. Other studies have previously
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shown that fetal epithelial cells expressing cTEC markers can give rise to cTECs and mTECs. The
EpCAM+BP1+UEA1- population might include the TEPC population as well as cTECs. Our
results indicate that the BP1-UEA1- and subsequently, the BP1+UEA1- TEPCs mainly undergo
Wnt signaling in the fetal thymic stroma at early embryonic days. At the later stages of thymic
development, cells undergoing active Wnt signaling were more frequent in medullary thymic
epithelial cells. It is important to mention that even though the frequency of cells undergoing Wnt
signaling decreased at the later stage of embryogenesis in BP1+cTECs, a small frequency of
GFP+BP1+ cells was still observed in this population. From this analysis, it can be hypothesized
that a high frequency of potential thymic epithelial progenitor cells undergoes active Wnt signaling
to regulate differentiation of TEPCs to mature mTECs and cTECs.
CD205 expressing fetal epithelial cells undergo active Wnt signaling.
CD205/ DEC205 is a cortical thymic epithelial progenitor cell marker. Previously it has
been demonstrated that the CD205+ cells also represent the bi-potent thymic epithelial progenitor
population (106). In our FACS analysis, BP1 was used as a cTEC marker. As explained in the
previous section, the BP1+UEA1-, cTEC population undergoes active Wnt signaling at the early
stages of thymic development. It has been previously demonstrated that a subset of IL7 expressing
TECs also expressed CD205 and BP1. They also demonstrated as the frequency of this
IL7+CD205+BP1+ population started to decrease, mTEC development started to unfold (128).
This data led us to hypothesize the BP1+UEA1- population observed in FACS analysis may also
include a DEC205+BP+ subpopulation. It would have been interesting to observe both BP1 and
DEC205 staining patterns, but we could not achieve that due to technical limitations. So, we did
the immunohistochemical analysis with both DEC205 and UEA1 to understand the relationship
between DEC205+ cells undergoing active Wnt signaling and UEA1+ mature mTECs undergoing
169

active Wnt signaling. The next question was if the CD205+ fetal cells undergo active Wnt
signaling during thymus development. Fetal thymic tissue was sectioned and analyzed using
immunohistochemical analysis with CD205 antibody to characterize Wnt signaling changes within
the DEC205-expressing TECs during fetal development. Those fetal thymic tissues were
simultaneously stained for UEA1 to visualize thymic epithelial cell patterning during
development. After staining and imaging the fetal thymic tissues derived from different embryonic
days, we manually counted UEA1, DEC205, and GFP expressing cells (figure 5.5 & 5.6).
Immunohistochemical data demonstrated that the number of CD205+GFP+ cells gradually
increase from E13.5 to E16.5, followed by a gradual decrease in this cell number from E17.5 and
E19.5. Additionally, histochemical analysis of the UEA1 binding mTECs showed that the
UEA1+GFP+ mTECs started to appear around E15.5, and the cell number increased with
advancing embryonic age as the medulla became more apparent. Both FACS analysis and
histochemical analysis showed that UEA1+GFP+ cell number increased with progressive
embryonic age.
Comparison between the analysis of BP1+GFP+ cell number and the CD205+GFP+ cell
number showed that both populations had an increasing number of cells undergoing active Wnt
signaling until E16.5. Even though the DEC205+GFP+ cell number started to decrease from
E17.5, interestingly, BP1+GFP+ cell number began to decline from E18.5. From this data set, it
can be hypothesized that CD205+ TEPCs undergo active Wnt signaling during E13.5-E16.5.
Immunohistochemistry data showed from E17.5 DEC205+GFP+ number started to decrease, and
more UEA1+GFP+ cells began to appear. From this result, it can be hypothesized that
DEC205+GFP+ cells present in early development were downregulated at the late stage of thymic
development when mature mTECs started to appear.
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FoxN1 and AIRE expression are dependent on Wnt signaling.
FoxN1 is a transcription factor critical for thymus development. It is well established that
in a FoxN1 null mouse, after the thymic primordium's initial development, further development of
the thymus is arrested (around E12.5) (323). FoxN1 expression is also essential for thymic
epithelial lineage differentiation and maturation (324). It has been previously demonstrated that
FoxN1 expression is regulated by Wnt4 signaling (22). Another study also showed that induced
expression of DKK1, a canonical Wnt signaling inhibitor, causes rapid loss of FoxN1+ and AIRE+
TECs. However, none of these studies directly determined if FoxN1 expressing cells undergo
canonical Wnt signaling during fetal thymus development. Analysis of TCF/LEF H2BGFP Wnt
reporter mice was used to understand the relationship between active Wnt signaling and the
expression of FoxN1 during fetal thymic development.
Suppression of canonical Wnt signaling causes a loss of AIRE+ TECs. AIRE+ mature
mTECs play an essential role in ensuring the development of a self-tolerant T-cell population
through the process of promiscuous gene expression and as well as the development of regulatory
T cells. In short, the AIRE+ mTECs are a vital cell population of the thymus. In the previous
sections, a relationship between UEA1+ mTECs and Wnt signaling was established, so we
hypothesized that the AIRE+ mTECs in the fetal thymus also undergo active Wnt signaling.
Thymic tissues from different embryonic ages were analyzed for AIRE expression. The fetal
thymic sections derived from TCF/LEFH2BGFP Wnt signaling reporter mice were stained with
AIRE and FoxN1. After staining and imaging the fetal thymic tissues from different embryonic
days, we manually counted FoxN1, AIRE, and GFP expressing nuclei. Analysis of GFP + AIRE+
cells revealed a negligible number of these cells at E13.5 and E14.5, which was expected as the
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E13.5 and E14.5 fetal thymus had very few AIRE+ cells. Beginning at E15.5, when the first
medulla begins to form, both AIRE+ and AIRE+ GFP+ cells started to increase with progressive
embryonic age (Figure 5.8 N). It is important to mention that both UEA1+ GFP+ cells and
AIRE+GFP+ cells followed the same Wnt expression pattern. It has been demonstrated before that
both cTECs and mTECs are derived from a bi-potent TEPC. Different models have been proposed
in the explanation of fetal TEC development. One of those popular models, the Serial progression
model, describes TEPCs first give rise to transitional thymic epithelial progenitors, which express
both cTEC and mTEC traits. These transitional thymic epithelial progenitors eventually commit
to either cTEC fate or mTEC fate. Taking FACS data and immunohistochemistry data together,
it can be hypothesized that probable thymic epithelial progenitor cell population undergoes active
Wnt signaling during the early stage of thymic development to drive the development of UEA1+
mTECs and subsequently more mature AIRE+ mTECs.
Next, analysis of histochemical images for FOXN1+GFP+ cells revealed a progressive
increase in GFP-expressing cell numbers with increasing embryonic age from E13.5 to E15.5.
From E16.5, the number of FoxN1+GFP+ cells started to decrease with advancing embryonic age.
From E17.5 to E19.5(8A, 8F, and 8J), a negligible number of FoxN1+GFP+ cells were observed.
The primary purpose of this set of experiments was to understand the relationship between FoXN1,
the key transcription factor of TEC development, AIRE, a mature mTEC marker, and active Wnt
signaling. This set of results demonstrated that from E16.5, when the GFP+ mature mTECs
population started expanding (figure 5.8N), FoxN1+GFP+ cell, as well as FoxN1+ cell numbers,
were down-regulated (figure 5.8M). From this result, it can be hypothesized that TECs undergoing
active Wnt signaling upregulates the FoxN1 expression, which drives the TECs to differentiate
into mature mTECs. Expansion of mature mTECs downregulates the expression of FoxN1 and
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Foxn1+GFP+ Cells. It is possible that both Wnt signaling and FoxN1 expression is tightly
regulated during TEC development.
Wnt Signaling is upregulated in thymic epithelial cells during castration recovery.
The thymus undergoes age-related involution characterized by a loss of thymic size, a
decrease in TEC number, an increase in adipogenesis, and a loss of thymic capacity to support
functional development of naïve T cells (139). A role for Wnt signaling has been implicated in
age-induced thymic involution (7). Inducing regrowth, albeit transient, is possible by castration,
which has long been considered a possible intervention in age-related degeneration of the thymus
(146). However, the regrown thymus' qualitative nature is far more similar to an aged thymus than
a young thymus (7). The canonical Wnt signaling pathway is the most significant pathway
characterized by down-regulated genes in both aging and regenerated cortex compared to a young
cortex (7). A preliminary relationship between thymic epithelial cells and Wnt signaling has been
established in the previous sections, and a possible connection between downregulation of Wnt-βcatenin signaling and age-induced atrophy has been demonstrated (7). We hypothesized that
canonical Wnt signaling would be upregulated in the thymic epithelial cell population in the
recovering thymus. To investigate this hypothesis, we analyzed Wnt signaling in the thymic
epithelial cells of the aged thymus as well as the regenerated thymus following castration.
12-month-old Wnt reporter mice were castrated, and after two weeks, their thymic
epithelial cells were analyzed for the presence of cells undergoing active Wnt signaling using
FACS. Additionally, FACS analysis of the 12-month-old mouse thymus was also performed to
observe the thymic epithelial cells undergoing active Wnt signaling in the aged thymus. C57BL6
mouse thymus was used to establish GFP expression gating in this set of experiments. Both the
samples were analyzed for active Wnt signaling in four thymic epithelial compartments, 1)
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BP1+UEA1- (cTEC), 2) BP1-UEA1+(mTEC), 3) BP1+UEA1+, and 4) BP1-UEA1-. As discussed
with the fetal thymus FACS result, BP1+UEA1+ and BP1-UEA1- TEC populations represent
potential TEPCs. It is crucial to understand if this population undergoes any changes in active Wnt
signaling in response to thymic regeneration. Comparison between aged and regenerated thymus
revealed that the number of cells undergoing Wnt signaling in both cTEC and mTEC population
is upregulated in the regenerated thymus than the aged thymus. It is worth noting that the mTEC
population had a higher number of cells undergoing active Wnt signaling than the cortical
epithelial cells undergoing Wnt signaling in the fetal thymus. This data set suggests that Wnt
signaling might play a role in mTEC regeneration in the reconstituted thymus.
5.3. DISCUSSION
Canonical Wnt signaling plays an essential role in thymus development (245). It has been
previously demonstrated that Wnt signaling regulates FoxN1 expression in both fetal and adult
thymus(22). Wnt signaling is also involved in the maintenance and regulation of progenitor cells
in the adult thymus, which are needed to maintain functional thymic tissue(6). Given its’ role in
TEC progenitor maintenance, we hypothesize that Wnt signaling will be more critical during fetal
thymic development. However, no characterization of Wnt signaling in the fetal thymic epithelial
cell had been previously performed. During embryogenesis, fetal T-cell development happens in
two phases: first, during embryonic development from E12.5 to E19.5, second, during postnatal
days 3-6. It is well established that fetal thymic epithelial cell development is regulated by critical
lymphostromal crosstalk. Given the essential role of thymic crosstalk in TEC development, we
analyzed thymic epithelial cells during E13.5 to E19.5. It would have been ideal to explore the
fetal thymus at E12.5, but due to technical limitations, we could not achieve that.
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This study demonstrates that ~95% of the thymic stromal cells undergoing Wnt signaling
are EpCAM+ thymic epithelial cells during thymus development. FACS and IHC analysis
revealed that during early embryogenesis, from E13.5-E14.5, cells undergoing active Wnt
signaling were mainly present in the EpCAM+BP1-UEA1-, DEC205+ TEC population. It has been
previously demonstrated that the DEC205+ cells in the fetal thymus represent a bi-potent thymic
epithelial progenitor cell population (106). Another study showed that EpCAM1+ cells present
during early thymic development also represent the TEPC population (92). From our result, it is
evident that during early embryogenesis, TEPCs undergo active Wnt signaling. It will be
interesting for future analysis to see if the DEC205+ cells are part of the EpCAM+BP-UEA1population. At E15.5, cells undergoing active Wnt signaling were mostly found in the DEC205+,
EpCAM+, and the BP1+UEA1-, cTEC population. But from E16.5 cells undergoing active Wnt
signaling started to decrease in the DEC205+ population and predominantly transitioned to the
EpCAM+ BP1+UEA1-, cTEC population and newly emerging UEA1 binding AIRE+ mature
mTEC population. During the late embryogenesis stage E17.5-E19.5, most of the UEA1+ AIRE+
mTECs and small frequency BP1+ and DEC205+ cTECs undergo active Wnt signaling.
To summarize, it appears that active Wnt signaling in thymic epithelial compartments
follows the thymic epithelial cell developmental model of serial progression given in Figure 5.10.
It is important to mention that FoxN1 expressing cells undergo active Wnt signaling during the
early developmental stage. Downregulation of FoxN1 cells and FoxN1+GFP+ cell number is
observed from E16.5 when the mature mTEC population started increasing in number. Our result
indicated that the FoxN1+ TECs undergo active Wnt signaling to go through developmental stages
to give rise to mature TEC lineages during fetal thymic development. Future analysis will be
necessary to see which Wnt ligands and receptors are expressed in the cells undergoing active Wnt
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signaling. It is also essential to compare the Wnt ligand profile of different thymic epithelial
populations at different time points to understand which Wnt signaling components play a role in
TEC development.
It has been previously demonstrated that suppression of Wnt-β-catenin signaling causes
thymic involution. This information led us to hypothesize that during recovery of the aged thymus
following castration, there will be an upregulation of cells undergoing active Wnt signaling in the
thymic stroma. It is possible Wnt signal transduction pathway can promote thymic epithelial
expansion, due to which thymic cellularity can be recovered. FACS analysis of recovered thymus
following castration revealed an upregulation of the number of cells undergoing active Wnt
signaling in every TEC compartment. This result indicates castration may promote Wnt signaling
in the thymic epithelial stroma, which induces thymic size recovery. It is also important to mention
that more mTECs were undergoing active Wnt signaling than the cTEC population in the
regenerated thymus. It has been demonstrated before that during castration induce thymic
regeneration, mainly expansion of the mTEC population was observed, and the cTEC population
frequency started to decrease(147). It is possible that during regeneration, a higher number of
mTECs undergo active Wnt signaling, due to which the mTEC compartment can undergo
expansion. As a smaller number of cTECs undergo Wnt signaling, their expansion was less or
negligible.
This study sets up a roadmap of active Wnt signaling during fetal thymus development.
Fetal thymus data and the regenerated thymus data together indicate that Wnt signaling might play
a critical role in medullary thymic epithelial cells development and maintenance. But this data is
not sufficient to prove the active role of Wnt signaling in TEC development. Future studies need
to perform analysis of active Wnt signaling TEC population to understand which Wnt ligands are
176

being expressed. Knockout mice of those active Wnt ligands can demonstrate their role in TEC
development.
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Figures & Figure Legends:
Figure 5.1

Figure 5.1. FACS representation of Epithelial cells at different embryonic days. A) FACS
representation of CD45 vs. EpCAM staining in the fetal thymus at different time points; B) FACS
representation of EpCAM+ cells undergoing Wnt signaling at different time points; C) FACS
representation of cells undergoing Wnt signaling at different time points. D) Bar graph
representation of total EpCAM+ epithelial cells at different time points; E) Bar graph
representation of EpCAM+ cells undergoing Wnt signaling at different time points; F) Bar graph
representation of the thymic stromal cells undergoing Wnt signaling at different time points; All
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the calculations were done for the absolute number of cells/lobe. All the experiments done in 4-10
replicates
Figure 5.2
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Figure 5.2. FACS representation of BP1, UEA1 staining at Different embryonic days. i A-G)
FACS representation of BP1 vs. UEA1 staining in the fetal thymus at different time points; ii AG) FACS representation of BP1+ cells undergoing Wnt signaling at different time points; iii A-G)
FACS representation of UEA1+ cells undergoing Wnt signaling at different time points; iv A-G)
FACS representation of BP1-UEA1- cells undergoing Wnt signaling at different time points; v AG) FACS representation of BP1-UEA1- cells are undergoing Wnt signaling at different time
points. All the experiments were done in 4-10 replicates

Figure 5.3

Figure 5.3. Cellularity of the Thymic epithelial compartments. A) Bar graph representation of BP1UEA1- cells in the fetal thymus at different time points; B) Bar graph representation of BP1+ cells
in the fetal thymus at different time points; B) Bar graph representation of UEA1+ cells in the fetal
thymus at different time points; C) Bar graph representation of BP1+UEA1+ cells in the fetal
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thymus at different time points; E) Bar graph representation of BP1-UEA1- cells undergoing Wnt
signaling at different time points; F) Bar graph representation of BP1+ cells undergoing Wnt
signaling at different time points; G) Bar graph representation of UEA1+ cells undergoing Wnt
signaling at different time points; H) Bar graph representation of BP1+UEA1+ cells undergoing
Wnt signaling at different time points. All the calculations were done for the absolute number of
cells/lobe. All the experiments were done in 4-10 replicates.

Figure 5.4

Figure 5.4. Bar graph representation of BP1-UEA1-, BP1+ UEA1-, BP1-UEA1+, BP1+UEA1+
cells in the fetal thymus at different time points. All the experiments were done in 4-10 replicates.
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Figure 5.5

Figure 5.5. DEC205 and UEA1 staining of the TCF/Lef: H2B-GFP Wnt reporter mouse fetal
thymus section at different Embryonic days (E13.5-E16.5): A-D) DEC205& UEA1 staining at
E13.5; A) DEC205, B) UEA1,C) GFP+ cells undergoing Wnt signaling D) Merged image of
DEC205, UEA1, and GFP; E-H) DEC205& UEA1 staining at E14.5; E)DEC205, F)UEA1,G)
GFP+cells undergoing Wnt signaling H) Merged image of DEC205, UEA1, and GFP; I-L)
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DEC205& UEA1 staining at E15.5; I) DEC205, J) UEA1,K) GFP+ cells undergoing Wnt signaling
L) Merged image of DEC205, UEA1, and GFP; M-P) DEC205& UEA1 staining at E13.5; M)
DEC205, N) UEA1,O) GFP+ cells undergoing Wnt signaling P) Merged image of DEC205,
UEA1, and GFP staining. All the experiments were done in 4-10 replicates
Figure 5.6

Figure 5.6. DEC205 and UEA1 staining of the TCF/Lef: H2B-GFP Wnt reporter mouse fetal
thymus section at different Embryonic days (E17.5-E18.5): A-D) DEC205& UEA1 staining at
E17.5; A) DEC205, B) UEA1,C) GFP+ cells undergoing Wnt signaling D) Merged image of
DEC205, UEA1, and GFP; E-H) DEC205& UEA1 staining at E18.5; E) DEC205, F) UEA1,G)
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GFP+ cells undergoing Wnt signaling H) Merged image of DEC205, UEA1, and GFP; I) Bar graph
representation of FOXN1+ cells undergoing Wnt signaling at different time points. J) Bar graph
representation of AIRE+ cells undergoing Wnt signaling at different time points. All the
experiments were done in 4-10 replicates.
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Figure 5.7

Figure 5.7. FoxN1 and AIRE staining of the TCF/Lef: H2B-GFP Wnt reporter mouse fetal thymus
section at different Embryonic days (E13.5-E16.5): A-D) FoxN1& AIRE staining at E13.5; A)
FoxN1, B) AIRE,C) GFP+ cells undergoing Wnt signaling D) Merged image of FoxN1, AIRE,
and GFP; E-H) FoxN1& AIRE staining at E14.5; E) FoxN1, F) AIRE, G) GFP+ cells undergoing
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Wnt signaling H) Merged image of FoxN1, AIRE, and GFP; I-L) FoxN1 & AIRE staining at
E15.5; I)FoxN1, J)AIRE, K) GFP+cells undergoing Wnt signaling L) Merged image of FoxN1,
AIRE, and GFP; M-P) FoxN1 & AIRE staining at E16.5; M)FoxN1, N)AIRE, O) GFP+ cells
undergoing Wnt signaling P) Merged image of FoxN1, AIRE, and GFP staining. All the
experiments were done in 4-10 replicates.
Figure 5.8

Figure 5.8. FoxN1 and AIRE staining of the TCF/Lef: H2B-GFP Wnt reporter mouse fetal thymus
section at different Embryonic days (E17.5-E19.5): A-D) FoxN1& AIRE staining at E17.5;
A)FoxN1, B)AIRE, C) GFP+cells undergoing Wnt signaling D) Merged image of FoxN1, AIRE,
and GFP; E-H) FoxN1& AIRE staining at E18.5; E)FoxN1, F)AIRE, G) GFP+cells undergoing
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Wnt signaling H) Merged image of FoxN1, AIRE, and GFP; I-L) FoxN1 & AIRE staining at
E19.5; I)FoxN1, J)AIRE, K) GFP+ cells undergoing Wnt signaling L) Merged image of FoxN1,
AIRE, and GFP; M) Bar graph representation of the Dec205+ cells undergoing Wnt signaling at
different time points. N) Bar graph represents the UEA1+ cells undergoing Wnt signaling at
different time points. All the experiments done in 4-10 replicates.
Figure 5.9

Figure 5.9. Thymic epithelial compartments undergo canonical Wnt signaling upregulation in the
regenerated thymus. FACS representation of thymic stromal cell at 12-month-old mouse and
castration recovery mouse. The upper panel of the figure represents a 12-month-old mouse's data,
and the lower panel shows the analysis of the Castration Recovery thymus. A) FACS
representation of EpCAM vs. CD45 staining in the thymus; B) FACS representation of EpCAM+
cells undergoing Wnt signaling; C) FACS representation of BP1 vs. UEA1 staining in the fetal
thymus; D) FACS representation of BP1+ cells undergoing Wnt signaling; E) FACS representation
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of UEA1+ cells undergoing Wnt signaling; F) FACS representation of BP1+UEA1+ cells
undergoing Wnt signaling; G) FACS representation of BP1+UEA1+ cells undergoing Wnt
signaling. H) Bar graph representation of EpCAM + cells undergoing Wnt signaling I) Bar graph
representation of BP1+ cells undergoing Wnt signaling; J) Bar graph representation of UEA1+
cells undergoing Wnt signaling; K) Bar graph representation of BP1+UEA1+ cells undergoing
Wnt signaling; L) Bar graph representation of BP1-UEA1- cells undergoing Wnt signaling at
different time points. All the calculations were done for the absolute number of cells/lobe. All the
experiments were done in 3-4 replicates
Figure 5.10

Figure 5.10. Panel A is adapted from Alves et al. 2014. In the “serial progression” model, TEPs
transverse through a “transitional TEC progenitor” stage (tTEP) that expresses phenotypic and
molecular traits associated with cTECs before the commitment into a cTEC or mTEC fate. tTEPs
are more closely linked, at the phenotypic and molecular levels, with cTEPs and have the potential
to generate both mTEC progenitors and mature cTECs, with the cortical lineage being the “default”
pathway(322). Panel B, shows serial progression of active Wnt signaling During fetal thymus
development observed in our study.
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CHAPTER 6
CONCLUSION
This current study is mainly motivated by the works of Osada et al.2013 and Krause et al.
2001. Recently it has come to light that adult stem cell populations can overcome tissue and lineage
barriers and differentiate into several other cell types(8, 149). Adult bone marrow cells are among
the most prominent examples of the new plasticity apparent in adult stem cells. Adult bone marrow
cells have been shown to contribute to the skeletal muscle(284), cardiac muscle(165), skin
epithelial cells(178), hepatocytes(156, 157), lung epithelial cells (183, 276), epithelial cells of the
GI tract(176), renal tubular epithelial cells (186), the endometrium of the uterus(155), endocrine
cells of the pancreas(184) and cells of the central nervous system(192). Even though the thymus
is epithelial tissue, no previous studies were performed to understand whether the BM-derived
stem cell population could contribute to the thymic epithelial cell populations.
Previous studies have demonstrated that the adult thymus maintains either bi-potent or
unipotent thymic epithelial progenitor cell populations. But interestingly, none of these studies
came to a consensus about the phenotype of the adult thymic epithelial progenitor population.
That’s why the identification of TEPCs represents an exciting field of research. While looking for
the TEPCs, all the previous studies limited their search to the CD45-EpCAM+ population;
however, in the current study, we explored the CD45+ populations of thymic stroma and BM as a
potential source for TEPCs.
This study identified a unique postnatal bone marrow population that can migrate to the
thymus and contribute to the non-hematopoietic component of thymic stroma, including TECs.
This population is also present in the adult thymus and expresses both the pan-hematopoietic cell
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marker, CD45, and the definitive thymic epithelial cell marker, EpCAM. IHC and qRT-PCR
analysis done with a highly pure CD45+EpCAM+ population from bone marrow and thymus
revealed that this population truly expresses both the markers. No expression of CD11c at both
the mRNA and protein levels in these populations confirmed that they are not thymic nurse cells
or thymic DCs as previously reported (50) or an artifact derived from enzymatic dissociation of
closely associated TECs and thymocytes. Additional qRT-PCR and FACS analysis showed that
both BM-derived and thymus-derived CD45+EpCAM+ populations express FSP1 in both mRNA
and protein levels. We also demonstrated that this unique population is present in the fetal thymus
during embryogenesis.
Our study challenged the established dogma of thymus development by demonstrating that
the CD45+EpCAM+ population from the periphery can migrate to the thymus and contribute to
the thymic epithelial cell pool. This data also revealed that a peripheral cell population could
differentiate into cortical and medullary thymic epithelial cells. Additionally, we confirmed that
the BM-derived CD45+EpCAM+ cells could migrate to the injured thymus and contribute to the
thymic stroma by injecting the CD45+EpCAM+ cells population into partially irradiated C57BL6
mice. The CD45+EpCAM population can contribute to the pan-keratin and FoxN1 expressing TEC
population and FSP1 expressing fibroblast population in a reaggregated thymic organ. The
CD45+EpCAM+ population appears to contribute to thymic stroma by directly giving rise to the
EpCAM and keratin expressing epithelial cells. FSP1 expression in these populations indicates
that these peripheral cells might be the source of FSP1 expressing fibroblasts in the thymic stroma.
A recent study has revealed FSP1 expressing fibroblasts support the maintenance of the medullary
thymic epithelial cell population(280). It is still not clear how the CD45+EpCAM+ population
differentiates into these two different cell lineages. Lineage relationships between the FSP1+ cells
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and the true keratin expressing TECs derived from the CD45+EpCAM+ population need to be
determined in future studies.
The CD45+EpCAM+ population is derived from the hematopoietic stem cells.
Interestingly, post-HSCT progressive time point analysis revealed an increased frequency of the
donor cells in the CD45+EpCAM+ population in the bone marrow and the thymus. This data
indicated more donor-derived HSC differentiated to the CD45+EpCAM+ population in the bone
marrow and successfully migrated to the thymus with a prolonged chase period. HSCT analysis
also revealed that the HSC derived cell population could contribute to the EpCAM+ population of
the thymic stroma. It will be important to analyze earlier time-points to observe if the HSC
population differentiates into the CD45+EpCAM+ population, leading to the recovery of the
CD45+EpCAM+ pool of the bone marrow and then migrate towards the thymus, or if they migrate
towards the injured thymus first and contributes to thymic recovery following radiation damage.
Frequency analysis of the BM-derived and the thymus-derived populations at different time
points revealed that, like the HSC population, the BM-derived CD45+EpCAM+ population
increases in number with progressive age. However, analysis of the thymic CD45+EpCAM+
population revealed a decrease in number with progressive age. These results might be caused by
the loss of differentiation and migration capacity of this population due to aging. It is possible that
the decline in the CD4+EpCAM+ cells may contribute to age-associated thymic involution. Our
study also revealed that in the castration induced regenerated thymus, the CD45+EpCAM+
population increases in frequency while the frequency of the same population decreases in the
bone marrow. This result indicates that even though the bone marrow-derived CD45+EpCAM+
population gradually decreases their homing capacity due to aging, castration induces this cell
population to migrate towards the thymus again to contribute to the thymic recovery.
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Next, it was important to understand if this population expresses the same set of surface
markers that are were used to define thymic stem cells by Osada et al.2013 (6). Our data showed
that both the BM-derived and thymus-derived CD45+EpCAM+ cell populations express Sca1,
CD49f, and CD29. This result hypothesized that the adult TEPC population identified by Osada et
al. 2013 could be a downstream population derived from the CD45+EpCAM+ population. Our
data also revealed that with progressive age, the CD49f and CD29 expression decreases in the
thymus. Loss of these stem cell markers likely correlates with a reduced capacity to differentiate
and augment thymic involution. We also observed a significant loss of CD49f and CD29
expression in this population following castration induced recovery of the thymus. This set of
results indicates that castration induces migration of CD45+EpCAM+ from the bone marrow to
the thymus, which results in a higher frequency of CD45+EpCAM+ cells in the thymic stroma. It
is possible, further loss of CD49f expression in the recovered thymus is responsible for the
transient recovery of the thymic epithelial cellularity. Another possibility is that as these cells are
induced for the thymic recovery, they lose CD49f and CD29 expression to leave the stem cell
niche and differentiate into the thymic epithelial cell pool.
Chemokine and chemokine receptor analysis of both the BM-derived and thymus-derived
CD45+EpCAM+ population expresses CCR7, CCR 9, and CCR10 chemokine receptors as well
as the chemokine ligands CXCL12, CCL20, and CCL22. Expression of CCR7 and CCR9 indicated
this cell population might use the same chemokine receptor-ligand axis as used by T-cell
progenitors to migrate to the thymus. CCR10 is also involved in cell mobilization in response to
injury. Future studies will analyze how this chemokine ligand and chemokine receptor expression
pattern of the CD45+EpCAM+ changes with progressive age. In the future, particular chemokine
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ligand knock-out mice can be used to determine which ligand-receptor pair is essential for
migration CD45+EpCAM+ population.
This study essentially revealed the potential role of hematopoietic stem cells in the
maintenance of the thymic epithelial microenvironment. The role of Wnt signaling in the
maintenance of quiescence and pluripotency of HSC in the bone marrow is well established (325).
Previous studies also confirm the role of Wnt signaling in T-cell development (325) and
maintenance of the thymic microenvironment (4). The role of canonical Wnt signaling in the
maintenance of the adult thymus (5, 6) and the degeneration of the aged thymus (7) is well
documented. Still, it is not clear if Wnt signaling plays any role in the TEC development. As we
explore the new avenue of research, which indicates the role of HSC in the maintenance of the
thymic microenvironment, it is important to understand the characteristics of Wnt signaling in the
thymic stroma. So as a secondary line of research, we also focused on characterizing what cells
were undergoing Wnt signaling in the fetal thymic stroma. Our study showed that the fetal thymic
epithelial cells undergo active Wnt signaling. This data sets up a roadmap of TEC development
and Wnt signaling dependency. Future studies need to analyze active Wnt signaling in TEC
populations to understand which Wnt ligands are being expressed in each thymic epithelial
population. Knockout mice of those active Wnt ligands can demonstrate their role in TEC
development. It is important to note that the regenerated thymus' Wnt signaling data showed that
this signal transduction pathway is upregulated in the TECs of the regenerated thymus. Taking this
data set and our CD45+EpCAM+ population analysis of the regenerated thymus, we hypothesized
that castration induces upregulation of the Wnt signaling in the regenerating thymus, which
induces migration of the CD45+EpCAM+ population of bone marrow to the thymus to contribute
to the thymic recovery. But as this population loses its stem cell-like properties with progressive
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age, this thymic recovery is not permanent.

Preliminary analysis of fetal thymic stroma has

revealed that a small number of fetal CD45+EpCAM undergo active Wnt signaling throughout
embryogenesis. We need to link these two studies together and investigate CD45+EpCAM+ cells
undergoing active Wnt signaling for further studies. We need to understand if the fetal
CD45+EpCAM+ population expresses the same Wnt ligands expressed by fetal TECs. It is also
important to understand if the adult CD45+EpCAM+ population also undergoes active Wnt
signaling. This study can demystify the elusive relation between Wnt signaling and TEPC
development.
In summary, this study demonstrates that the bone marrow-derived population expressing
both CD45 and EpCAM can migrate and contribute to the thymic stroma and can give rise to two
different non-hematopoietic cell populations there, including both FSP1-expressing fibroblasts and
keratin/FoxN1- expressing TECs under the condition of demand. The CD45+EpCAM+ population
is HSC derived unique stem cell-like population express several chemokine ligand and receptor,
which are probably necessary for its migration towards thymus. With advanced age, both thymic
and bone CD45+EpCAM+ population lose their stem cell-like properties. Loss of stem cell-like
properties of these populations might be why even after this population is present, the thymus still
undergoes age-related involution, and the thymic reconstitution is transient. This population is
mobilized in response to radiation-induced thymic tissue injury, and castration induces thymic
microenvironment repair of the aged thymus. These results indicate that the CD45+EpCAM+
population may play an important role in thymic tissue repair. This hypothesis is parallel to the
finding of many other bone marrow plasticity studies. It was demonstrated that the BM-derived
cells are only mobilized in response to tissue injury to contribute to the tissue repair. Further
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analysis of this population is necessary to understand if this population can migrate to other
epithelial organs and contribute to other tissue maintenance.
Although a progenitor cell population is present in BM that can contribute to TECs, the
thymus still undergoes age-related involution. Understanding mechanisms responsible for the
migration of the BM-derive CD45+EpCAM+ population to the thymus and how they contribute
to TEC maintenance will be critical in counteracting age-associated involution, particularly cancer
patients' enhanced degeneration in response to therapy. It should provide an additional target for
overcoming thymic atrophy and developing more strategic treatments for immunological-based
diseases and cancer.
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